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 Preface  
The main task of the Nordic Expert Group for Criteria Documentation of Health 
Risks from Chemicals (NEG) is to produce criteria documents to be used by the 
regulatory authorities as the scientific basis for setting occupational exposure 
limits for chemical substances. For each document, NEG appoints one or several 
authors. An evaluation is made of all relevant published, peer-reviewed original 
literature found. The document aims at establishing dose-response/dose-effect 
relationships and defining a critical effect. No numerical values for occupational 
exposure limits are proposed. Whereas NEG adopts the document by consensus 
procedures, thereby granting the quality and conclusions, the authors are 
responsible for the factual content of the document. 
The present document on Occupational exposure to chemicals and hearing 
impairment was developed within an agreement between the United States, 
National Institute for Occupational Safety and Health (NIOSH)1 and NEG.  
The evaluation of the literature and the drafting of the document were done by  
Dr. Ann-Christin Johnson, Karolinska Institutet, Sweden and Dr. Thais C. Morata, 
NIOSH. The draft versions were discussed within NEG and the final version was 
accepted by the present NEG experts on December 15, 2009. Editorial work and 
technical editing were performed by the NEG secretariat. The following present 
and former experts participated in the elaboration of the document: 
Present NEG experts  
Gunnar Johanson   Institute of Environmental Medicine, Karolinska Institutet, Sweden 
Kristina Kjærheim  Cancer Registry of Norway 
Anne Thoustrup Saber  National Research Centre for the Working Environment, Denmark 
Tiina Santonen   Finnish Institute of Occupational Health, Finland 
Vidar Skaug    National Institute of Occupational Health, Norway  
Mattias Öberg  Institute of Environmental Medicine, Karolinska Institutet, Sweden 
Former NEG experts  
Maria Albin   Department of Occupational and Environmental Medicine,  
Lund University Hospital, Sweden 
Vidir Kristjansson  Administration of Occupational Safety and Health, Iceland 
Kai Savolainen  Finnish Institute of Occupational Health, Finland 
Karin Sørig Hougaard   National Research Centre for the Working Environment, Denmark 
NEG secretariat  
Jill Järnberg and  
Anna-Karin Alexandrie  
Swedish Work Environment Authority, Sweden 
This work was financially supported by the Swedish Work Environment 
Authority, the former Swedish National Institute for Working Life, and the 
Norwegian Ministry of Labour. 
All criteria documents produced by the Nordic Expert Group may be down-
loaded from www.nordicexpertgroup.org. 
Gunnar Johanson, Chairman of NEG John Howard, M.D. Director, NIOSH 
                                                 
1
 Disclaimer: The findings and conclusions in this document are those of the authors and NEG. 
They do not necessarily represent the views of US NIOSH. 
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Abbreviations and acronyms  
ACGIH American Conference of Governmental Industrial Hygienists 
CI confidence interval 
CRA cortical response audiometry  
CYP cytochrome P450 
dB 1 decibel 
dBHL decibel hearing level 
EPA Environmental Protection Agency 
EU European Union 
HI 1 hazard index (also called hygienic effect or additive effect) 
Hz 1 Hertz 
Leq 1 equivalent sound pressure level 
LOAEL lowest observed adverse effect level 
MA mandelic acid 
NIOSH National Institute for Occupational Safety and Health 
NOAEL no observed adverse effect level 
OEL occupational exposure limit 
OR odds ratio 
OSHA Occupational Safety and Health Administration 
PCB polychlorinated biphenyl 
PGA phenylglyoxylic acid 
REL recommended exposure level 
ROS reactive oxygen species 
SCOEL Scientific Committee on Occupational Exposure Limits 
SPL 1 sound pressure level 
SD standard deviation 
TEOAE transient evoked otoacoustic emissions 
TWA 1 time-weighted average 
US United States 
WEI work-life exposure index 
WHO World Health Organization 
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 See also “Terms as used in this document” (next page). 
 
  
Terms as used in this document 
Action level  
A guideline used by many international occupational health bodies to express the 
level of a harmful or toxic substance/activity which requires medical surveillance, 
increased industrial hygiene monitoring or biological monitoring. For chemicals,  
it is usually 50 % of the occupational exposure limit. For noise, it indicates the 
sound level which, when reached or exceeded, necessitates implementation of 
activities to reduce the risk of noise-induced hearing loss. The new European noise 
directive has two exposure action levels (See Section 2.3).  
 
Continuous noise 
Noise of a constant level as measured over at least one second using the “slow” 
setting on a sound level meter. Note that a noise which is intermittent, e.g. on for 
over a second and then off for a period, would be both variable and continuous. 
 
Decibel (dB)  
A dimensionless unit expressing the relative loudness (intensity) of sound on a 
logarithmic scale. The decibel was named after Alexander Graham Bell.  
A-weighted decibels, dBA or dB(A). A-weighting is the most commonly used  
of a family of curves defined in various standards relating to the measurement of 
perceived loudness, as opposed to actual sound intensity. The others are B, C and 
D-weighting (for dBB, dBC and dBD). The A-weighting is the most used in noise 
measurements since its corrections are aimed to replicate the sensitivity of the 
average human ear to sound at different frequencies. 
 
Equivalent sound pressure level (Leq) 
The steady sound level that, over a specified period of time, would produce  
the same energy equivalence as the fluctuating sound level actually occurring. 
Occupational exposure limits for a hazard expressed as an 8-hour time-weighted 
average value includes the total exposure during a shift exposure. For noise, a 
single number gives the value in decibels that represents the equivalent average 
level of the actual changing noise levels. When the exchange rate (see below) of  
3 dB is used in this calculation, the average noise level is called the Leq. 
 
Exchange rate 
The amount of decrease (or increase) in noise level which would allow doubling 
(or require halving) of the exposure time in order to have the same risk. The 3-dB 
exchange rate is also known as the “equal-energy” exchange rate because the equi-
valent acoustic energy is preserved when the sound level changes by 3 dB and the 
exposure duration changes by a corresponding factor of 2. Most countries use a 3-
dB exchange rate, thus, if the intensity of an exposure increases by 3 dB, the dose 
doubles or the allowable time is halved.  
 
  
Hazardous noise 
Any sound for which any combination of frequency, intensity or duration is 
capable of causing permanent hearing loss in a specified population. 
 
Hazard Index (HI) 
A single chemical hazard index (also called hygienic or additive effect) is the ratio 
of a hazardous air pollutant concentration divided by its reference concentration, 
or safe exposure level. If this “hazard index” exceeds one, people are exposed to 
levels of that substance that may pose health risks. A cumulative hazard index  
or total hazard index is the result of the summation of the hazard quotients for  
all chemicals to which an individual is exposed. It is calculated according to the 
formula HI = C1/T1 + C2/T2 + C3/T3 … where C1, C2, C3, etc. are the measured 
exposure levels of the different agents, and T1, T2, T3, etc. are the individual 
occupational exposure limits of the corresponding agent. If the hazard index 
exceeds 1, the total exposure load is considered excessive. 
 
Hearing loss 
Hearing loss is often characterised by the area of the auditory system responsible 
for the loss. For example, when injury or a medical condition affects the outer or 
middle ear (i.e. from the pinna, ear canal and ear drum to the cavity behind the ear 
drum - which includes the ossicles) the resulting hearing loss is referred to as a 
conductive hearing loss. When an injury or medical condition affects the inner ear 
or the auditory nerve that connects the inner ear to the brain (i.e. the cochlea and 
the vestibulo-cochlear nerve) the resulting hearing loss is referred to as a sensori-
neural loss. Because noise can damage the hair cells located in the cochlea, it 
causes a sensorineural hearing loss (see also Section 3.1). Hearing loss that results 
from damage or impairment to the central nervous system, especially the brain 
itself, is called central hearing loss. Unless stated otherwise, hearing loss means 
sensorineural hearing loss in this document. 
Mid- and high-frequency hearing loss. Hearing loss can be defined by audio-
metric frequency bands, but these definitions are species specific. In humans, the 
terms mid- and high-frequency hearing loss, refer to hearing losses affecting 
frequencies at 1-3 kHz and above 3 kHz, respectively. In rats, high-frequency 
hearing loss is usually defined as affecting frequencies above 16 kHz, whereas a 
hearing loss at 4 -12 kHz is considered as a mid-frequency hearing loss. Other 
animal models may have other definitions depending on the hearing frequency 
range of that particular species. 
 
Hearing threshold level 
The hearing level, above a reference value, at which a specified sound or tone is 
heard by an ear in a specified fraction of the trials. It corresponds to the minimum 
sound level of a pure tone that an ear can hear. The International Organization for 
Standardization (ISO) specifies in ISO 389 a standard reference zero dB for the 
scale of hearing threshold level applicable to air conduction audiometers, which 
  
corresponds to the threshold of hearing in the mid-frequencies for young adults. 
Audiometric zero was determined by the average hearing of young adults who 
have never been exposed to loud noise or suffered ear disease or injury. However, 
in the clinic, because people differ considerably in their hearing, hearing thresholds 
up to 25 dB are considered to be in the normal range.  
 
Hertz (Hz) 
The Hertz is a unit of frequency. One Hertz simply means one cycle per second 
(typically what is being counted is a complete cycle). Hertz can be prefixed and 
commonly used multiples are kHz (kilohertz), MHz (megahertz), etc. The frequency 
range for human hearing lies between approximately 20 and 20 000 Hz. The sen-
sitivity of the human ear drops off sharply below about 500 Hz and above 4 000 
Hz. Different animal species have different hearing frequency ranges. Guinea pigs 
have the same frequency range as humans (20 Hz-20 kHz), whereas rats hear 
between 500 Hz and 40 kHz. Bats can hear above 100 kHz.  
 
Noise 
Any unwanted sound. 
 
Noise dose  
The noise exposure expressed as a percentage of the allowable daily exposure.  
If 85 dBA is the maximum permissible level, an 8-hour exposure to a continuous 
85-dBA noise would equal a 100 % dose. If a 3-dB exchange rate is used in con-
junction with an 85-dBA maximum permissible level, a 50 % dose would equal a 
2-hour exposure to 88 dBA or an 8-hour exposure to 82 dBA. 
 
Noise-induced hearing loss 
A sensorineural hearing loss attributed to noise exposure, bilaterally symmetrical 
and often irreversible. In humans, it has its onset in the frequency range between  
3 and 6 kHz and for which no other aetiology can be determined. 
 
Ototoxic  
A term typically associated with drugs or other substances that are toxic to audi-
tory and/or vestibular systems, affecting the senses of hearing and/or balance. 
 
Ototraumatic  
A broader term than the term ototoxic. As used in hearing loss prevention, 
ototraumatic refers to the potential of an agent (e.g. noise, drugs or industrial 
chemicals) to cause permanent hearing loss subsequent to acute or prolonged 
exposure. 
 
Sound pressure level (SPL) 
A measure of the ratio of the pressure of a sound wave relative to a reference 
sound pressure. Sound pressure level in decibels is typically referenced to 20 mPa. 
  
When used alone (e.g. 90 dB SPL), a given decibel level implies an unweighted 
sound pressure level.  
 
Time-weighted average (TWA) concerning noise 
A normalised 8-hour average sound level expressed in dBA which is computed  
so that the resulting average would be equivalent to an exposure resulting from  
a constant noise level over an 8-hour period. 
 
Tinnitus 
Tinnitus is a perception of sound that has no external source. It is normal for 
almost all people to perceive a transient noise in the ear either spontaneously  
or associated with temporary hearing loss after exposure to loud noise. These 
temporary auditory sensations are reversible and resolved after a few minutes.  
For a sound without an external source to be defined as tinnitus it has to last at 
least 5 minutes per day more than once a week. For most patients with tinnitus,  
the internal sound is constantly present. The prevalence of tinnitus is 10-15 %  
in adult populations.  
Tinnitus is often associated with noise exposure and hearing loss and usually  
of neurophysiological origin. Tinnitus can also be generated by vascular, muscular 
or teeth disorders. Another underlying cause of tinnitus is depressive disorders. 
Whatever the cause of tinnitus is, signals are processed in the central auditory 
system and perceived as a sound. 
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1. Introduction and problem identification 
Noise is often present in occupational settings where also chemical exposures 
occur. As a consequence, hearing disorders observed in several occupations are 
often attributed to noise exposure alone and not much consideration, if any, is 
given to the possibility of involvement of other agents. The term occupational or 
work-related hearing loss has been used as a synonym for noise-induced hearing 
loss, which may not be accurate. Current standard hearing conservation practices 
do not take into account the potential risk to hearing posed by chemical exposures.  
Before the 1980s, no research programme had systematically focused on chemical- 
induced hearing loss and only isolated studies reported such effects. This scenario 
started changing following reports from groups dedicated to investigations of the 
neurotoxic properties of chemicals (309). Since then, progress has been consider-
able towards understanding the effects of certain environmental and occupational 
chemicals on the auditory system and their interactions with noise (62, 121, 208, 
225, 229, 251, 257, 351). 
Chemicals such as organic solvents, metals and asphyxiants are known for their 
neurotoxic effects on both the central and peripheral nervous systems. Researchers 
therefore hypothesised that these agents could injure the sensory cells and peripheral 
nerve endings of the cochlea (23). A more central effect on the auditory system could 
also be expected due to the general neurotoxicity of these classes of chemicals.  
A 20-year longitudinal study of hearing sensitivity in 319 employees revealed 
that a large proportion of the workers in the chemical division showed a hearing 
loss severe enough to be regarded and compensated as a work-related hearing loss 
(23 %) as compared to groups working in non-chemical environments (5-8 %). 
This effect was found despite the lower noise levels in the chemical division  
(80-90 dBA) when compared to the other divisions (95-100 dBA). Thus, the 
exposure to industrial solvents was suggested as an additional causative factor  
for the observed hearing losses (30). 
Since the early 1980s, a few research groups began investigating the ototoxic 
properties of chemical agents systematically, and ototoxic properties have been 
identified among metals, solvents, asphyxiants, organotins, nitriles, polychlori-
nated biphenyls (PCBs) and pesticides. It has also been shown that if these 
chemicals occur in sufficiently high concentrations, hearing may be affected 
despite the lack of exposure to noise. Increased prevalence of hearing loss has 
been reported following occupational as well as environmental exposures, in-
cluding ingestion of contaminated fish and water and environmental exposures  
to lead or mercury. Reports on the auditory effects of exposures to chemicals  
in the (outdoor) environment as well as reports on intentional or accidental 
inhalation are not included in this document.  
The objective of the present document is to describe the currently available 
evidence regarding exposure to chemicals found in the workplace and their 
auditory effects. No observed adverse effect levels (NOAELs) and lowest 
observed adverse effect levels (LOAELs) in this document relate to effects  
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on hearing if not stated otherwise and may thus be lower for other end-points. 
When chemical exposure at a certain level does not potentiate noise-induced 
hearing loss, that level is regarded as the NOAEL for the combined exposure to 
the chemical and noise.  
2. Occurrence of occupational hearing loss 
2.1 Estimates of noise-exposed working population 
It is difficult to estimate the number of workers exposed to potentially hazardous 
noise in the Nordic countries, in Europe and in the world. Most scientific studies 
focus on noise levels from different workplaces or economic sectors. To get an 
overall picture from different countries or regions, self-report questionnaire 
surveys are often used. In the year 2000, such surveys were collected in the 15 
European Union (EU) member states (EU-15) and in 2001 in the 9 member states 
(EU-9) that joined the EU in 2004. The results from the questions on noise ex-
posure at work from these surveys were published by the European Agency for 
Safety and Health at Work (104). Self-estimated noise levels were based on 
assumptions like “if it is necessary to shout to converse with someone 2 metres 
away in the workplace, noise levels are potentially hazardous”. The surveys showed 
that in the year 2000, about one third of the working population in Europe (29 % 
in EU-15 and 35 % in EU-9) was exposed to hearing damaging noise at least 25 % 
of their work time. The figures for all day exposures were 11 % for EU-15 and 
15 % for EU-9. The figures from EU-15 were similar for Denmark and Finland, 
the two Nordic countries whose data appear in the report. The Statistics Norway 
estimated the percentage of the working population exposed to damaging noise  
for most of their working hours to be 7 % (354). The latest Swedish work environ-
ment survey showed that 30 and 15 % of the men and women, respectively, were 
exposed to noise that made conversation impossible more than 25 % of their work 
shift (self-estimated figures) (360).  
In a recent publication, the proportion of the global population exposed to 
occupational noise was estimated (274). The calculations were performed using 
data from the United States (US) National Institute for Occupational Safety and 
Health (NIOSH) (282). Between 1981 and 1989, NIOSH conducted nationwide 
surveys in which inspectors visited and conducted measurements on various 
workplaces in the US. These surveys provided the basis for an estimation of the 
proportion of workers exposed to noise above 85 dBA. The data suggest that 12 % 
of service workers, 20 % of fishermen, agriculture and forestry workers, 18-22 % 
of construction and manufacturing workers and 85 % of workers in the mining 
industry were commonly exposed to noise levels above 85 dBA during working 
hours. Nelson et al (274) combined these data with several scientific studies of 
occupational noise exposure from third world countries and adjusted the values  
by the distribution of work force in different occupational settings and regions of 
the world according to a method established by the World Health Organization 
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(WHO) (275). Since the noise levels in third world countries according to the 
cited studies were higher than those in the US data, the proportions of exposed 
workers were estimated to be higher in regions outside the developed countries 
even when the criterion of noise-induced hearing loss was set to > 41 dB (274).  
2.2 Estimates of noise-induced hearing loss 
In Europe, 4 068 cases of noise-induced hearing loss were recognised as an 
occupational disease in 2001 in ten of the member states. Extrapolation of these 
data to EU-15 makes 6 700 cases per year (188). Thus, noise-induced hearing loss 
is the 4th most common recognised occupational injury in Europe. The total pre-
valence is approximately 4.7 in 100 000 workers. This is not an exact figure of the 
prevalence since the European countries have different criteria for recognising and 
reporting occupational diseases. In Sweden, the number of recognised occupational 
noise-induced hearing loss cases has been around 1 200 each year during the late 
1990s. This is about 7 % of the total number of occupational diseases and makes 
noise-induced hearing loss the 4th most common occupational condition in Sweden 
(361, 363, 364). Approximately the same figures appear in the other Nordic 
countries. In Denmark, around 400 cases are recognised annually (367) and in 
Finland, 800 cases (188).  
Nelson et al estimated that the prevalence of noise-induced hearing loss (> 41 
dB) attributable to occupational exposure in the world was 16 % of the work force 
(22 % in males and 11 % in females, all ages and regions) ranging from 9 % in 
Europe and the US to 18-19 % in Africa and South East Asia. The highest pre-
valences were found in the age groups between 15 to 30 years, in the eastern 
European countries, countries from the former Soviet Union, China and South 
East Asia (274). 
2.3 Regulations for noise exposure in Europe 
In 2003, the EU passed a new noise directive concerning noise exposure at work-
places (108). In summary, two exposure action levels and one exposure limit level 
were given. The lower exposure action level is 80 dBA Leq8h (time-weighted 
average (TWA) of the noise exposure levels for a nominal 8-hour working day). 
At this level, workers are entitled to a hearing test and to information about 
hearing conservation and the risk of hearing loss. Hearing protection should be 
provided on demand. The upper exposure action level is 85 dBA Leq8h at which 
technical measures to reduce noise exposure and hearing conservation programmes 
including obligatory use of hearing protection should be implemented. The ex-
posure limit value is 87 dBA Leq8h measured inside the hearing protectors. The 
directive indicates that this value must not be exceeded under any circumstances. 
According to the new EU directive, the employer is obligated to give particular 
attention to any effects on workers’ health and safety due to interactions between 
noise and work-related ototoxic substances, and between noise and vibrations 
(108).  
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The EU directive has been implemented in Finland (289). The new directive 
was taken also in Denmark (83), Sweden (362) and Norway (285), but in these 
countries the old threshold limit value of 85 dBA Leq8h was kept. 
3. Definitions 
In this session, general descriptions are given on hearing loss, the effects of noise 
and ototoxic substances. 
Abbreviations used and the definitions of terms used in the document are found 
at the beginning of the document. Descriptions of methods used to assess auditory 
effects are presented in Chapter 4. 
3.1 Hearing loss 
The sense of hearing is essential for communication between people and hearing 
loss is a common handicap that can severely affect the well-being of the individual. 
The physiology of hearing is rather complex and it is not within the scope of this 
review to explain that mechanism. However, for clarity, it is necessary to mention 
some aspects of hearing physiology. The inner ear houses the cochlea (Figure 1), 
the structure responsible for the conversion of the physical sound waves of 
different frequencies and different amplitudes into electrical nerve signals. The 
cochlea is tonotopically organised, which means that sounds of different fre-
quencies stimulate different regions of the cochlea. These regions are also con-
nected to different parts of the cochlear nerve. This tonotopic organisation is pre-
sent also in the different nuclei in the brainstem, as well as in the auditory cortex 
in the central nervous system where the nerve signals are perceived.  
Hearing loss can be divided in conductive hearing loss and sensorineural 
hearing loss (92). Conductive hearing loss is the impairment of the sound con-
duction on the way to the inner ear. Sensorineural hearing loss is defined as 
hearing loss caused by changes in the cochlea, the auditory nerve or the auditory 
nervous system. Hearing loss that results from damage or impairment to the 
central nervous system, especially the brain itself, are sometimes also referred to 
as central hearing loss. The sensorineural hearing loss may affect only certain 
frequency regions of our hearing due to the tonotopical organisation of the hearing 
system. Unless stated otherwise, hearing loss means sensorineural hearing loss  
in this document. If the impairment affects only the auditory nerves or the brain 
itself, we refer to it as a central hearing loss. The most common form of sensori-
neural hearing loss involves structural effects in the cochlea. Cochlear hearing loss 
is mostly caused by an injury to the outer hair cells of the cochlea. This damage 
usually develops gradually and starts at the high frequencies of hearing from where 
it progresses towards the lower frequencies. 
Age-related changes and exposure to noise are the most common causes of 
damage to cochlear hair cells. Sensorineural hearing loss may also be hereditary,  
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Figure 1. Overview and details of the anatomy in the inner ear. 
 
either manifested as complete deafness or as a gradual deterioration during early 
life. Hearing loss may be caused by diseases such as Menière’s disease or by viral 
infections that affect the auditory nerve. Damage to the auditory nervous system 
may also happen as a consequence of a benign or non-cancerous growth that arises 
from the vestibulo-cochlear nerve (called acoustic neuroma, neurinoma or vesti-
bular schwannoma (270). 
Even if ageing and noise exposure are the most common causes, several other 
factors such as exposure to ototoxic substances may also cause hearing loss. The 
hearing loss caused by noise can be potentiated or additive to the effects caused by 
exposure to e.g. chemical agents. 
3.2 Noise 
Sound is a prerequisite for oral communication between people and it provides  
us with many pleasant experiences that are essential to our well-being. However, 
sound can also disturb our work, sleep and communication, cause annoyance and 
even damage our physical health. Unwanted, unpleasant or loud sound is defined 
as noise (Cambridge advanced learner’s dictionary). When sound is measured at 
workplaces, an assessment is made of its potential effects on humans. These 
effects include elevated blood pressure, annoyance, disturbed performance, stress, 
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speech interference and tinnitus but the far best documented health effect of loud 
sounds is irreversible hearing damage, i.e. noise-induced hearing loss (381).  
The damaging properties of noise exposure to hearing depend partly on the 
characteristics of the sound reaching the sensory structures in the inner ear of  
the person exposed. However, a great variation in individual susceptibility exists. 
The characteristics of noise considered as critical are the intensity (Figure 2), 
usually measured as sound pressure level (SPL) in decibels (dB, a logarithmic 
measurement unit that describes a sound’s relative loudness), sound spectrum 
(distribution of sound energy by frequency), duration and temporal distribution 
during a typical workday, and the expected cumulative exposure over a given 
duration of days, weeks or years (1). 
The variability in susceptibility to noise-induced hearing loss may be due to 
both endogenous and exogenous factors. Among the endogenous factors that have 
been shown to influence the degree of hearing loss, genetic factors, health status, 
and physical characteristics of the ear should be mentioned. Exogenous factors, in 
addition to noise and ototoxic drugs and chemicals that are the main subject of this 
review, are e.g. vibrations and smoking (314, 372). Also physical exercise has 
been shown to increase the susceptibility to noise (87, 224). 
In some environments, in particular at work, noise can reach damaging levels to 
the ear. With 10 or more years of noise exposure, 8 % of the workers exposed to 
85 dBA, 22 % of the workers exposed to 90 dBA, 38 % of the workers exposed to 
95 dBA and 44 % of those exposed to 100 dBA are estimated to develop hearing 
 
 
Figure 2. The principle of equal energy. If the permissible noise level of 85 dB is 
allowed for 8 hours, then the double noise level 85 + 3 dB = 88 dB can be allowed  
for 4 hours, etc. The principle is described in ISO 1999:1990 (175). 
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Figure 3. Calculated percentages of the population at risk for developing noise-induced 
hearing loss at different exposure levels and exposure time in years. Calculations made 
according to ISO 1999:1990 (175). 
impairment (302). The population at risk can also be calculated according to the 
International Organization for Standardization (ISO) who describes a practical 
relation of occupational noise exposure (dBA) and an estimation of the percentage 
of personnel at risk for a noise-induced hearing loss (≥ 25 dB, averaged from 0.5, 
1 and 2 kHz) based on duration of exposure within a normal 40-hour working 
week (Figure 3) (175). 
Noise-induced hearing loss is a specific condition with established symptoms 
and objective findings (21, 337). It is an irreversible hearing loss, often bilateral 
and sensorineural with damage mainly to the cells in the peripheral auditory organ, 
which are responsible for transforming the sound waves into neural signals. Noise-
induced hearing loss develops gradually after a long period (8-10 years) of ex-
posure to intense levels of noise. This means exposure to continuous noise levels 
greater than 85 dBA for 8 hours/day or exposure to impact noise (a noise that 
arises as the result of the impact between two objects), even if for shorter periods, 
sufficient to cause the degree and pattern of hearing loss found in pure-tone audio-
metry. The results are displayed as an audiogram. An audiogram indicates the 
individual’s hearing detection thresholds. The results are given in decibels, which 
indicate the intensity, or how loud a sound has to be for the listener to be able to 
detect it. Thresholds up to 20-25 decibel hearing level (dBHL) are considered as 
normal. Several frequencies are tested. Frequency determines the pitch of a sound. 
Noise-induced hearing loss is usually not a profound hearing loss but may reach 
up to 75 dBHL in the higher frequencies such as 4 and 6 kHz and up to 40 dBHL 
in the lower frequencies of 1 and 2 kHz. An example audiogram of noise-induced 
hearing loss is shown in Figure 4. 
 
Exposure level (dBA) 
Exposure time (years) 
% risk 
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Figure 4. Typical audiogram showing a noise-induced hearing loss.  
A noise-induced hearing loss usually develops most rapidly during the first 6-10 
years of exposure, and the rate of loss decreases as hearing thresholds increase, in 
contrast to age-related loss. In a noise-exposed population, a marked individual 
variability is seen within groups exposed to the same noise levels regardless of age 
differences. A common scientific opinion is that hearing loss due to noise exposure 
should not continue to progress if the patient is removed from noise exposure. 
There is however limited knowledge about how noise-induced hearing impairment 
is influenced by, or interacts with, age-related hearing impairment. In a recent in-
teresting animal study, Kujawa and Lieberman showed that mice exposed to noise 
at different ages (4-124 weeks) demonstrated differences in their sensitivity to 
noise exposure. The mice exposed when young acquired a larger hearing impair-
ment in comparison to elderly mice. Another finding was that when the young 
mice aged, and their hearing was measured between 8 and up to 96 weeks after the 
noise exposure, they had a more divergent and more severe age-related hearing 
loss than the non-noise exposed mice of the same age. According to the authors, 
the results show that sub-lethal changes caused by the noise exposure made the 
mice more sensitive to age-related hearing changes (198). 
The degree of hearing loss is usually defined by the average value of the 
audiometric measure dBHL for a range of frequencies (Table 1).  
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Table 1. The World Health Organization classification system for hearing impairment 
using the frequencies 0, 0.5, 1, 2 and 4 kHz and the audiometric values shown below (382). 
Grade of impairment Corresponding audiometric 
ISO value 
Performance 
Slight hearing impairment  26-40 dBHL Able to hear and repeat words 
spoken in normal voice at 1 metre. 
Moderate hearing impairment 41-60 dBHL Able to hear and repeat words 
spoken in raised voice at 1 metre. 
Severe hearing impairment 61-80 dBHL  Able to hear some words when 
shouted into better ear. 
Profound hearing impairment 
  ≥ 81 dBHL Unable to hear and understand 
even shouting. 
dBHL: decibel hearing level, ISO: the International Organization for Standardization. 
 
Many studies use slight impairment (26-40 dBHL) as a definition for noise-
induced hearing loss since early detection is essential to any preventive initiative. 
WHO uses moderate hearing impairment or worse (≥ 41 dBHL) as a definition for 
hearing loss since this is easier to detect in e.g. self-report studies (274). 
3.3 Ototoxicity 
Ototoxicity is a selective organ toxicity directed towards the inner ear. An ototoxic 
agent is defined as a drug or other chemical substance that causes functional im-
pairment or cellular damage in the inner ear, especially upon the end organs and 
neurons of hearing or balance, or the vestibulo-cochlear nerve.  
The mechanisms of action of ototoxic substances may involve the entire organ, 
specific cells within the organ, components of specific cells or individual bio-
chemical pathways. Drugs and other substances that alter hearing or equilibrium 
by acting primarily at the level of the brainstem or the central auditory pathways 
are considered to be neurotoxic and not strictly ototoxic (151, 370). In this docu-
ment we will, however, consider also some substances for which the mode of 
action is primarily neurotoxic but the functional adverse effect is hearing loss. 
Ototoxins are of interest in the work environment, not only because of their 
actions on the hearing system of man but also because they may interact with each 
other and with noise when exposure is combined (simultaneously or sequentially). 
It is well known that the effects of many drugs or agents when given concurrently 
cannot necessarily be predicted on the basis of their individual effects (264). In 
such instances, the damage incurred by agents acting together may exceed the 
simple summation of the damage each agent produces alone (166, 303). Since 
noise is the most common exposure that causes hearing loss in humans, special 
attention has been given to the combined exposure to noise and agents with 
ototoxic effects. 
The ototoxicity of therapeutic drugs has been a concern in the health field for  
a long time. In comparison, only since the 1980s has the ototoxicity of chemicals 
found as contaminants in air, food or water, and in the workplace become a con-
cern for health professionals and researchers. 
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Currently, the only hearing test required by the Organization for Economic 
Cooperation and Development (OECD) when a chemical is to enter the market  
is the qualitative assessment of the startle reflex (115 dB SPL click). This test  
is not sufficiently sensitive for the detection of ototoxicity (presented as an 
abstract) (235). For this reason, existing ototoxicity information is restricted to  
a limited number of substances. 
Chemicals with confirmed ototoxic properties and with some significance for 
the work environment and therefore within the scope of the present document are 
listed in Table 2. 
The classes of chemicals investigated as potential ototoxicants include organic 
solvents, heavy metals, nitriles, organotins, asphyxiants and pesticides. These 
chemicals have diverse structures suggesting a number of targets for injury within 
the auditory system and an array of possible underlying mechanisms (113). 
Among the solvents, primarily the aromatic solvents have been found to be 
ototoxic. Some aliphatic solvents like n-hexane and n-heptane have been shown  
to affect the auditory system (34, 286, 287, 344) but in these cases the effect is 
connected to the neurotoxicity of these solvents. Also carbon disulphide is known 
to be a neurotoxicant that affects the central auditory system (251, 323, 324). 
 
Table 2. Examples of substances confirmed to be ototoxic (36, 37, 253, 335, 338). 
Class of medicinal drug Examples 
Aminoglycoside antibiotics Streptomycin, dihydrostreptomycin, neomycin, 
amikacin, gentamicin, kanamycin, tobramycin, 
nentilmicin, sisomycin 
Other antibiotics Erythromycin, minocyclin 
Chemotherapeutics Cisplatin, carboplatin, mechloroethamine, vincristine, 
bleomycin, nitrogen mustard, vinblastine 
Diuretics Ethacrynic acid, furosemid, bumetanid, azoseamid, 
ozolinone 
Malaria prophylaxes Quinine, chloroquine 
Non-steroidal anti-inflammatory drugs Acetyl salicylic acid, ibuprofen, indomethacin, 
naproxen, phenylbutazone, sulindac 
Antimicrobials Chloramphenicol, colistin, erythromycin, 
minocycline, polymyxin B, vancomycin 
Chelating agents Deferoxamine 
Arsenicals Atoxyl, salvarsan 
Class of chemical Examples 
Organic solvents Styrene, toluene, p-xylene, ethylbenzene, chloro-
benzene, trichloroethylene, n-hexane, n-heptane, 
carbon disulphide, solvent mixtures  
Metals Lead, mercury, organotins 
Asphyxiants Carbon monoxide, hydrogen cyanide, acrylonitrile, 
3,3'-iminodipropionitrile  
Other substances Pesticides (organophosphates, paraquat, pyrethroids, 
hexachlorobenzene), polychlorinated biphenyls 
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4. Methods used to assess auditory effects  
4.1 Audiometry  
4.1.1 Pure-tone audiometry (PTA) 
Pure-tone audiometry is a clinical test used to determine a person’s hearing 
sensitivity at specific frequencies, i.e. the softest sound which can be perceived  
in a quiet environment. Most audiograms cover 0.125-8 kHz.  
Pure tones are played to a person via earphones to right and left ears separately. 
The test results are summarised in a curve, in a frequency continuum, in an audio-
gram (Figure 4). The reason pure-tone thresholds form the core of the hearing  
test battery is that these tones are easily generated, calibrated and controlled. 
Additionally, pure-tone audiometry, if performed properly, has a very high intra-
clinic and interclinic reliability (231). In several countries, workers who are 
exposed to noise levels above 85 dBA are required to have their hearing tested 
periodically by means of pure-tone air-conduction audiometry. Subjects must be 
tested in a room that meets the background noise requirements for audiometric 
testing environment. The equipment calibration records should be recent and 
available, and biologic calibration checks should also be performed everyday 
immediately before testing the subjects.  
4.1.2 High-frequency audiometry 
Pure-tone audiometry testing can be extended to include the frequencies of 10, 
12.5, 14 and 16 kHz, which is known as high-frequency audiometry. This pro-
cedure has been suggested to be an early indicator of hearing deficits following  
the administration of ototoxic drugs (111).  
4.1.3 Immittance audiometry  
This is a routine clinical audiology test. It consists of a physical volume test, 
tympanometry, static compliance, contra and ipsilateral acoustic reflex testing,  
and contralateral acoustic reflex decay testing. The main objective in performing 
immittance audiometry and middle ear compliance is to obtain information on  
the type of hearing loss and the site of lesion. 
4.1.4 Reflex modification audiometry (RMA) 
RMA is used in experimental animals to determine sensory detection thresholds by 
finding the lowest intensity sensory stimuli which modifies the amplitude of the 
acoustic startle reflex (392). Within each test chamber, a cage is mounted on a coil 
to which a magnet is attached (through the centre of the wire coil). Ballistic ver-
tical movements by the animals such as a startle response cause the magnet to 
move with the cage. This induces a voltage with the coil, which is proportional to 
cage velocity and, hence, to the amplitude of the startle response. The extent of 
such modification is related to the intensity of the initial low-intensity stimulus. A 
smooth function can be fitted illustrating the relationship between startle response 
amplitude and the intensity of the inhibiting stimulus. The resulting audiometric 
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curves closely approximate audiometric data obtained from traditional operant 
methods both in sensitivity and shape.  
4.1.5 Behavioural audiometry (BA) or conditioned avoidance response (CAR)  
This test can be used for multisensory stimuli. The animal is taught to pull or 
climb from the ceiling of the test chamber to avoid or escape a 1-mA shock on  
the grill floor (309). The aversive current is preceded by a pure-tone from the 
loudspeaker in the ceiling of the chamber. A response during the warning signal 
terminates the trial and is scored as a successful avoidance.  
4.2 Otoacoustic emissions 
Otoacoustic emissions are spontaneous or evoked acoustical signals that are 
produced by the cochlea and travel laterally out through the middle ear (190). 
Otoacoustic emission testing measures the reflection of sounds that are generated 
by the cochlear hair cells. These signals provide important objective information 
about the functional health of cochlear outer hair cells and can be analysed by 
placing a small microphone inside the ear canal. 
Otoacoustic emissions facilitate the differentiation between sensory and neural 
hearing disorders. They can be measured by presenting a series of very brief 
sounds (clicks or tones) to the ear through a probe that is inserted in the outer 
portion of the ear canal. The probe contains a loudspeaker that generates clicks 
and a microphone that measures the resulting sounds that are produced in the 
cochlea and are then reflected back through the middle ear into the outer ear canal. 
The resulting sound that is picked up by the microphone is digitised and pro-
cessed. If there is damage to the outer hair cells or problems with the eardrum  
or middle ear, the emissions will not be present. They are a sensitive measure  
of outer hair cell integrity and provide an indication of cochlear damage before 
hearing loss is observed. Transient (click) evoked otoacoustic emissions (TEOAE) 
and distortion product otoacoustic emissions (DPOAE) offer information on the 
status of the cochlea. The former provide an overview of cochlear function, while 
the latter provide frequency-specific data. Contralateral suppression of the TEOAE 
evaluates the auditory efferent function (239). 
4.3 Central auditory processing tests 
Tests that can be used to assess central auditory function fall into two categories, 
electrophysiological and behavioural tests. 
4.3.1 Electrophysiological tests  
Electrocochleography  
Cochlear and auditory nerve electrical activity can be recorded from electrodes 
advanced through the tympanic membrane and placed on the otic capsule. This 
method allows assessment of cochlear and auditory nerve function independent  
of the patient’s subjective response. Two electrical events are recorded from the 
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inner ear in response to sound: the cochlear microphonic (receptor) potential and 
the compound action potential of the auditory nerve. Distortion of the waveform 
of either of these potentials is an indication of inner ear disease. The cochlear 
microphonic is an alternating current signal recorded from the cochlea that exactly 
reproduces the auditory signal. 
Generally, the results are reported as a ratio of the summating potential (SP)  
to the action potential (AP) (the SP/AP ratio), for which a ratio of 0.5 or greater  
is considered abnormal. The endocochlear potential (EP), a direct current resting 
potential in the scala media, is a constant positive potential in the endolymphatic 
space with respect to the surrounding tissues. This potential is present in all 
healthy cochleas and is not dependent upon the presence of auditory stimulation. 
The other three electrical potentials depend on the presence of sound. The vestibulo-
cochlear nerve action potential is typical of other nerve responses. For a given 
nerve fibre, it has a discrete threshold of stimulus. The polarity and shape of  
the signal are identical from stimulus to stimulus, and it is an “all or none” 
phenomenon. 
Auditory brainstem response (ABR) 
The auditory brainstem response is an evoked potential test of auditory brainstem 
function in response to auditory stimuli, a brief click or tone beep transmitted 
from an acoustic transducer in the form of an insert earphone or headphone. The 
waveform response is detected by surface electrodes typically placed at the vertex 
of the scalp and ear lobes. The amplitude of the signal is averaged and charted 
against time. The waveform peaks are labelled I to VII. These waveforms norm-
ally occur within a 10-millisecond time period after a click stimulus presented at 
high intensities (70-90 dB normal hearing level).  
Middle latency evoked functions 
Middle latency-response testing is similar to the brainstem auditory evoked 
response but evaluates the auditory system central to the brainstem. 
Late latency evoked functions  
The cortical response audiometry (CRA) and the P300-potential are electro-
physiological measures that test the central pathways of the auditory system. 
4.3.2 Behavioural tests 
While the electrophysiological tests provide information on the integrity of specific 
sites within the auditory system, behavioural tests measure the response of the 
entire auditory system and evaluate the hearing function. Behavioural tests are 
generally broken down into four subcategories, including monoaural low-re-
dundancy speech tests, dichotic speech tests, temporal resolution or patterning 
tests, and binaural interaction tests.  
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Random gap detection test (RGDT)  
This behavioural test of central auditory function is designed to measure an im-
portant aspect of audition called temporal resolution. A random gap detection task 
is one in which a short silent gap (inter-pulse interval) is inserted between a pair  
of stimuli and the listener reports whether the stimulus is heard as one or two. 
Speech tests 
The ability to understand speech is a very important and complex function of the 
human auditory system and is typically affected in varying degrees in people with 
cochlear and central auditory dysfunction. The most accurate assessment of this 
function is achieved with hearing tests that use speech material as stimuli. Speech 
tests, by evaluating speech discrimination, assist in the determination of the site  
of lesion. They are accomplished through the use of standardised recorded speech 
materials. 
Northwestern University auditory test No. 6 
This test uses lists of phonetically balanced monosyllabic words for assessing 
speech discrimination. The test result is expressed in percentage of words correct-
ly identified and reflects the relationship of understanding to changes in intensity. 
Dichotic digits test 
The use of dichotic speech tests has proven effective in the evaluation of central 
auditory processing. This test consists of two digits presented simultaneously in 
each ear at a comfortable listening level, utilising a free-recall response mode. It 
has a reported high sensitivity and specificity for the detection of central auditory 
dysfunction and only requires approximately five minutes to administer and score. 
5. Mechanisms for inner ear damage after exposure to different 
ototraumatic agents 
The different ototraumatic agents considered in this document damage the 
auditory function by several different mechanisms. However, some common 
features can be found for the physical agent noise and some of the ototoxic 
chemicals. The most common finding in sensorineural hearing loss affecting the 
inner ear is the degeneration of the sensory hair cells in the cochlea (for details  
of inner ear anatomy, see Figure 1 in Section 3.1). In animal studies, both noise 
and solvent exposure have been shown to cause a loss of hair cells. A hypothesis 
is that the damage to the hair cells is caused by the formation of free radicals,  
so called reactive oxygen species (ROS) (see e.g. references (64, 152)). Other 
chemicals such as metals and pesticides may affect both the cochlea (331) and the 
central auditory pathways (89, 204, 293) depending on the substance. A schematic 
overview of the site of action for some chemicals is shown in Figure 5. More 
details will be given below.  
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Figure 5. Schematic picture of the auditory system showing the possible site of action of 
some ototoxic chemicals. Figure adapted with permission from presentation by Mariola 
Śliwińska-Kowalska at the Transfer of Knowledge “NoiseHear” Meeting at the Nofer 
Institute of Occupational Medicine, Łódź, Poland, November 15-16, 2006.  
Noise-induced hearing loss causes a degeneration of the sensory hair cells of  
the cochlea. The degenerative process starts within the outer hair cells and then 
continues to affect the inner hair cells and the supporting cells. The destruction 
may spread over the entire cochlea, leaving the basilar membrane naked (38). 
Morphologic studies have shown that the severity of hair cell damage and loss 
increases with the duration of the noise exposure (222). 
Two different mechanisms, mechanical and metabolic, may cause this damage 
to the hair cells as supported by several studies (220, 283, 313). Mechanical injury 
occurs due to acoustic overstimulation of the stereocilia of the hair cells or, if the 
intensity of the noise is high enough, of the membranes of the inner ear (220). 
This overstimulation disrupts structures in the cells and kills the hair cells by 
necrosis or apoptosis (243, 263, 380). 
Such damage to a cell causes a high level of metabolic activity and may initiate 
the formation of ROS (135). It has been shown that ROS form in the inner ear 
following noise exposure (152, 390) and appear to be involved in cell death (109, 
styrene 
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152). It has also been shown that scavengers of ROS can reduce the effect of noise 
trauma on hearing (152, 215). Le Prell et al also reported that the formation of free 
radicals after noise trauma continued up to 10 days after cessation of the exposure 
(215), which could explain why the loss of hair cells gets worse also after exposure. 
Toxic insults on the cochlea have been shown to continue also after cessation of 
exposure to solvents (184). 
There is solid evidence from experimental animal studies that exposure to 
solvents such as toluene, styrene and xylene produces cochlear lesions (48, 184, 
310, 358). An example of loss of outer hair cells after exposure to toluene is seen 
in Figure 6. Clinical and occupational studies have linked exposures to a variety  
of solvents (e.g. styrene, solvent mixtures and jet fuels) also with disorders in the 
central auditory pathway (2, 137 , 147, 187, 214, 254, 272, 397, 398). Metals such 
as lead and mercury and organophosphate pesticides may affect both the cochlea 
(331, 333) and the central auditory pathways (89, 204, 205, 293) depending on the 
substance. 
The outer hair cells are electromotile, i.e. the cells change their length in re-
sponse to sound stimulation. This process is dependent on the calcium con-
centration within the hair cell. Thus, outer hair cells may be vulnerable to ototoxic 
agents that interfere with intracellular calcium regulation. In vitro studies with 
isolated outer hair cells exposed to toluene have shown dysmorphia and impaired 
regulation of intracellular levels of free calcium. Changes occurred rapidly at the 
low concentration of 100 µM toluene, a level predicted to occur in the brain of 
humans exposed to 80-100 ppm toluene in air (228).  
Certain criteria have been shown to be necessary for the aromatic solvents to 
exhibit ototoxicity in the rat animal model. Gagnaire and Langlais studied 21 
different aromatic solvents and found that only 8 (toluene, para-xylene, ethyl-
benzene, n-propylbenzene, styrene, α-methylstyrene, trans-β-methylstyrene and 
allylbenzene) caused loss of hair cells. Within those 8 solvents, the degree of  
hair cell loss differed. The degree of ototoxicity was not clearly related to the 
 
 
 
Figure 6. Scanning electron micrograph showing 3 rows of outer hair cells and 1 row of 
inner hair cells in the middle turn of the cochlea in a control rat (left) and in a rat exposed 
to toluene (1 000 ppm, 16 hours/day during 5 days). 
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octanol/water partition of the solvent but correlations between some structural 
properties and ototoxicity were observed. A single side-chain on the aromatic ring 
is essential. Only one solvent with two side-chains, para-xylene, was ototoxic. 
When the side-chain was branched no ototoxicity was found. Also the saturation 
and the number of carbon atoms in the side-chain are of importance. No more than 
three carbons must be present in the side-chain for ototoxicity to occur (139).  
Studies investigating the differences between the three isomers of xylene 
(ortho-, meta- and para-xylene) have shown that only p-xylene is ototoxic (140). 
Both o- and m-xylene induce liver enzymes and are thereby eliminated faster from 
the body of rats. p-Xylene reaches a higher level in the blood and also gives rise  
to more potentially toxic intermediates than the other two isomers, which could 
explain why only p-xylene is ototoxic (238). However, Gagnaire et al showed that 
even when using a higher dosage and thereby obtaining the same blood and brain 
levels with m-xylene as with a known ototoxic dose of p-xylene, no ototoxic effect 
was observed after exposure to m-xylene. Therefore, the differences in metabolic 
rates probably do not explain the different ototoxic potentials of the xylene iso-
mers (142). Instead, the presence of two methyl groups in the para-position on the 
aromatic ring may be necessary for the ototoxic properties of p-xylene (140). 
Laboratory investigations appear to identify a common pattern of cochlear dys-
function and injury following solvent exposure. This pattern, produced by toluene, 
styrene, xylenes and trichloroethylene, involves impairment of outer hair cells that 
normally encode middle-frequency tones and are located in the middle turns of the 
cochlea (48, 74, 78). This tonotopicity of the cochlear damage is different from 
that induced by aminoglycoside antibiotics, which mainly affect the high-frequency 
tones. The pattern of damage is probably due to the intoxication route taken by the 
solvents to reach the organ of Corti as shown for styrene (48, 211). 
In these studies, as well as in a recent study by Chen et al, it was shown that 
styrene reaches the hair cells in the cochlea from the blood via the stria vascularis 
(structures of the inner ear are shown in Figure 1, Section 3.1) and through the 
supporting cells (64). This explains why the third row of other hair cells is affected 
first, i.e. this row of outer hair cells is closer to the supporting cells.  
The disorganisation of the membranous structures is thought to be the starting 
point for the cochlear injury induced by styrene. A corollary of the outer hair cells 
susceptibility is the progression of the trauma from the third to the first row of hair 
cells within the organ of Corti. This feature is likely related to the intoxication 
route taken by the solvents to reach the organ of Corti. It also explains why the 
ototoxic effect of styrene progresses beyond the cessation of styrene exposures to 
700 ppm and above, i.e. organ exposure continues some time after cessation of air 
exposure and when the apoptotic cascade has been initiated, it takes some time 
before it turns off (48, 229, 230). 
In rats, levels of solvents were measured in the blood, brain, auditory nerves, 
organ of Corti and in cerebrospinal and inner ear fluids after exposure to either 
toluene or styrene for one day. Solvents were detectable in the tissues but not in 
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the fluids, indicating that toluene and styrene are transported through the tissues  
of the organ of Corti rather than through the fluids of the inner ear (48). 
Chen et al measured the concentration of styrene in different regions in the 
cochlea and found a higher solvent concentration in the middle region with lower 
levels in the apex and the basal turn, explaining the higher vulnerability in the 
middle-frequency region. The reason for the higher concentration in the middle 
region is not fully understood but it could be partly due to easier removal of 
solvents by diffusion to the perilymph in the basal turn of the cochlea, which is 
closer to the cochlear aqueduct (64). 
Trichloroethylene has been shown to impair inner hair cell and spiral ganglion 
cell function through electrophysiological testing and cochlear histopathology. 
Loss of spiral ganglion cells was significant in the middle turn of the cochlea but 
not in the basal turn. The data suggested that the behaviourally determined loss  
in auditory function can be accounted for by a cochlear impairment and that the 
spiral ganglion cell may be a prominent target of this solvent (129). 
Effects on the central auditory pathways after toluene exposure in rats have been 
further investigated in two recent studies. In these experiments, it was shown that 
toluene can inhibit the auditory efferent system by modifying the response of the 
protective acoustic reflexes from the efferent system originating from the olive 
complex in the brainstem. Toluene acted in these experiments in the same way as 
other known cholinergic receptor antagonists (45, 209). Maguin et al showed that 
toluene acts also on the regulation of acetylcholine release in muscles by blocking 
the voltage gated Ca2+ channels involved in the protective middle ear reflex ex-
hibited by the stapedius muscle. This reflex is also mediated by efferent motor-
neurons emanating from the olive complex in the brainstem (237). These studies 
(45, 209, 237) all give an interesting insight into the mechanism of the interaction 
between solvents and noise. It is a probable hypothesis that when solvents cause 
the blocking of the protective middle ear reflex as well as disturb the efferent 
system, noise will be more damaging to the inner ear in the presence of solvent 
exposure. 
Solvent-induced hearing loss is species dependent. The rat is sensitive to 
solvents, while the guinea pig and chinchilla seem unaffected. Davis et al reported 
no effects in the chinchilla auditory system following toluene exposure alone or 
combined with noise (84). The authors argued that the chinchilla liver was able to 
detoxify toluene. Hepatic microsomes from chinchillas, rats and humans were 
tested for their ability to convert toluene to the more water-soluble compound 
benzyl alcohol. Chinchillas had higher levels and activities of liver cytochrome 
P450 (CYP) enzymes than both rats and humans. Similar observations were 
reported by Lataye et al regarding the effects of toluene and styrene exposures in 
the rat and guinea pig (213). Lataye et al found that the styrene concentration in 
the blood of the rat was four times higher than the concentration in the blood of 
the guinea pig. The authors indicated that the difference in susceptibility between 
these species may be explained by: 1) the different amount of solvent transported 
by blood and capable of reaching the organ of Corti, 2) the difference in meta-
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bolism, 3) the difference of glutathione within the sensory epithelium and 4) the 
morphological differences of the lateral membranes of the outer hair cells of the 
cochlea (213). Gagnaire et al investigated the difference in blood and brain levels 
of p-xylene between guinea pigs and rats. The blood level of p-xylene in the 
guinea pig was only half of that in the rat and the level in the brain reached only 
about 20-30 % of that in the rat. The rat also had four times slower elimination 
rate than the guinea pig (142). Thus, toxicokinetic factors may explain the species 
difference between rats and guinea pigs (54, 142). Solvent metabolism in humans 
is closer to that of the rat than to that of the guinea pig (213).  
As mentioned above, several experimental studies have shown that noise ex-
posure produces ROS in the inner ear (152, 390). Accumulating evidence links 
ROS to cochlear damage for both ototoxins and/or noise trauma (109, 193). This 
may also explain the interaction between noise and oxidising chemical agents like 
solvents and asphyxiants. It has been shown that combinations of non-damaging 
noise and oxidising chemical agents lead to oxidative stress that causes the death 
of hair cells in the inner ear (124, 125, 131, 297). A recent study by Chen et al 
produces evidence for apoptotic cell death by detecting activated caspase path-
ways in the outer hair cells after styrene exposure in rats (64).  
6. Auditory effects of pharmaceuticals  
Ototoxicity has been recognised since the 19th century. In 1884, it was reported 
that certain drugs such as quinine and acetyl salicylic acid could produce tem-
porary hearing loss as well as dizziness and tinnitus (339). Drug ototoxicity was 
recognised as a problem in the 1940s when permanent damage to the vestibular 
and cochlear organs was reported in several patients treated with the newly dis-
covered drug for treatment of tuberculosis, the aminoglycoside antibiotic strepto-
mycin (155). Today there are many well-known ototoxic drugs used in clinical 
situations (143, 370). Groups of drugs and substances confirmed to be ototoxic  
are listed in Table 2 (Section 3.3). However, it is beyond the scope of this docu-
ment to discuss the ototoxic features and risks of drugs. Most of them are used  
for treatment of serious health conditions after prescription, including antibiotics, 
chemotherapeutics, diuretics and malaria prophylaxes. 
In the following section, some features of the common over-the-counter 
pharmaceutical acetyl salicylic acid are discussed, since it may interact with  
noise or solvents and thereby increase the risk of occupational hearing loss. 
6.1 Acetyl salicylic acid  
Acetyl salicylic acid or aspirin is one of the most commonly used drugs in the 
world, with effects on fever, pain and inflammation. This drug has many side-
effects including irritation of the gastrointestinal system, dysfunction of kidneys 
and liver, allergies and hearing loss. There exists limited understanding of the 
mechanisms underlying these side-effects. Cazals has published a comprehensive 
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review about many aspects of the ototoxicity of acetyl salicylic acid (55) and his 
conclusions are summarised here. 
The ototoxicity of acetyl salicylic acid in humans can be divided into loss of 
hearing, tinnitus and alterations of sound perception. The salient feature of the 
slight to moderate hearing loss connected with acetyl salicylic acid intake is that it 
is always reversible after the end of treatment. It is dose-dependent and correlates 
linearly to the plasma salicylate level. A slight hearing loss (10 dB) was observed 
at plasma levels of 50-100 mg/l salicylate corresponding to approximately 2 g 
acetyl salicylic acid/day in volunteers given slow release tablets for one week (85). 
The hearing loss can reach thresholds above 40-50 dB, which occurs around 300-
500 mg salicylate/l plasma, corresponding to approximately 6-8 g acetyl salicylic 
acid/day (55). Several studies have demonstrated a large interindividual variability 
in the susceptibility to acetyl salicylic acid. Tinnitus is a common feature in acetyl 
salicylic acid induced auditory impairment especially after several days of drug 
intake. Tinnitus can be defined as a subjective perception of sound when no ex-
ternal sound source is present. Also tinnitus is reversible and correlates with the 
plasma level of salicylate. Acetyl salicylic acid has even been used to induce 
tinnitus in animal experiments. In these experiments, behavioural methods have 
been used to quantify the loudness of the tinnitus-tone (180, 181). In humans, the 
alterations of the perceptions of sounds after acetyl salicylic acid intake include 
loss of speech discrimination, change in frequency filtering and temporal de-
tection, as well as hypersensitivity to noise-induced temporary elevation of 
thresholds. The mechanism of the effects of acetyl salicylic acid on the auditory 
system relates to the outer hair cells and their motility, the cochlear blood flow, 
and the spontaneous activity in the cochlear nerve (55). 
In animal studies, interactions between acetyl salicylic acid and noise exposure 
have been shown, but limited evidence supports permanent hearing loss or loss of 
hair cells after combined exposure. One study in rats showed that acetyl salicylic 
acid may increase the severity of the permanent hearing loss caused by toluene 
(182). 
7. Auditory effects of organic solvents 
Organic solvent ototoxicity was suggested already in the 1960s (216) but was not 
clearly demonstrated until the 1980s. In a review paper that briefly discussed five 
occupational studies and four case reports, it was observed that the incidence of 
sensorineural hearing loss was higher than expected in noise-exposed workers 
who were also exposed to solvents (23). An ototraumatic interaction between 
noise and organic solvents was suggested and its biological plausibility discussed. 
Since organic solvents are known for their neurotoxic effects in both the central 
and the peripheral nervous system, it was argued that solvents might injure the 
sensory cells and peripheral endings in the cochlea. It was further hypothesised 
that, since solvent-related effects had been detected in the brain, a more central 
component on the auditory disorders could also be expected.  
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The aromatic solvents of the alkylbenzene family (e.g. toluene, ethylbenzene 
and xylene) are the largest group among the solvents that have been found to 
affect the auditory system (Table 2). The relative ototoxicity varies among the 
aromatic solvents. A tentative ranking of decreasing ototoxocity for 8 aromatic 
solvents based on histological hair cell losses was proposed as: allylbenzene > 
ethylbenzene, styrene > n-propylbenzene > p-xylene ≥ toluene, α-methylstyrene, 
trans-β-methylstyrene. Of the xylene isomers, p-xylene showed ototoxic effects 
whereas o-xylene and m-xylene did not (139, 238). Benzene itself is not ototoxic. 
Aliphatic solvents like n-hexane and n-heptane as well as carbon disulphide are all 
known neurotoxic substances that can affect the auditory system but their effects 
are probably due to effects on neurons in the central nervous system (251, 286, 
287, 344).  
In animal experiments as well as in human studies, the ototoxic effect after 
inhalation of organic solvents has been established using many different methods. 
In animals, the most sensitive method to discover the ototoxic effect of solvents is 
morphological studies detecting the loss of hair cells in the cochlea as shown after 
toluene and styrene exposure in rats (see e.g. references (64, 184, 208, 210, 229, 
268)). Detailed information on the different methods used to assess the auditory 
function in man and animals is found in Chapter 4. 
The auditory system of the guinea pig is not as sensitive to the ototoxic effects 
of solvents as that of the rat. This has been shown in experiments using styrene 
and xylene exposure of guinea pigs (114, 142, 213). Differences in solvent meta-
bolism are likely to explain the differences in susceptibility between species (142, 
213). As solvent metabolism in humans is more similar to that of rats, the latter is 
the best animal model for studying the ototoxic effects of solvents.  
7.1 Styrene  
7.1.1 General  
Styrene (vinylbenzene) is a colourless to yellow, volatile liquid with a sweet sharp 
odour (192, 377). 
Originally, styrene was used primarily in the synthetic rubber industry. It is 
currently used as an intermediate chemical for polymers in making plastics, resins, 
coatings and paints. Styrene is obtained from crude oil or liquefied petroleum gas 
and produced throughout the world in large quantities (192). 
The most significant occupational exposures to styrene occur in the manu-
facturing of fibreglass-reinforced polyester products, especially in plants involved 
with the fabrication of reinforced plastics and composites including boat producers. 
In addition, exposures to styrene may occur during the use of miscellaneous 
products such as floor waxes and polishes, paints, adhesives, metal cleaners and 
varnishes (245, 377). 
The major route of exposure is via the respiratory system. The absorption of 
styrene vapour by skin is negligible compared to the uptake via the lungs. Liquid 
styrene may be absorbed through the skin to a limited extent (4). In humans, some 
90-97 % of absorbed styrene is eliminated as the urinary metabolites mandelic acid 
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(MA) and phenylglyoxylic acid (PGA) with only a small fraction accounted for as 
parent compound in expired air or urine (318). 
The neurotoxic properties of styrene including effects on colour vision (65, 250, 
265) represent the main health hazards that are recognised in humans. Also geno-
toxic effects have been reported (169). 
7.1.2 Effects in animals  
7.1.2.1 Styrene alone 
In several animal experiments, the effects of styrene alone on the auditory system 
have been investigated (Table 3). These studies show that styrene exposure causes 
a permanent and progressive damage to the auditory system of the rat.  
Concentration and duration of styrene exposure were shown to influence the 
ototoxic effects in rats (48, 64, 229). In most of the experiments, animals were 
exposed to styrene by inhalation. However, intraperitoneal injections (114, 378) 
and gavage (64, 139) were also used in some studies. The results obtained by 
various modes of administration do not differ significantly because the solvent 
reach the cochlea whatever route is used (47).  
In animal experiments, the ototoxic effect of styrene has been established using 
electrophysiological methods (showing a permanent loss of auditory sensitivity) 
and by morphological examination of the cochlea (showing loss of outer hair 
cells).  
The histological findings demonstrate that the supporting cells are the first 
targets of the solvent. Then, the outer hair cells of the third row are disrupted, 
followed successively by the cells from the second and first rows from the basal 
(20 kHz) to the upper turn (4 kHz) of the cochlea. The ototoxic effects of styrene 
in rats progressed beyond the cessation of exposure to 700 ppm and above (48, 
208, 298).  
In rats, inhalation of 600 ppm styrene (12 hours/day, 5 days/week for 4 weeks) 
caused hearing loss and a loss of outer hair cells that amounted to 50-100 %. 
Animals exposed to 300 ppm did not display such effects (268). 
Lataye et al exposed rats to 300-1 000 ppm styrene (6 hours/day, 5 days/weeks 
for 4 weeks) and found higher concentrations of styrene in the blood when rats 
were forced to be active during the exposure. Consequently, a loss of outer hair 
cells occurred at the lower exposure level of 300 ppm in active rats when com-
pared to sedentary rats that displayed a similar effect at 500 ppm. These results 
show that the ototoxic effect of styrene is affected by physical activity (210). 
The age of the rats also influence the degree of hair cell loss in the cochlea.  
A significant loss of hair cells was seen in young rats (3 months of age) exposed  
to 700 ppm styrene (6 hours/day, 5 days/week for 4 weeks) despite the fact that 
almost no hearing loss could be measured by auditory brainstem response. In 
comparison, aged rats (24-26 months of age) displayed less outer hair cell loss 
than the young rats but more hearing loss, which might be due to aging and not 
only to styrene exposure (49). In a follow up study, 14-week old rats (corresponding 
to young adults) lost more outer hair cells and had more hearing loss compared to 
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21-week old rats, suggesting a critical sensitive period around the age of 3 months 
for rats exposed to solvents (212). 
Styrene has been shown to be a more potent ototoxicant than toluene (47, 139, 
229). Permanent auditory threshold shifts in rats occurred with a styrene dose 2.4 
times lower than that of toluene. The sequence and location of histopathological 
trauma along the organ of Corti was compared between styrene and toluene. The 
same magnitude of outer hair cell loss was observed at 650 ppm styrene and 1 500 
ppm toluene and also, but more severe, at 850 ppm styrene and 1 750 ppm toluene 
(all exposures 6 hours/day, 5 days/week for 4 weeks) (229). 
In a recent study, Chen et al investigated the dose-response relationship after 
exposure to styrene by gavage to different doses (0-800 mg/kg body weight, 5 
days/week for 3 weeks). The noise level was around 45 dBA. A dose-dependent 
increase in hearing loss was seen from 300 mg/kg. Also the loss of outer hair cells 
increased in a dose-dependent manner with small losses (5 %) present already at 
200 mg/kg. The loss of outer hair cells started after 7 days of exposure and the 
magnitude grew with increasing time (investigated only at 800 mg/kg). The 
styrene levels in blood were directly proportional to the oral dose given (2-3 % of 
the oral gavage dose on weight basis). The level of styrene in blood after the oral 
dose of 800 mg/kg was approximately 20 µg/g, measured after one dose as well  
as after 6 days of dosing (64). This corresponded to the styrene blood levels after 
inhalation exposure to 1 000 ppm (22.8 µg/g, 6 hours/day for 5 days) (64, 213). 
Thus, linear extrapolation suggests that an oral dose of 200 mg/kg corresponds to 
inhalation exposure at approximately 250 ppm. The magnitude of outer hair cell 
loss at 800 mg/kg was the same as that observed following the exposure to 850 
ppm for 4 weeks described above (229). The styrene blood levels measured in rats 
exposed to the lowest styrene dose (200 mg/kg) in the study by Chen et al (64) 
were only 3 times higher than blood levels of styrene found in workers (248). 
Prolonged middle latency auditory potentials and damage to central nervous 
system structures were found after intraperitoneal injection of high daily doses 
(800 mg/kg body weight) of styrene to rats during two weeks indicating also a 
central nervous effect on the auditory system (378). 
7.1.2.2 Styrene combined with noise 
Some experiments have revealed that noise interacts with styrene in a synergistic 
manner (Table 4) (208, 210, 269). 
Combined exposure to 600 ppm styrene and noise at 100-105 dB SPL (12 
hours/day, 5 days/week for 4 weeks) caused a synergistic effect in rats, shown  
by hearing loss and outer hair cell loss. At 300 ppm, no interaction was observed 
(269). 
Exposure to 400 ppm styrene in combination with noise at 86.2 dB SPL (= 85 
dB Leq8h) (6 hours/day, 5 days/week for 4 weeks) resulted in a greater loss of 
outer hair cells than exposure to styrene alone in rats forced to be active. Noise 
only exposure did not induce any loss of outer hair cells at this exposure level 
(210).  
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7.1.2.3 Styrene combined with other agents 
Ethanol consumption, which by itself did not affect the auditory function in rats 
when administered by gavage once a day (4 g/kg body weight, 5 days/week for  
4 weeks), has been shown to potentiate the effects of styrene (750 ppm, 6 hours/ 
day, 5 days/week for 4 weeks) on the auditory system. Styrene alone caused a 
permanent hearing loss of about 10 dB at 2 and 16-20 kHz as shown by auditory 
brainstem response and a corresponding loss of outer hair cells. The combined 
exposure to styrene and ethanol caused a greater hearing loss (20-30 dB) over a 
wider frequency range (2-24 kHz) together with increased loss of outer hair cells. 
Rats simultaneously exposed to styrene and ethanol had increased CYP enzyme 
activity in the liver compared to rats exposed to styrene alone (Table 4) (230). 
Trichloroethylene did not show synergistic or antagonistic interaction with 
styrene among groups of rats who received iso-effective concentrations of solvent 
pairs (8 hours/day for 5 days). Decreased auditory brainstem responses indicative 
of hearing loss correlated with blood levels of total solvent as predicted by a linear 
dose-addition model (Table 4) (329). 
7.1.3 Observations in man 
7.1.3.1 Styrene alone 
Several occupational studies have been conducted regarding the effects of styrene 
on the auditory system as well as on the interaction of styrene with noise (Table 5).  
No studies exist in which workers were exposed to styrene alone in a totally 
quiet environment. However, in several studies, groups of workers were exposed 
to styrene at noise levels below 85 dBA. These studies are discussed below.  
7.1.3.2 Styrene combined with noise and other agents 
In an early study, routine audiometric results of workers exposed to styrene in a 
plastic boat plant were evaluated. The plant records indicated that exposures had 
ranged from 5.6 to 24 ppm although rare peaks above 70 ppm did occur. Also 
acetone exposure occurred at the plant but no other solvent exposure. Noise levels 
were not measured but were estimated to be below 85 dB. Audiometric records 
did not indicate hearing losses resulting from causes other than exposure to noise. 
Seven of 18 workers, however, displayed abnormal results in central auditory 
system testing. In addition, 16 of the workers showed abnormal results in tests 
involving the vestibular system (271).  
A similar study in workers exposed to 3-92 ppm styrene was reported by 
Calabrese et al who found no effects when measuring pure-tone audiometry but 
concluded that 17 out of 20 workers had deficient vestibular reflexes (43). 
Muijser et al compared two groups exposed to styrene, directly (mean 32 ppm) 
and indirectly (14 ppm). Individual exposures did at times reach up to 164 ppm in 
the directly exposed group. Noise levels were generally low, 66-70 dBA, but 
occasionally up to 104 dB. A significant difference in hearing thresholds at the 
high frequencies was noted between the groups (261). 
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Styrene and noise exposures were assessed for 299 workers in the reinforced 
fibre industry in Canada. TWA styrene exposures for directly and indirectly ex-
posed were 25 ppm and 8 ppm, respectively, while noise exposures were similar 
in the groups, i.e. 88 and 90 dBA. The association between noise exposure (based 
on an estimated life-time noise dose) and hearing loss was significant. Styrene 
exposure approached significance for hearing loss only at specific frequencies (4 
and 6 kHz) in the left but not in the right ear. Noise and styrene exposures were 
highly correlated. Both noise exposure and age were found to be confounding 
factors regarding the possible hearing loss caused by styrene and might shadow 
the styrene effect (336). 
More recently, the effects of styrene were investigated in male workers exposed 
in factories producing plastic buttons or bathtubs (258, 259). In the first study, 
workers whose noise exposures exceeded 85 dBA were excluded from the study 
population. Participants were exposed to a mixture of solvents, mainly styrene  
and toluene. Of the 93 participants, only 6 were exposed to levels of styrene that 
exceeded 50 ppm and 2 were exposed to toluene levels exceeding 50 ppm (258). 
In the second study, the 48 study participants were divided into 3 subgroups based 
on exposure: an unexposed control group, a group exposed to noise levels of 82-
86 dBA, and a group exposed to low average levels of both styrene (22 ppm, range 
3.7-46) and noise (69-76 dBA) (259). No effects of the solvents were detected by 
routine audiometric testing up to 8 kHz. In both investigations, the hearing as 
assessed by high-frequency audiometry (10-16 kHz) was reduced in workers ex-
posed to styrene for 5 years or more, although both noise levels and styrene con-
centration in air were within limits recommended by several international agencies. 
Hearing impairment was associated with styrene concentrations in air and MA 
(biomarker of styrene) concentrations in urine. No effects of other solvent ex-
posures were detected (258, 259).  
The association between MA and hearing loss was also observed in a cross-
sectional study conducted in Sweden, which aimed to investigate the effects  
of occupational exposure to low levels of styrene and noise (187, 256). Styrene 
measurements were conducted for all exposed workers by personal air samples 
and biological monitoring of MA in urine. Also historical and life-time exposures 
to styrene were estimated using company records. For about 60 % of the participants 
in the groups exposed to noise (with or without styrene), the noise levels were 
above 85 dB Leq measured outside ear protection. The range of noise exposure 
was similar in these two groups (75-116 dBA). Styrene exposures were low, 
averaging 3.5 ppm, with a maximum level of 22 ppm (8-hour values) in the styrene 
only group and 2.8 ppm in the group exposed also to noise. Workers exposed to 
styrene (with and without noise) had significantly worse pure-tone thresholds at 2, 
3, 4 and 6 kHz when compared to noise-only exposed or non-exposed workers. 
From the numerous variables that were analysed for their contribution to the de-
velopment of hearing loss, only age, current noise exposure and MA levels were 
significant in the final multiple logistic regression model. The odds ratio (OR) 
estimates for hearing loss were 1.18 times greater for each dB of current noise 
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exposure (95 % confidence interval (CI) 1.01-1.34), 1.19 times greater for each 
year of age (95 % CI 1.11-1.28) and 2.44 times greater for each increment of 
1 mmol (152 mg) of MA/g creatinine (95 % CI 1.01-5.88). At the NIOSH re-
commended exposure limit (REL) of 300 mg of MA/g creatinine (~19 ppm in  
air), the OR for hearing loss would be 4.88 (2 × 2.44 mg). Testing for interaction 
between noise and styrene exposure was not significant, suggesting an additive 
effect between the two agents (256). Interaction between agents certainly de- 
pends on the exposure levels of the studied populations. The audiometric results 
were later compared to a Swedish database of an otologically unscreened, non-
occupationally noise-exposed population (187). The audiological test battery 
included pure-tone audiometry, distortion product otoacoustic emissions, psycho-
acoustic modulation transfer function, interrupted speech, speech recognition in 
noise, and cortical response audiometry. Workers exposed to both noise (> 85 
dBA) and styrene and to styrene alone (noise < 85 dBA) had significantly poorer 
pure-tone thresholds in the frequency range of 3-8 kHz than controls, noise-only 
exposed workers, and those listed in the Swedish age-specific database. Even 
though abnormalities were noted on distortion product otoacoustic emissions  
and cortical response audiometry testing, the interrupted speech and speech 
recognition in noise tests were the more sensitive tests for styrene effects (187). 
Śliwińska-Kowalska et al evaluated the effects of occupational exposure to 
styrene and combined exposure to styrene and noise on hearing (346, 347). The 
study group, 290 yacht and plastic factory workers, was exposed to a mixture of 
solvents having styrene as its main compound. The mean of individual work-life 
average styrene exposure levels was 14 ppm (range 0.8-71) and the mean noise 
level 82 dBA (range 71-93). The reference group, totalling 223 subjects, included 
white collar workers exposed neither to solvent nor noise (n = 157) and metal 
factory workers exposed exclusively to noise (n = 66). The mean noise level in the 
noise-only exposed group was 89 dBA and in the non-exposed controls 73 dBA. 
Hearing loss was observed in 63 % of the styrene exposed workers and in 42 % of 
the referents. The OR for hearing loss in the styrene exposed group was 3.9 (95 % 
CI 2.4-6.2, adjusted for age, gender, current occupational exposure to noise and 
exposure to noise in past). The mean hearing thresholds differed significantly from 
the reference group in a wide range of frequencies from 1 to 8 kHz. Depending on 
type of exposure, the styrene exposed group was divided into 4 subgroups: exposed 
to styrene only (n = 194), styrene and noise (n = 56), styrene and toluene (n = 26), 
and styrene, toluene and noise (n = 14). Hearing loss was observed in 79 % of the 
workers exposed to styrene, toluene and noise, in 77 % of the styrene and noise 
group, in 77 % of the styrene and toluene group, in 56 % of the styrene only group, 
in 63 % of the noise only exposed group and in 34 % of the unexposed group. The 
ORs for hearing loss adjusted for age and gender were: 5.2 for the styrene only 
group, 3.4 for the noise only group, 10.9 the for styrene and noise group, 13.1 for 
the styrene and toluene group and 21.5 for the styrene, toluene and noise group  
(all significant when compared to the unexposed group). A significant increase in 
hearing thresholds was found in all subgroups within the frequency range 2-8 kHz 
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as compared to the unexposed group. The highest hearing threshold was found in 
the group exposed to styrene and noise even if only an additive effect between 
styrene and noise could be statistically verified (346, 347). 
In a smaller study of 16 workers in a boat manufacturing plant in Germany, no 
consistent correlations were reported between hearing ability and the biological 
exposure measurements of styrene. The exposure level was assessed by biological 
exposure index using the sum of MA+PGA in urine. The mean value was 656 
mg/g creatinine (standard deviation (SD) 639, range 72-2 213) for the laminators 
and 130 mg/g creatinine (SD 129, range 25-478) for the controls (161). This 
corresponds to approximately 22 ppm styrene in the air for the laminators and 4.3 
ppm for the controls assuming that 20 ppm corresponds to 600 mg/g creatinine 
(88). Noise levels were not reported. 
This study was recently followed by a larger study by Triebig et al (374) 
investigating workers from the same boat manufacturing plant as in the study 
above (161). Workers currently exposed to noise above 85 dBA were excluded. 
Hearing, including high-frequency thresholds, was assessed with pure-tone audio-
metry between 0.125 and 16 kHz and with transient evoked otoacoustic emissions 
(TEOAE). The exposure levels of styrene were assessed by biological monitoring 
using MA+PGA in urine as well as styrene levels in the blood. Also historical and 
life-time exposures to styrene were estimated using company records. A total of 
248 workers were divided in three different groups with low, medium or high 
current exposure to styrene. The mean current MA+PGA urinary values for the 
three exposed groups were 51 (SD 27), 229 (SD 103) and 970 (SD 410) mg/g 
creatinine. According to the authors’ transformation of MA+PGA urinary levels  
to styrene air levels, these values would correspond to approximately 2-3, 8-15 
and 40-50 ppm styrene in air, respectively. Extensive statistical analyses were 
made regarding the relationship between hearing thresholds and both current and 
life-time exposure levels. No differences between the three exposed groups were 
found in thresholds of pure-tone audiometry or in the results of TEOAE. However, 
elevated thresholds at some frequencies (> 25 dB, 3-6 kHz) and an increased risk 
for hearing loss were found in a subgroup (n = 17) exposed to high levels of styrene 
(30-50 ppm, with levels above 50 ppm in the past) during 10-26 years as com-
pared to a group (n = 34) exposed to low levels for a shorter time (2-16 years). The 
OR was 7.5 (95 % CI 1.1-51.4) adjusted for education, age, alcohol intake, tenure 
and mother tongue. Air levels were estimated from the life-time average MA+PGA 
urinary value of 660 mg/creatinine (SD 613). The corresponding value for the low-
exposure group was 200 mg MA+PGA/g creatinine (SD 171) (374). 
Mascagni et al measured pure-tone audiometry in 32 workers exposed to styrene 
in a fibreglass reinforced plastic boat manufacturing industry in Italy with an 
average exposure duration of 7 years. Hearing thresholds were compared to 60 
unexposed control subjects. Styrene exposure was measured using biological 
monitoring of MA+PGA in urine. The mean value for the exposed group was 149 
mg/g creatinine (SD 80, range 20-410) (240). This corresponds to approximately 5 
ppm styrene (88). The noise levels were measured to 73 dBA (Leq). Twenty-four 
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of the exposed workers were compared to age-matched controls and had slightly 
but significantly (p < 0.05) higher thresholds at all frequencies (except at 8 kHz on 
the right ear) (240). The study confirms the results from earlier studies with larger 
population that styrene alone can cause a slightly elevated hearing threshold.  
7.1.4 Conclusion on styrene  
The ototoxic effects of styrene in animals have only been demonstrated in rats. 
Styrene does not cause hearing loss in guinea pigs (114, 213).  
Based on available rat studies, the LOAEL for styrene alone is 200 mg/kg body 
weight by gavage (64). This corresponds to approximately 250 ppm by inhalation 
(for details, see Section 7.1.2.1). In rat inhalation studies, 300 ppm (4 weeks) was 
identified as a no effect level, both with and without simultaneous noise exposure 
(100 dB SPL) (268, 269). However, in rats forced to be active, a LOAEL of 300 
ppm styrene alone was obtained (210). Thus, no NOAEL for styrene alone can  
be identified in animals. Synergistic interaction between styrene and noise was 
manifested only at concentrations above the LOAEL for styrene alone, i.e. at and 
above 400 ppm (208, 210, 269).  
In occupational studies, current levels of styrene averaged approximately 3.5-50 
ppm. The lowest current average exposures among workers exhibiting significant 
hearing loss when compared to non-exposed controls were 3.5-22 ppm (187, 240, 
256, 258, 259). In these studies, the styrene exposed groups were exposed to noise 
below 85 dBA at the time of study. However, exposure to higher styrene and noise 
levels in the past, as well as peaks of high concentration in the present, is likely 
and may have contributed to the effect. One study demonstrated a significant 
positive correlation between the average work-life styrene concentration of 14 
ppm and hearing loss (346, 347). In another study, neither life-time (average 16 
ppm) nor current air styrene (3.5 ppm) levels were associated with hearing loss, 
whereas current urinary MA levels were positively correlated with hearing 
thresholds (256). 
The influence of long-term exposure was shown in the study by Triebig et al, 
which demonstrated auditory effects in workers estimated to have been exposed  
to 30-50 ppm for at least 10 years with levels above 50 ppm in the past (374).  
In humans, the type of interaction taking place between noise and styrene 
exposure is not yet clear. 
International 8-hour occupational exposure limits (OELs) for styrene vary from 
20 to 100 ppm (Appendix 1). The main concerns are neurotoxicity, genotoxicity 
and potential carcinogenic effects (250). 
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7.2 Toluene 
7.2.1 General 
Toluene or methylbenzene is a colourless, flammable and explosive liquid with an 
aromatic odour (399).  
Toluene is a commercially important intermediate chemical produced through-
out the world in large quantities. It is used as a solvent carrier in paints, thinners, 
adhesives and inks, and is added to gasoline to increase the octane number. The 
vast use makes toluene present in many industrial settings (399). 
Numerous groups of individuals are occupationally exposed to toluene. Occupa-
tions in which exposure to toluene may occur include production, handling and 
use of toluene and toluene containing products, e.g. chemical laboratory workers, 
gasoline blenders, lacquer workers, paint and paint thinner makers, petrochemical 
workers, maintenance workers, painters and printers (168, 399). 
The major route of exposure is via the respiratory system. In human studies, the 
uptake of toluene has been estimated to be 40-60 % of the total amount inhaled 
(171). Physical work increases the respiratory uptake. Liquid toluene may be ab-
sorbed through the skin to a limited extent. Toluene is partly excreted via exhaled 
air but 80-90 % of the absorbed toluene is biotransformed and excreted by the 
kidneys mainly as hippuric acid (399). 
7.2.2 Effects in animals 
7.2.2.1 Toluene alone 
Several animal studies have shown effects of toluene on the auditory system 
(Table 6). 
Toluene causes permanent auditory dysfunction in rats. No permanent effects on 
hearing have been shown in chinchillas (84) or guinea pigs (244). In mice, toluene 
increased the progression of age-related hearing loss in a strain (C57BL/6J) with a 
genetic predisposition for presbyacusis (hearing loss as part of the aging process) 
but not in normal (CBA/Ca) mice (218). 
Effects of toluene on the auditory system of the rat were first reported by Pryor 
et al in a study addressing neurobehavioural effects of toluene (308). Effects on 
the auditory system in this and several other studies were shown at high exposure 
concentrations (at and above 1 000 ppm, 14-21 hours/day, 5-7 days/week for 2-14 
weeks) (182, 185, 186, 287, 288, 305, 307, 308, 310, 326). Light microscopy or 
scanning electron microscopy examination of the cochlea confirmed the initial 
findings and revealed a progressive severe loss of hair cells (184). The morpho-
logical appearance of toluene-induced cochlear damage has since been documented 
in other studies (46, 206, 358). Later studies revealed that a shorter daily exposure 
time (6 hours) caused no effect on the auditory brainstem response at 1 000 ppm 
exposure (39, 229). 
Considerably lower toluene concentrations were able to acutely produce equi-
valent auditory dysfunction in the guinea pig (244) as compared to published data 
in the rat (46, 183). Concentrations as low as 250 ppm toluene (8 hours/day, 5 
days/week for 1-4 weeks) temporarily disrupted auditory function in the guinea 
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pig, and 500 and 1 000 ppm toluene produced greater acute dysfunction. However, 
no permanent hearing loss developed in the guinea pigs and hair cell death was not 
observed (244).  
Effects of prenatal exposure to toluene and hearing loss in the offspring were 
reported by Hougaard et al. Pregnant rats were exposed to 1 800 ppm toluene, 
6 hours/day during gestation days 7-20. Body weights of exposed offspring were 
lower until day 10 after parturition. A behavioural test battery revealed some 
cognitive effects on learning and memory, most marked in female offspring. The 
hearing function of the offspring, tested with auditory brainstem response 3 months 
after exposure, showed a slight tendency towards hearing loss in the male off-
spring, significant from controls only at 8 kHz (162). 
7.2.2.2 Toluene combined with noise 
Several animal studies have investigated the interactions between toluene exposure 
and noise on the auditory system (Table 7). 
The most serious effect was observed in a study of sequential exposure to toluene 
(1 000 ppm, 16 hours/day, 5 days/week for 2 weeks) and noise (100 dB Leq8h, 10 
hours/day, 7 days/week for 4 weeks) in rats. Toluene exposure followed by noise 
caused a greater loss (synergism) of auditory sensitivity than toluene or noise alone 
(186). Additionally, Lataye and Campo observed that simultaneous exposure to 
toluene (2 000 ppm, 6 hours/day, 5 days/week for 4 weeks) and noise (92 dB OBN 
at 8 kHz), which each alone resulted in hearing loss, generated an auditory deficit 
that exceeded the summated losses for successive exposure to toluene and noise 
(206). Brandt-Lassen et al observed interaction on auditory threshold shifts in rats 
between toluene exposure at 1 000, 1 500 and 2 000 ppm (6 hours/day for 10 days) 
and noise exposure (96 dB SPL, 2 hours following the daily toluene exposure). In 
the same study, exposure to 500 ppm toluene plus noise resulted only in a threshold 
shift similar to that found after noise only exposure (39).  
Impulse noise is known to cause more hearing loss than wide band noise. In  
a study by Lund and Kristiansen, combined exposure to toluene (500, 1 000 or  
1 500 ppm, 6 hours/day for 10 days) and either impulse noise or wide band noise 
(both equivalent to 90.8 dB Leq8h) showed that toluene (1 500 ppm) potentiated 
the noise-induced hearing loss. The combination of toluene and impulse noise 
caused a larger hearing loss than wide band noise and toluene (234). The possible 
mechanisms underlying these interactions are discussed in Chapter 5. 
Lund and Kristiansen also performed a long-term experiment with low doses  
of toluene (100, 200 and 500 ppm, 6 hours/day, 5 days/week for 90 days), known 
to not cause a hearing loss, combined with steady state noise equivalent to 87 dB 
Leq8h. The rats exposed to 100 or 200 ppm toluene and noise had a tendency 
towards less hearing loss than the rats exposed to noise alone (234). 
7.2.2.3 Toluene combined with other agents 
Interactions between toluene exposure and intake of alcohol or acetyl salicylic 
acid or exposure to other solvents (with and without noise) have been reported 
(Table 7). 
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Combined exposure to toluene and n-hexane or to iso-effective concentrations 
of toluene and trichloroethylene or toluene and chlorobenzene caused additive 
effects on the auditory system in rats (305, 328). One study showed synergistic 
effects of toluene and n-hexane 3 months after exposure to high levels of both 
solvents (1 000 + 1 000 ppm, 21 hours/day, 7 days/week for 28 days) (287). 
Ethanol alone (6 % in drinking water for 2 weeks or 4 g/kg body weight by 
gavage for 4 weeks) did not cause hearing loss but potentiated the ototoxic effects 
of toluene (1 000 ppm for 2 weeks and 1 750 ppm for 4 weeks, respectively) (50, 
312). However, in another study on rats, ethanol (6 % in drinking water for 8 
weeks) reduced the effect of toluene (1 000 ppm for 8 weeks) (288). A synergistic 
interaction between acetyl salicylic acid and toluene was shown by Johnson. Rats 
were given high daily doses (100 mg/kg body weight) of acetyl salicylic acid by 
gavage and were simultaneously exposed to 1 000 ppm toluene for 10 days. Acetyl 
salicylic acid alone did not cause hearing loss but potentiated the permanent 
ototoxic effect caused by toluene (182). These results might be of interest since 
ethanol is commonly used and pain killers of the acetyl salicylic acid type are 
likely to be used by workers exposed to toluene although in lower doses. 
Recent studies have demonstrated that adding several factors, e.g. another 
solvent and noise or carbon monoxide and impact noise, much reduce the lowest 
level of toluene exposure needed to elicit an auditory damage (133, 233). 
Synergistic interaction was seen in rats exposed to 400 ppm toluene and 660  
ppm ethylbenzene together with 93 dB noise (6 hours/day for 10 days) (133). 
Exposure 6 hours/day for 10 days to toluene (500 or 1 000 ppm) together with 
carbon monoxide (300 or 500 ppm) and impulse noise (84 dB SPL noise with 
75 % impulses at 4-20 kHz) caused a synergistic interaction, which increased with 
increasing doses of both carbon monoxide and toluene. Combined exposure to 
toluene and impulse noise did not cause interaction at the tested levels (233). 
7.2.3 Observations in man 
7.2.3.1 Toluene alone 
No studies were identified. 
7.2.3.2 Toluene combined with noise 
Several occupational studies have been conducted regarding the effects of toluene 
on the auditory system and the interaction between toluene and noise (Table 8). 
A group of rotogravure printers with normal hearing ability and exposed to an 
average of 97 ppm toluene for 12-14 years showed alterations of brainstem audi-
tory evoked responses (2). Thus, auditory nervous system modifications were 
demonstrated before clinical signs of chronic exposure to toluene appeared. 
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Similar results were reported by Vrca et al. Printing workers exposed to low 
concentrations of toluene for an average of 21 years were compared to controls. 
The current exposure to toluene in both groups was evaluated by measuring the 
concentration of toluene in peripheral blood and the concentrations of hippuric 
acid and ortho-cresol (biomarkers of toluene exposure) in urine. The mean value 
for toluene in blood was 36 µg/l (SD 25, range 0.2-94) for the exposed and 0.96 
(SD 3.7, range 0.0-19) for the controls (384). This corresponds to approximately 
34 ppm toluene in the air for the printers (160). Decrease in amplitudes, pro-
longation of latencies and increased interpeak intervals of the auditory brainstem 
responses were shown after chronic exposure to these low concentrations of 
toluene (384).  
In a cross-sectional study, workers from rotogravure printing and paint manu-
facturing industries had their hearing function tested by pure-tone audiometry, 
impedance audiometry and stapedius reflex testing (reflex threshold and decay) 
(254). Hearing loss was compared among workers exposed to both noise (88-98 
dBA) and toluene (75-365 ppm), workers exposed solely to noise (88-97 dBA),  
or solely to a mixture of solvents in which toluene was the major component,  
and workers exposed to neither. Compared to the unexposed control group, the 
adjusted relative risks for hearing loss were 4.1 (95 % CI 1.4-12.2) for the noise 
group, 5.0 (95 % CI 1.5-17.5) for the solvent-mixture group, and 10.9 (95 % CI 
4.1-28.9) for the combined noise and toluene group. The results from the acoustic 
reflex measurements suggested a predominantly non-cochlear site of the damage, 
since the percentage of workers with acoustic reflex decay was largest in the group 
exposed to noise and toluene. Also, the decay was largest after contralateral sti-
mulation, suggesting a lower brainstem disorder. A peripheral component of the 
observed hearing loss was, however, not excluded (254). 
Another study involved 124 rotogravure printing workers exposed to various 
levels of noise and an organic solvent mixture of toluene, ethyl acetate and ethanol 
(257). Toluene exposures were below 50 ppm for 109 of the 124 studied workers. 
Forty-nine per cent of the workers exhibited hearing loss. Among the numerous 
variables that were analysed for their contribution to the development of hearing 
loss, only age and hippuric acid met the significance level criterion in the final 
multiple logistic regression model. The OR estimates for hearing loss were 1.07 
for each increment of 1 year of age (95 % CI 1.03-1.11, p = 0.0003) and 1.76 for 
each g hippuric acid/g creatinine (95 % CI 1.00-2.98, p = 0.0338). Since low 
hippuric acid levels were observed in the majority of the studied group with no or 
little occupational exposure to toluene, this marker provided reliable information 
on occupational exposure. At the hippuric acid limit level of 1.6 g/g creatinine 
recommended by the American Conference of Governmental Industrial Hygienists 
(ACGIH) (7), the OR for hearing loss can be calculated to 2.8 (OR 1.76 × 1.6 g 
hippuric acid/g creatinine). Moreover, results of the acoustic reflex decay test 
suggested that there might be retrocochlear or central auditory pathway involve-
ment in some of the hearing disorders observed. The workers in this study had a 
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relatively short history of noise exposure and had presumably not been exposed 
long enough for noise effects to develop (257). 
The ototoxicity of occupational exposure to toluene below 50 ppm was in-
vestigated in a longitudinal study over 5 years with four repeated examinations  
of workers from rotogravure printing plants (342). Past life-time weighted average 
exposures to toluene and noise were determined from individual work histories 
and were 10 ppm in the low-exposure group and 45 ppm in the high-exposure 
group, with noise levels of 82 dBA in both groups. Recent averaged individual 
exposure was 3 ppm in the low-exposure group and 26 ppm in the high-exposure 
group with noise levels of 82 and 81 dBA, respectively. Repeated measurement 
analyses (grouping factors: toluene intensity, exposure duration and noise in-
tensity) and logistic regressions did not reveal significant effects of toluene level, 
exposure duration or interactions between toluene and noise. Hippuric acid levels 
elevated the OR for high frequency hearing loss to 1.28 (95 % CI 0.75-2.18) but 
this association was not significant. Stratification according to noise intensity 
alone (79 ± 3 versus 84 ± 1 dBA) was significantly associated with increased 
auditory thresholds. The authors of this study suggested that the threshold level  
for developing a hearing loss as a result of occupational toluene exposure might  
be above 50 ppm (342). 
Chang et al investigated hearing loss among workers exposed to both toluene 
and noise in an adhesive material manufacturing plant (57). Fifty-eight workers 
were exposed to both toluene and noise (79-87 dBA) and were compared to 58 
workers exposed to noise only (83-90 dBA) and to a control group of 58 persons 
(68-73 dBA). Seven breathing-zone air samples were collected in each of the three 
divisions with toluene exposure with average levels of 33, 108 and 165 ppm and 
corresponding average noise levels of 83, 84 and 84 dBA. The toluene levels were 
also given as a cumulative exposure index in year-ppm, calculated as the average 
toluene level in each division multiplied by the years of employment. The pre-
valence of hearing loss (≥ 25 dB) was higher in the toluene plus noise group (86 %) 
than in the noise-only group (45 %) or the controls (5 %). Multivariate logistic 
regression analysis to evaluate dose-response effects based on cumulative exposure 
index showed that the OR for hearing loss was 6 times higher for the toluene plus 
noise group compared to the noise alone group (57). 
In a cross-sectional study conducted in the same printing company as by Morata 
et al (254), Bernardi examined 140 workers (31). Participants were subdivided in 
controls and exposed groups according to exposures to noise alone or combined 
with toluene. Participants’ age ranged from 18 to 48 years and to be included in 
the study, participants had to have normal hearing (all pure-tone audiometric 
thresholds < 25 dBHL, type A tympanogram and presence of acoustic reflexes). 
TEOAE testing and their suppression by continuous contralateral white noise were 
used to evaluate the effects of toluene exposure. Absence of TEOAE response was 
slightly higher in the group exposed to both toluene and noise (64 %) compared to 
the noise alone group (62 %), which both by far exceeded the non-exposed group 
(27 %). The absence of the contralateral suppression of the TEOAE was much 
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more prevalent among the workers exposed to both agents (49 %) than in the noise 
exposed (17 %) or non-exposed group (7 %). The OR for absence of contralateral 
suppression was estimated to be 12 (95 % CI 3.1-43.5) compared to non-exposed 
workers (31). These results suggest a retrocochlear effect of toluene.  
7.2.3.3 Toluene combined with other agents 
Several of the occupational studies investigating the auditory effects of solvents 
were performed in populations simultaneously exposed to many different solvents 
in their workplaces. In some of these studies, toluene was one of the main com-
ponents. The effects of mixed solvent exposures are reported in Section 7.8 and  
in Table 20. 
7.2.4 Conclusion on toluene  
The ototoxic effects of toluene in animals have been clearly demonstrated in rats. 
Toluene exposure caused temporary disruption of auditory functions in guinea 
pigs (244) and hearing loss in a strain of mice genetically predisposed for hearing 
loss (218). 
In adult rats, the NOAEL for toluene is 700 ppm (311) and 500 ppm when 
combined with noise (39, 234). The LOAEL is 1 000 ppm both with and without 
noise exposure (39, 46, 182, 185, 186, 229, 311). In weanling rats, the NOAEL for 
toluene alone is 900 ppm (308). Synergistic interaction between toluene and noise 
was manifested at the same concentration as the LOAEL for toluene alone, i.e. at 
and above 1 000 ppm (39, 186).  
In some occupational studies, ototoxic effects from toluene were associated 
with current exposure levels of approximately 10-50 ppm (31, 257, 384). Historic 
toluene and/or noise exposure levels were not well characterised and some groups 
of workers were co-exposed to other solvents. It is likely that participants were 
exposed to higher concentrations in the past, as well as to peaks of high exposure 
in the present that could explain the observed effects. In one study, however, 
chronic exposure (12-14 years) to an average of 97 ppm caused hearing loss but 
noise levels were not given (2). No auditory effects were observed in a study in 
which both current and historic levels of toluene (up to 50 ppm) and noise were 
low (342). 
International 8-hour OELs for toluene vary from 20 to 200 ppm (Appendix 1). 
The ACGIH threshold limit value is set to protect from subclinical changes in 
blue-yellow colour vision and the potential for spontaneous abortion in female 
workers (6). 
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7.3 Xylenes 
7.3.1. General  
Xylene (or dimethylbenzene) exists in three isomeric forms: ortho, meta and para. 
At room temperature, the xylenes are colourless liquids with an aromatic odour. 
After inhalation exposure the retention in the lungs is about 60 % of the inhaled 
dose. More than 90 % is biotransformed to methylhippuric acid, which is excreted 
in urine (173). 
Xylene is produced from coal tar or by the aromatisation of petroleum hydro-
carbons. Xylene is marketed principally as a mixture of the o-, m- and p-isomers, 
generally denoted “mixed xylenes”. The individual isomers are also available 
commercially. Most commercial mixed xylenes also contain ethylbenzene (170, 
173, 192).  
The main use of xylene is as a constituent in motor and aviation fuel but it is 
also used as a solvent in the paint, printing, rubber and leather industries (173, 
279). 
7.3.2 Effects in animals  
7.3.2.1 Xylene alone 
Several studies have investigated the effects of xylene on the auditory system in 
rats (Table 9). In the earlier studies, rats were exposed to mixed xylenes con-
taining all three isomers in different often unstated proportions. Mixed xylene 
(10 % o-, 80 % m- and 10 % p-xylene, ethylbenzene content not mentioned) 
affected the auditory sensitivity after exposure to 1 450 ppm (8 hours/day for  
3 days) or 800 ppm (14 hours/day, 7 days/week for 6 weeks), as shown by be-
havioural audiometry and/or auditory brainstem response (306). Xylene mainly 
affected the mid-frequency range (8-24 kHz) of the cochlea (78). Gagnaire et al 
showed that outer hair cells were the primary targets within the organ of Corti  
and that only one of the isomers, p-xylene, was ototoxic (see Chapter 5). Thus, 
loss of outer hair cells was seen after exposure to 900 ppm p-xylene (6 hours/day, 
6 days/week for 13 weeks), while no effects on the auditory system was found 
after exposure to up to 1 800 ppm of either o-xylene or m-xylene. At the lower 
level of 450 ppm p-xylene, hair cells were unaffected (140). Later, Manguin et al 
confirmed that only p-xylene was ototoxic in rats after exposure to 1 800 ppm  
(6 hours/day, 5 days/week for 3 weeks) (238). 
7.3.2.2 Xylene combined with noise 
No studies were identified. 
7.3.2.3 Xylene combined with other agents 
In studies by Rebert et al, combined exposure to iso-effective concentrations  
of mixed xylenes and chlorobenzene, and mixed xylenes and trichloroethylene 
caused additive effects on the diminished amplitudes of auditory brainstem 
responses in rats (Table 10) (328). 
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A recent study on rats using different mixed xylenes with a known content of 
the three isomers as well as of ethylbenzene showed loss of outer hair cells after 
exposure to 250 ppm of the mixture (≈ 50 ppm p-xylene and 50 ppm ethyl-
benzene) and increased auditory brainstem response thresholds at 1 000 ppm  
of the mixture (all exposures 6 hours/day, 5 days/week for 13 weeks) (141).  
The combined exposure caused enhanced ototoxicity compared to exposure to 
ethylbenzene alone (Section 7.4.2.2). 
7.3.3 Observations in man 
7.3.3.1 Xylene alone or combined with noise  
No studies were identified. 
7.3.3.2 Xylene combined with other agents 
There are some studies in humans where xylene is one of several solvents. The 
effects of the mixed solvent exposures are reported in Section 7.8 (Table 20). 
7.3.4 Conclusion on xylenes  
No effects on the auditory system have been found in rats after exposure to o-  
or m-xylene only. Only p-xylene has been found ototoxic (140, 141, 238).  
In rat inhalation studies, exposure to 450 ppm pure p-xylene for 13 weeks 
caused no auditory effects (NOAEL) whereas exposure to 900 ppm caused outer 
hair cell loss (LOAEL) (140).  
Auditory effects were observed after exposure to 800 ppm mixed xylenes for 6 
weeks (lowest dose tested) (306) and after exposure for 13 weeks to 250 ppm of a 
mixture (LOAEL, lowest dose tested) containing approximately 50 ppm p-xylene 
but also 50 ppm ethylbenzene (141). The combined exposure caused enhanced 
ototoxicity compared to exposure to ethylbenzene alone. Interaction with noise has 
not been studied.  
No human studies of auditory effects of xylenes alone or in combination with 
noise were identified. 
International 8-hour OELs for xylene vary from 25 to 100 ppm (Appendix 1). 
According to ACGIH, the suggested threshold limit value is primarily set to 
prevent irritation and acute as well as chronic effects on the central nervous 
system (4). 
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7.4 Ethylbenzene  
7.4.1 General  
Ethylbenzene is a colourless liquid aromatic solvent produced from benzene and 
ethylene. It is mainly used as a raw material in the production of styrene. It is also 
a component of technical xylene, which usually contains approximately 20 % 
ethylbenzene. The estimated yearly production in the western world is about 8-10 
million tonnes (172) 
Exposure to pure ethylbenzene is unusual in the work environment. As part  
of mixed xylenes, ethylbenzene is often one of many solvents in solvent mix- 
tures, e.g. in paints and lacquers and in the rubber and chemical manufacturing 
industries (97, 172). 
7.4.2 Effects in animals  
7.4.2.1 Ethylbenzene alone 
The ototoxic effect of ethylbenzene was investigated in a series of studies by 
Cappaert et al (51-54). Dose-dependent loss of outer hair cells (300-550 ppm) as 
well as increased hearing thresholds (400 and 550 ppm) were observed in rats 
exposed 8 hours/day for 5 days (51, 52, 54). Guinea pigs exposed to 2 500 ppm  
(6 hours/day for 5 days) did not display signs of ototoxicity. In another experi-
ment, measurements of ethylbenzene blood levels after exposure to 500 ppm, 8 
hours/day for 3 days showed that the guinea pigs had much lower levels than the 
rats (2.8 ± 0.1 µg/ml and 23.2 ± 0.8 µg/ml, respectively) (54). 
Recently, Gagniere et al showed ototoxic effects in rats at all ethylbenzene 
exposure levels (200-800 ppm, 6 hours/day, 5 days/week for 13 weeks) (141).  
In a comparison study of 21 different solvents, ethylbenzene (gavage for 2 
weeks) was shown to be one of the most potent ototoxic solvent as measured by 
outer hair cell loss in rats (Table 11) (139).  
7.4.2.2 Ethylbenzene combined with noise or other agents 
Combined exposure (8 hours/day for 5 days) to 300 or 400 ppm ethylbenzene  
and 105 dB broadband noise induced synergistic effects on outer hair cell loss. 
Exposure to 95 dB noise caused no effect on hearing neither alone nor in com-
bination with the solvent (52).  
The ototoxic effect of two different xylene mixtures with controlled amounts  
of the xylene isomers as well as of ethylbenzene was investigated. Rats exposed  
to 250 ppm (6 hours/day, 5 days/week for 13 weeks) of the mixture containing 50 
ppm ethylbenzene and 50 ppm p-xylene exhibited loss of outer hair cells (Table 
12) (141). 
Synergistic interaction was seen in rats exposed to 400 ppm toluene and 660 
ppm ethylbenzene together with 93 dB noise (6 hours/day for 10 days) (133). 
7.4.3 Observations in man 
No studies on ethylbenzene alone or combined with noise were identified. 
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In several occupational studies, workers exposed to ethylbenzene were exposed 
also to other solvents. The effects of the mixed solvent exposures are reported in 
Section 7.8 (Table 20).  
7.4.4 Conclusion on ethylbenzene  
Ethylbenzene has proven ototoxic in rats (51-54, 139, 141) but not in guinea pigs 
(54). No NOAEL has been identified for rats. In rat inhalation studies, 200 ppm 
ethylbenzene (13 weeks, lowest level tested) caused outer hair cell loss (LOAEL) 
and 400 ppm caused hearing loss (51, 141). 
In combination with noise (105 dB SPL), exposure for 5 days to 300 ppm 
ethylbenzene (lowest dose tested) induced synergistic effects on outer hair cell 
loss (LOAEL) (52). Exposure to 250 ppm of a commercial xylene mixture (13 
weeks, lowest level tested) containing approximately 50 ppm ethylbenzene but 
also 50 ppm p-xylene induced outer hair cell loss (LOAEL) (141).  
No human studies on the auditory effects of ethylbenzene alone or combined 
with noise were identified. 
International 8-hour OELs for ethylbenzene vary from 5 to 100 ppm (Appendix 1). 
The ACGIH threshold limit value is set to minimise the potential risks of dis-
agreeable irritations. Other main concerns are effects on the central nervous 
system, liver and kidneys. Ethylbenzene is classified as an animal carcinogen (5). 
7.5 Chlorobenzene 
Chlorobenzene is a colourless liquid with a mild aromatic odour. It is used 
primarily as a degreasing solvent, as a chemical intermediate in the synthesis of 
nitrochlorobenzenes, in the dry cleaning industry and in manufacture of resins, 
dyes, perfumes and pesticides (100).  
The only animal study of chlorobenzene showed that 2 000 (LOAEL) and 2 400 
ppm (8 hours/day for 5 days) was ototoxic in rats. Interaction with noise was not 
studied. Combined exposure to iso-effective concentrations of chlorobenzene and 
toluene or chlorobenzene and mixed xylenes caused additive effects on the di-
minished amplitudes of auditory brainstem responses in rats (Table 13) (328). 
No human studies on the auditory effects of chlorobenzene were identified. 
International 8-hour OELs for chlorobenzene vary from 1 to 75 ppm (Appendix 
1). According to the EU Scientific Committee on Occupational Exposure Limits 
(SCOEL), the main concern is haematological, liver and kidney effects (100). 
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7.6 Trichloroethylene 
7.6.1 General  
Trichloroethylene is a colourless liquid with a boiling point of 89 ˚ C and an odour 
resembling that of chloroform (197). 
The major use of trichloroethylene is as a degreaser in metal cleaning operations 
and in textile cleaning. It is also used as paint stripper, adhesive solvent, ingredient 
in paints and varnishes, and in the manufacture of organic chemicals. Occupational 
exposure is mainly by inhalation but skin uptake of liquid trichloroethylene may 
also pose a problem (197, 385).  
7.6.2 Effects in animals  
7.6.2.1 Trichloroethylene alone 
The auditory effects of trichloroethylene are shown in Table 14. In an early study, 
Yamamura et al investigated the ototoxic effect of trichloroethylene in guinea 
pigs. Exposures to high concentrations (≥ 6 000 ppm) caused no effect in this 
species using electrophysiological measurements (389). However, findings from 
experiments on rats demonstrated auditory effects after exposure to trichloro-
ethylene at and above 2 000 ppm. All the studies showed that the mid-frequency 
region of the rats’ cochlea was affected after exposure to trichloroethylene (10, 74, 
75, 78, 129, 179, 327-329). Crofton and Zhao calculated the benchmark concen-
trations (estimated as the 95 % lower bound of the concentration that produced a 
15-dB increase in threshold) to be 1 418 ppm (4-week exposure data) and 1 707 
ppm (13-week exposure data) in their extensive study. The experimental NOAEL 
was 1 600 ppm and the LOAEL was 2 500 ppm in this study (75).  
Fechter et al exposed rats to 4 000 ppm trichloroethylene (6 hours/day for 5 
days) and examined auditory changes through several tests and histology of the 
outer hair cells and spiral ganglion cells. Trichloroethylene caused increased 
hearing thresholds in the mid-frequency region of the cochlea as measured by 
reflex modification audiometry. Some test results and histopathological changes 
suggested that trichloroethylene affects the innervation of the cochlea more than  
it damages the outer hair cells (129). 
Albee et al exposed rats to lower concentrations of trichloroethylene (250, 800 
and 2 500 ppm, 6 hours/day, 5 days/week for 13 weeks) and confirmed a mid-
frequency hearing loss by trichloroethylene as measured by auditory brainstem 
response at 2 500 ppm. The study also showed loss of outer hair cells in the basal 
turn of the cochlea at the same level (only dose tested). No auditory brainstem 
response effects were seen at lower exposure levels (250 and 800 ppm) (10).  
Rebert et al showed that rats exposed to 2 000 ppm trichloroethylene (12 hours/ 
day, 7 days/week for 3 weeks) had diminished amplitudes of auditory brainstem 
responses indicating a mid-frequency hearing loss whereas another strain exposed 
to 1 600 ppm for 12 weeks was unaffected (NOAEL) (327). Diminished amplitudes 
of auditory brainstem responses were also observed at higher concentrations of 
trichloroethylene for shorter duration (at and above 2 500 ppm, 8 hours/day for 5 
days) (328, 329). 
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7.6.2.2 Trichloroethylene combined with noise or other agents 
Muijser et al exposed rats to 3 000 ppm trichloroethylene (18 hours/day, 5 days/ 
weeks for 3 weeks), alone or in combination with 95 dB SPL noise (Table 15). 
Trichloroethylene caused hearing loss at the low and middle frequencies but not  
at the high frequencies tested. Noise exposure caused hearing loss in the mid-
frequency region of the cochlea only. The combined exposure caused greater 
threshold shifts than the sum of the individual effects at 4 kHz, whereas effects 
were additive at 8, 16 and 20 kHz (262). 
Rebert et al exposed rats to iso-effective combinations of trichloroethylene  
and mixed xylenes, of trichloroethylene and toluene, and of trichloroethylene  
and styrene (Table 15). The combined exposures caused additive effects on the 
diminished amplitudes of auditory brainstem responses (328, 329). 
7.6.3 Observations in man 
7.6.3.1 Trichloroethylene alone and combined with other agents 
Individual medical case histories implicate trichloroethylene as a toxicant with 
possible oto- and vestibulotoxic properties. A 54-year-old male dry cleaner with 
10 years of occupational exposure to trichloroethylene had many health com-
plaints and suffered from high frequency (≥ 4 kHz) sensorineural hearing loss 
(371). No exposure details were given. The hearing impairment was considered  
to be caused by damage to the auditory nerve due to trichloroethylene exposure.  
Among 40 trichloroethylene exposed workers examined, 26 cases of hearing 
loss were observed. The hearing loss was bilateral, sensorineural, and affected 
high frequencies (≥ 4 kHz). Electronystagmographic investigations indicated 
lesions of the balance system (366). No details on occupations, noise or trichloro-
ethylene or other solvent exposures were given, but the authors mentioned that the 
examined groups were often exposed to high concentrations of trichloroethylene 
(trichloroacetic acid in urine ranging from 40 to 200 mg/l). 
There are some more recent studies in humans where trichloroethylene is one  
of several solvents. The effects of the mixed solvent exposures are reported in 
Section 7.8 (Table 20). 
7.6.4 Conclusion on trichloroethylene 
In rat inhalation studies, no auditory effects were observed after exposure to 1 600 
ppm trichloroethylene alone (12 or 13 weeks) (NOAEL) (75, 327). Exposure to 
2 000 ppm TCE alone for 3 weeks caused hearing loss (LOAEL) (327). The cal-
culated benchmark concentrations causing a 15-dB increase in hearing threshold 
were 1 418 ppm (4-week exposure data) and 1 707 ppm (13-week exposure data) 
(75). Combined exposure to 3 000 ppm trichloroethylene (only dose tested) and 95 
dB SPL noise caused a synergistic interaction (262).  
Available human studies indicate that trichloroethylene may be ototoxic also  
in humans, but the exposure levels in these studies cannot be assessed (366, 371). 
International 8-hour OELs for trichloroethylene vary from 10 to 100 ppm 
(Appendix 1). The EU SCOEL recommended an OEL based on avoidance of renal 
toxicity and thereby preventing renal cell cancer (103). 
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7.7 n-Hexane  
7.7.1 General  
n-Hexane is a saturated aliphatic hydrocarbon (C6H14), liquid at room temperature 
with a boiling point of 68 ˚ C. n-Hexane is widely used as a solvent in different 
industrial settings such as the rubber industry in the production of tires, as a 
solvent in glues for shoe production, as a cleaning solvent for textiles and leather, 
as a raw material in the production of other chemicals, and as an additive to petrol. 
It is often used together with other aliphatic solvents, toluene and acetone (201). 
n-Hexane is neurotoxic to both the peripheral and the central nervous system. 
The formation of ketone metabolites is responsible for the dying back polyneuro-
pathy of myelinated axons caused by n-hexane exposure in both animals and 
humans (201, 352). 
7.7.2 Effects in animals  
7.7.2.1 n-Hexane alone 
Rats were exposed to n-hexane in seven studies (Table 16). High levels (4 000 
ppm, 14 hours/day, 7 days/week for 9 weeks) caused prolonged latencies of the 
auditory brainstem response, i.e. a neurotoxic effect (305). Reversible neurotoxic 
effects of n-hexane at lower exposure levels (1 000 ppm, 24 hours/day, 5 or 6 
days/week for 11 weeks) has been shown as prolongation of the latency of a late 
component of the auditory brainstem response (163, 322). In another study, a 
slight but persistent decrease of the amplitude of a late component of the auditory 
brainstem response at 1 000 ppm was observed (325). Exposure to 1 000 ppm  
(18 or 21 hours/day, 7 days/week for 28 or 61 days) did not cause any significant 
effects on non-frequency specific click auditory brainstem response. However, a 
marked decrease in peripheral nerve conduction velocity (neurotoxic effect) was 
observed (286, 287).  
7.7.2.2 n-Hexane combined with other agents  
The auditory effect of n-hexane in combination with xylene or toluene was tested 
(Table 16). Although no significant ototoxic effect was found after exposure to n-
hexane alone (1 000 ppm for 28 or 61 days), a potentiation of the ototoxic effect 
caused by toluene (1 000 ppm for 28 days) or xylene (1 000 ppm for 61 days) was 
found (286, 287). In contrast, Pryor and Rebert did not observe any potentiation of 
the auditory effect after 9 weeks of combined exposure to n-hexane (4 000 ppm) 
and toluene (1 200 ppm) (305).  
Interaction with noise has not been studied. 
7.7.3 Observations in man 
In a few studies on workers occupationally exposed to n-hexane, prolonged inter-
peak latencies of the auditory brainstem response and P300 waves were observed 
and interpreted as a sign of central nervous system neurotoxicity (32, 59, 60, 165).  
There are some studies in humans in which n-hexane is one of several solvents. 
The effects of the mixed solvent exposures are reported in Section 7.8 (Table 20). 
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7.7.4 Conclusion on n-hexane  
The neurotoxic effect of n-hexane was shown in several studies investigating its 
auditory effects in rats (163, 286, 287, 305, 322, 325). In most of these studies, 
inhalation exposure to 1 000 ppm n-hexane (up to 11 weeks) did not cause 
significant effects on the auditory brainstem response (non-frequency specific 
click) (NOAEL) (163, 286, 287, 322). In contrast, one study with the same ex-
posure level (1 000 ppm, 11 weeks) caused prolonged latencies and decreased 
amplitude of the auditory brainstem response (LOAEL) (325). 
Although 1 000 ppm n-hexane had only a slight ototoxic effect alone, it 
potentiated the effects caused by xylene (1 000 ppm) and toluene (1 000 ppm), 
respectively (286, 287). The ototoxicity of n-hexane in combination with noise  
has not been investigated. 
In the human studies, observed auditory effects of n-hexane have been inter-
preted as a sign of its well-known central nervous system neurotoxicity (32, 59, 
60, 165). Risk evaluation regarding this outcome is beyond the scope of this 
document. 
International 8-hour OELs for n-hexane vary from 20 to 500 ppm (Appendix 1). 
The ACGIH threshold limit value is set to prevent central nervous system impair-
ment, peripheral neuropathy and eye and mucous membrane irritation (4). 
7.8 n-Heptane  
n-Heptane is another aliphatic hydrocarbon (C7H16), which resembles n-hexane 
although it is not as widely used in industry. Like n-hexane, n-heptane is neuro-
toxic and depresses the central nervous system but it does not cause polyneuro-
pathy (149). 
In the only animal study investigating the ototoxicity of n-heptane alone, 
inhalation exposure to a high dose of 4 000 ppm n-heptane (6 hours/day, 7 
days/week for 28 days) caused hearing loss (reduction in auditory brainstem 
response amplitudes) in rats (LOAEL). At 800 ppm, no such effects were ob-
served (NOAEL) (Table 16) (344). Interaction with noise or other agents were  
not studied.  
No human studies investigating the ototoxicity of n-heptane were identified.  
International 8-hour OELs for n-heptane vary from 85 to 500 ppm (Appendix 1). 
The ACGIH threshold limit value for heptanes is based on the narcotic and 
irritative effects (4).  
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7.7 Carbon disulphide 
7.7.1 General 
Pure carbon disulphide, CS2, is a colourless liquid with a pleasant odour resemb-
ling that of chloroform. The carbon disulphide as used in most laboratory and 
industry processes is a colourless to faintly yellow liquid with a strong, disagree-
able cabbage-like odour detectable at 0.016-0.42 ppm. It is highly flammable and 
slightly soluble in water (192). 
Since the 1800s, carbon disulphide has been an important industrial chemical 
because of its ability to dissolve fats, rubbers, phosphorus, sulphur and other 
elements. Its fat-solving properties also make it indispensable in preparing fats, 
lacquers and camphor, in refining petroleum jelly and paraffin, and in extracting 
oil from bones, olives and rags (273). 
The most important industrial use of carbon disulphide has been in the manu-
facture of regenerated cellulose rayon (by the viscose process) and cellophane. 
Other industrial uses for carbon disulphide include carbon tetrachloride pro-
duction, the vulcanisation and manufacture of rubber and rubber accessories, the 
production of resins, xanthates, thiocyanates, plywood adhesives, flotation agents, 
solvent and spinning-solution applications, conversion and processing of hydro-
carbons, petroleum-well cleaning, brightening of precious metals in electroplating, 
rust removal from metals, and removal and recovery of metals and other elements 
from waste water and other media (273). 
7.7.2 Effects in animals 
7.7.2.1 Carbon disulphide alone 
Several animal experiments have addressed the effects of carbon disulphide on the 
auditory system (Table 17). In rats, the ototoxic effect after inhalation exposure to 
800 ppm (11 or 15 weeks) or intraperitoneal administration (286-400 mg/kg body 
weight for 11 weeks) of carbon disulphide has been established using electro-
physiological methods (157, 323, 324), while reflex modification audiometry was 
not affected after inhalation exposure to 500 ppm carbon disulphide (12 weeks) 
(66). 
7.7.2.2 Carbon disulphide combined with noise or other agents 
No studies were identified.  
7.7.3 Observations in man 
7.7.3.1 Carbon disulphide combined with noise  
Several occupational studies have been conducted in viscose rayon factories 
regarding the auditory effects of carbon disulphide (Table 18).  
All five studies involved combined exposure with noise. Comparable noise 
levels ranging from 80 to 92 dBA were reported in the plants. Due to limitations 
in the exposure histories, none of these studies tested for statistical interaction 
between noise and solvent. In four of these studies, the prevalence of hearing loss 
in carbon disulphide exposed workers (observed in pure-tone audiometric tests) 
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was compared with that of groups with comparable noise levels or unexposed 
controls. Consistently, not only was the percentage of hearing loss higher among 
the workers exposed to both agents (carbon disulphide and noise) but hearing 
losses were also more serious and had an earlier onset than if the only environ-
mental factor had been noise exposure (58, 196, 251, 356). In the remaining study, 
workers were evaluated using auditory brainstem response and history of exposure 
in years. Exhaust ventilation apparatus had undergone major improvements 14 
years ago. The results were consistent with the pattern of increased interpeak 
latency observed in experimental animals. Noise levels were not given (158).  
7.7.4 Conclusion on carbon disulphide  
In rats, inhalation exposure to 500 ppm for 12 weeks did not cause auditory effects 
(NOAEL), while significant effects were observed at 800 ppm (11 and 15 weeks, 
LOAEL) as measured by auditory brainstem response (66, 157, 323). Interaction 
with noise has not been studied.  
In humans, age-adjusted ORs for audiometric hearing loss were significantly 
increased for exposures above 14 ppm in combination with noise in the range 80-
91 dBA (58). Auditory effects (evoked potentials) were also observed in workers 
exposed for at least 20 years (ventilation improved 14 years ago). Current ex-
posure ranged between 3 and 8 ppm. Past or present levels of noise were not 
reported in this study (158). The workers were weavers, and thus a rather high 
noise level could be expected.  
International 8-hour OELs for carbon disulphide vary from 1 to 20 ppm 
(Appendix 1). According to the EU SCOEL, the critical effects in humans are 
neurotoxicity and cardiotoxicity (102). 
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7.8 Solvent mixtures 
7.8.1 General 
This part of the document addresses the most common exposure situation in the 
workplace, exposure to solvent mixtures of different compositions. In most human 
studies on solvent ototoxicity, exposure to such mixtures was investigated. Also 
studies on humans and animals exposed to solvents that are mixtures per se such 
as white spirit and jet fuels are included here. 
Exposure estimation in human occupational studies is always difficult and even 
more complicated when mixed exposures are involved. A method often used to 
describe the influence of the different solvents on the total exposure load is the 
hazard index. The exposure hazard index, HI (also called hygienic or additive 
effect), is calculated according to this formula: 
 
 HI = C1/T1 + C2/T2 + C3/T3 … 
 
C1, C2, C3, etc. are the measured exposure levels of the different solvents and 
T1, T2, T3, etc. are the individual OELs of the corresponding solvent. If any of  
the quotas exceeds 1.0, that specific solvent exceeds its OEL. If the hazard index 
exceeds 1.0, the total exposure load is considered too high. 
White spirit of different types, Stoddard solvent and kerosene are all refined 
petroleum solvents. They are all complex mixtures containing normal and branched 
paraffins, naphtenes and aromatic hydrocarbons. The contents of these different 
substances in the mixtures differ and depend on the raw petroleum product as well 
as the distillation process used (249). All the mentioned substances are colourless 
to yellowish, oily liquids with a strong, characteristic odour. 
The different types of white spirit are characterised by the percentage contents 
of aliphatic versus aromatic hydrocarbons. White spirits are used as solvents and 
thinners in paints and lacquers as well as degreasers in industrial processes (249). 
Jet fuels are also called aviation kerosene. Jet fuels have different names (such 
as JP-4, JP-5, JP-7 and JP-8) depending on the composition of the mixture from 
the distillates. Jet fuels differ due to distillation temperature and additives. The 
additives determine the specific uses of the fuel. Since jet fuels are often used by 
the military, the exact components are not known (14, 15). 
7.8.2 Effects in animals 
Animal studies of solvents that are mixtures per se such as white spirits and jet 
fuels are described in detail in Table 19. Animal studies involving mixtures of 
specific solvents have been reported earlier under the heading of the different 
solvents. 
7.8.2.1 Mixtures per se alone 
Lund et al exposed rats to 400 or 800 ppm dearomatised white spirit for 6 months. 
Central nervous system functions including auditory evoked responses (auditory 
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brainstem response) were studied. The exposure did not cause any effects on 
hearing thresholds (236).  
In a study of Fechter et al, repeated but not single exposure to jet fuel (JP-8) 
caused auditory impairment in rats. Partial though not complete recovery was 
observed over a 4-week post-exposure period (for details, see 7.8.2.2) (132). 
7.8.2.2 Mixtures per se combined with noise 
Fechter et al studied the effects of jet fuel (JP-8) exposure with or without noise 
exposure in rats (Table 19). Exposure to JP-8 alone (1 000 mg/m3, 4 hours/day for 
5 days) caused some effects on outer hair cells as measured by distortion product 
otoacoustic emissions. The effect was more evident and permanent when JP-8  
was followed by noise exposure (97 dB for 4 hours or 102 dB for 1 hour). After a 
single inhalation exposure as well as after repeated exposures over the course of  
5 days, JP-8 exposure increased the susceptibility to noise exposure. In addition, 
JP-8 markedly depleted glutathione levels in liver tissue (132).  
7.8.3 Observations in man 
7.8.3.1 Solvents mixtures alone and combined with noise 
Several occupational studies have addressed the effects of solvent mixtures on the 
auditory system, as well as the interaction between solvent mixtures and noise 
(Table 20). Single solvent studies are described under the respective headings in 
previous sections. 
The central auditory system was investigated in two clinical studies using a 
variety of tests. Noise exposure levels were not reported but self-estimated data 
indicated low occupational levels (below 85 dBA). Varney et al showed that 
patients heavily exposed to solvents performed worse than age-matched controls 
in a dichotic listening test (379). Fuente et al used an extensive test battery to 
evaluate the central auditory system in a study of 10 workers long-term exposed  
to solvent mixtures in a furniture factory (current hazard index = 0.25). Apart from 
test of hearing by pure-tone audiometry, the test battery included filtered speech, 
random gap detection, dichotic listening and the hearing-in-noise test. Differences 
were detected in the filtered speech tests, random gap detection and dichotic 
listening but not in the hearing-in-noise test or in the pure-tone audiometry as 
compared to unexposed controls (137). 
The relationship between self-assessed hearing disorders and occupational ex-
posure to solvent mixtures was investigated in a cross-sectional study with 3 284 
men. Exposure to solvents for 5 years or more resulted in an adjusted relative risk 
for hearing impairment of 1.4 in men without occupational exposure to noise. In 
the group reporting combined occupational exposure to solvents and noise, the 
effects from noise dominated. The occupational exposure to noise had an effect 
twice that of solvents. A sub-sample of 51 men was examined with pure-tone 
audiometry. Twenty of the 21 men who reported abnormal hearing also fulfilled 
an audiometric criterion for hearing impairment, giving an indication that the self-
assessment of hearing loss was valid (178).  
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Two early reports showed that workers exposed to combinations of solvents and 
noise might have a worse hearing loss than could be expected from noise exposure 
alone (23, 30). In a long-term follow-up of hearing tests performed at a paper mill, 
Bergström and Nyström found that 23 % of the workers in the chemical department, 
where the noise exposure was lower than in the rest of the paper mill plant, de-
veloped a severe hearing loss after 20 years. In other departments, without solvent 
exposure but with higher noise exposure (95-100 dB), only 8 % of the workers 
developed a severe hearing loss (30). 
Clinical studies were conducted on auditory and vestibular functions of workers 
exposed to a mixture of unspecified alcohols, jet fuels and aromatic solvents. Noise 
exposure levels were not reported but because of the nature of the participants’ 
occupations, noise was indicated to be a factor. The findings in pure-tone audio-
metry and speech discrimination testing were essentially normal for age and noise 
exposure history, not indicating measurable cochlear damage due to solvent ex-
posure. However, significant abnormalities were found in tests that assessed more 
central portions of the auditory pathways such as distorted or interrupted speech 
(272, 294, 397). The central auditory system was also affected after long-term 
solvent exposure in a group of workers (214) as well as in a group of patients with 
suspected chronic toxic encephalopathy due to solvent exposure (278). Vestibular 
dysfunction was seen in 47.5 % and hearing loss in 42 % of 61 solvent exposed 
workers compared to 5 % (of each effect) in age-matched controls (357).  
For a group of workers (n = 39) exposed to a mixture of solvents (mainly toluene 
and xylene) in a quiet environment, the OR for hearing loss was 5 times greater 
(95 % CI 1.4-17.5) compared to non-exposed controls (254). 
Morata et al tested the hearing in solvent-exposed workers from a refinery (n = 
438). Participants were exposed to a solvent mixture containing mainly toluene, 
xylene, cyclohexane and ethylbenzene. The exposures to noise and solvents were 
at or below the US Occupational Safety and Health Administration (OSHA) ex-
posure limits. Workers were also exposed in their homes, evident from available 
water and air samples. The prevalence of hearing loss within the exposed groups 
ranged from 42 to 50 %, significantly exceeding the prevalence for unexposed 
groups (15-30 %). The adjusted ORs for hearing loss were 2.4 (95 % CI 1.0-5.7) 
for groups exposed to aromatics and paraffins, 3.0 (95 % CI 1.3-6.9) for the 
maintenance group and 1.8 (95 % CI 0.6-4.9) for the group from shipping, when 
compared to unexposed controls (255). 
Workers (n = 517) in the paint and lacquer industry in Poland exposed to a 
mixture of organic solvents with or without concomitant noise exposure were 
investigated for hearing loss. Average work-life solvent exposures were calculated 
using the exposure index for the mixed solvents at each workplace multiplied with 
the duration of years at that workplace. The different products were then added 
and divided by the total number of exposed years thus creating a “work-life exposure 
index” (WEI). The group was subdivided according to exposure: 1) solvent 
mixture (mean WEI 0.6, range 0.3-1.6) with noise exposure above 85 dBA, 2) 
solvent mixture only (mean WEI 0.8, range 0.3-3.0, noise equal to or below 85 
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dBA), and 3) non-exposed controls (noise equal to or below 85 dBA). The relative 
risks for hearing loss for the solvent with noise group and the solvent-only group 
were significantly increased (2.8, 95 % CI 1.6-4.9 and 2.8, 95 % CI 1.8-4.3) when 
compared to the control group. In a subgroup of the solvent-only exposed group 
with noise equal to or below 80 dBA, the relative risk for hearing loss was 4.4 
(95 % CI 2.3-8.1) as compared to the noise-matched control subgroup. The mean 
hearing thresholds at frequencies of 2-4 kHz were poorer for workers exposed to 
solvents and noise than for the solvent-only group (348, 350). 
In a study of dockyard workers in Poland, the effect on hearing of exposure to a 
mixture of solvents together with noise (n = 517) was compared to a noise exposed 
group (n = 184) and non-exposed controls (n = 205). The OR for hearing loss in the 
noise alone group was 3.3 (95 % CI 2.1-5.4) and differed significantly from the 
group with combined exposure with an OR of 4.9 (95 % CI 3.1-7.7). The main 
solvent in the mixture was xylene and the current exposure hazard index for the 
mixture of solvents was 6.3 (0.8-23.2). The current noise levels were 93 dBA 
(range 85-102 dBA) in the combined exposure group and 90 dBA (range 85-100 
dBA) in the noise alone group (349). 
Śliwińska-Kowalska et al assessed the auditory effects in a large cohort of 
workers exposed to different solvents and solvents together with noise. In the 
group exposed to mixtures of solvents (n = 731), the WEI for mixture together 
with noise (90 dBA) was 4.8 (0.01-9.9), the prevalence of hearing loss was 63 % 
and the OR 2.4 (95 % CI 1.6-3.7). A group exposed mainly to a mixture of toluene 
and n-hexane (hazard index for mixture 1.6 (0.8-4.5)) and moderate noise levels 
(79 dBA) had a prevalence of hearing loss of 73 % and an OR of 5.3 (95 % CI 2.6-
11). When the workers were divided into subgroups according to the noise ex-
posure and adjusted for age, the OR for the solvent mixtures without noise (equal 
to and below 85 dBA) was 4.1 and with noise (above 85 dBA) 6.7, whereas in the 
group exposed to n-hexane plus toluene the OR was 8.0 without noise and 20.2 
with noise (347). 
Pure-tone audiograms were measured in 100 workers in a car painting factory. 
Half of the workers were exposed to an unspecified mixture of solvents (levels not 
known) together with moderate noise (81.5-85 dBA) and the other half to noise 
only, at a similar level. These workers were also compared to a group exposed to 
high levels of noise (92.5-107 dB). The group exposed to solvent mixtures dis-
played significantly higher hearing thresholds compared to the moderate noise 
only group. The hearing loss in the solvent group was of the same magnitude as  
in the group exposed to high levels of noise (95). 
Using parts of a selected test battery (pure-tone audiometry including high 
frequencies 0.5-16 kHz and dichotic listening test), Fuente et al investigated 110 
workers exposed to a solvent mixture with toluene and methyl ethyl ketone as the 
main components but including also other solvents. Samples taken over the past 
20 years were available and the geometrical means of toluene in the air were 3.21 
ppm (geometrical SD 3.17, range 0.3-26, n = 18) and 4.77 ppm (SD 4.18, range 
0.001-131, n = 72) for the groups of workers classified as moderately and highly 
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exposed, respectively. Workers from the office (n = 20) served as controls. Noise 
levels the past 10 years ranged from 74 to 84 dBA. Pure-tone audiometry and high-
frequency audiometry as well as the dichotic listening test showed significantly 
worse results in the highly exposed group compared to the control group. The 
multiple regression analysis showed that outcomes of pure-tone audiometry were 
best predicted by solvent exposure group and male gender. Outcomes of high-
frequency audiometry and dichotic listening test were also predicted by solvent 
exposure group, but also by some factors such as race and ethnicity (Hispanic) 
(138). 
Bernardi investigated 136 workers of which 90 were exposed to a combination 
of noise and a mixture of solvents, 24 exposed to noise alone, 10 exposed to n-
hexane alone (reported under n-hexane) and 12 controls. The solvent mixture 
included among others n-hexane and petroleum and the exposure levels were 
subdivided into high, medium, and low. Auditory function was measured using 
pure-tone audiometry and long latency auditory evoked potentials. High and 
medium noise exposure caused a 4-fold increase in the OR for hearing loss (4.06, 
95 % CI 1.28-13). A dose-response gradient was detected for the simultaneous 
exposure to noise and solvents and hearing loss, with a significant association for 
medium or high exposure to the solvents with noise (OR 9.5, 95 % CI 2-44.5). 
Also the long latency auditory evoked potential was affected by the solvent 
exposures (32). 
Kaufman et al investigated the risk for hearing loss in military personnel (n = 
138) exposed to jet fuels and/or noise. The exposure to jet fuels was estimated by 
measurements and historical records, with levels clearly below the US Air Force 
Exposure Standards of 700 mg/m3 for JP-4 and 350 mg/m3 for JP-8 (calculated 
cumulative annual JP-4 exposures ranged from 0 to 33 % of this maximum for JP-
4 and from 0.5 to 11 % for JP-8). The exposure to noise was estimated through 
current and historical noise dosimetry measurements. Three years of jet fuel and 
noise exposure caused a 70 % increase in adjusted OR for hearing loss (1.7, 95 % 
CI 1.14-2.5). The OR increased to 2.41 (95 % CI 1.04-5.6) for 12 years of fuel and 
noise exposure (189). 
In a study by Kim et al, the hearing of 328 workers in aviation industry was 
investigated. Workers were divided into 4 groups after a classification system, 
where noise exposure was scored from 0-3 (78-90 dB) and solvent exposure  
was scored from 0-2 (hazard index 0.046, 0.256, and 0.857). The subjects were 
classified as exposed to solvents when the cumulative index (exposure index × 
years) was above 10 (this was equal to e.g. more than 11 years of exposure to low-
level solvents or more than 3 years of exposure to high-level solvents). The pre-
valence of hearing loss was 55 % in the group exposed concomitantly to noise and 
mixed solvents compared to 28 % in the group exposed to solvent mixtures only, 
17 % in the noise-only and 6 % in unexposed controls. The relative risks adjusted 
for age were estimated to be 8.1 (95 % CI 2-32.5) for the noise and solvents group, 
2.6 (95 % CI 0.6-10.3) for the solvents group and 4.3 (95 % CI 1.7-11) for the 
noise-only group (191).  
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Prasher et al investigated aircraft maintenance workers exposed to solvent 
mixtures and intermittent noise with an extensive audiological test battery. The 
group was compared to mill workers exposed to noise alone, to a small group 
exposed only to solvent mixtures and to unexposed controls. Besides pure-tone 
audiometry, the tests included acoustic reflex thresholds, transient and distortion 
product otoacoustic emissions, auditory brainstem responses as well as different 
vestibular tests. The noise alone group had a higher prevalence of hearing loss as 
well as decreased otoacoustic emissions. The group exposed to solvents and noise 
showed significant effects in the tests evaluating the central parts of the auditory 
system such as auditory brainstem responses and acoustic reflexes. In the group 
exposed to solvents and noise, 32 % showed abnormal results in the balance tests 
(301). 
Hearing loss development during 5 years was investigated in petrochemical 
workers exposed long-term to low levels of solvents and different levels of noise. 
Twenty-six per cent of the workers in the department with solvent exposure and 
low noise exposure (< 83 dBA) had their hearing thresholds significantly worsened 
in the 5-year period, 27 % in the department with solvent exposure and moderate 
noise (≤ 88 dBA) and 36 % in the utility department without solvent exposure but 
higher noise levels (up to 91 dBA). Of all workers, 29 % had significant poorer 
thresholds in the year 2002 as compared to 1998. Such percentages can be con-
sidered excessive (86). 
Prevalence of, and risk factors for, hearing loss in the Canadian armed forces 
were investigated using current and first time audiograms and a questionnaire. The 
prevalence of moderate to severe hearing loss progressed with age. In the oldest 
age group among flight engineers, signal operators and cooks, 15 % or more had  
a moderate to severe hearing loss of 40 dBHL or more at 4 or 6 kHz. The results 
from the questionnaire revealed that the poor use of hearing protection was the 
most frequent explanation for the prevalence of hearing loss but also the solvent 
exposure was of importance since more than 60 % of the total sample was exposed 
to solvents at work (3). 
A retrospective cohort study examined the relationship between solvent 
exposure and hearing loss in a cohort of 1 319 (age 35 years or less) aluminium 
industry workers. Employment, industrial hygiene and audiometric surveillance 
records allowed for estimation of noise and solvent exposures over the study 
period. The most common solvent exposures identified through the industrial 
hygiene records were to xylene, toluene and methyl ethyl ketone. Recorded solvent 
exposure levels varied widely both within and between jobs. While the highest 
levels recorded were several times higher than the ACGIH threshold limit values 
for individual solvents, TWAs over the study period in general were well below. 
Significant risk factors for hearing loss (3-6 kHz average) included age, reported 
hunting and shooting, higher baseline hearing threshold and solvent exposure (OR 
1.9, 95 % CI 1.2-2.9) (317).  
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7.8.4 Conclusion on solvent mixtures  
There are only a few animal studies regarding ototoxicity of solvent mixtures. In a 
rat inhalation study, exposure to 800 ppm dearomatised white spirits for 6 months 
caused no effects on hearing thresholds (NOAEL) (236).  
In rats, inhalation exposure for 5 days to 1 000 mg/m3 JP-8 (only dose tested) 
caused some effects on outer hair cells (LOAEL). When JP-8 exposure was 
followed by noise, the effects were more evident and permanent and appeared 
after 1 day of exposure (132). Thus, JP-8 exposure increased the susceptibility  
to noise exposure.  
In the human studies, it should be noted that the exposure to solvent mixtures 
varied regarding both levels and composition. Some studies with large study groups 
reported an association between low to moderate exposure to solvent mixtures and 
hearing disorders. However, exposure information is often incomplete, and current 
levels do not necessarily reflect exposure history. Even though solvent exposures 
were low in some of the studies described, it is possible that past exposure was 
much higher, and that peak non-trivial exposures (current or past) may have con-
tributed considerably to the hearing losses. 
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(37
9) 
TO
L,
 
X
Y
L 
an
d 
n
-
H
EX
 
 
Lo
w
 
le
v
el
s,
 
cu
rr
en
t H
I 0
.
25
 
D
u
ra
tio
n
 
(m
ea
n
 
±
 
SD
): 
17
.
5 
±
 
10
 
yr
s 
 
 
Se
lf-
es
tim
at
ed
 
da
ta
 
 
su
gg
es
t <
 
85
 
dB
 
Fu
rn
itu
re
 
w
o
rk
er
s 
10
 
M
IX
 
10
 
co
n
tr
o
ls 
M
IX
 
ex
po
se
d 
ha
d 
n
o
rm
al
 
PT
A
 
bu
t s
ig
n
ifi
ca
n
tly
 
po
o
re
r 
re
su
lts
 
th
an
 
co
n
tr
o
ls 
in
 
se
v
er
al
 
te
st
s 
fro
m
 
a 
ba
tte
ry
 
o
f c
en
tr
al
 
au
di
to
ry
 
te
st
s.
 
(13
7) 
Ex
po
su
re
 
in
 
v
ar
io
u
s 
o
cc
u
pa
tio
n
s 
Le
v
el
s 
n
o
t g
iv
en
 
Se
lf-
es
tim
at
ed
 
3 
28
4 
su
bje
ct
s 
R
R
 
1.
4 
(95
 
%
 
CI
 
1.
1-
1.
9) 
fo
r 
se
lf-
as
se
ss
ed
 
he
ar
in
g 
lo
ss
 
in
 
su
bje
ct
s 
ex
po
se
d 
to
 
so
lv
en
ts
 
≥
 
5 
yr
s 
w
ith
o
u
t 
N
.
 
(17
8) 
V
ar
io
u
s 
so
lv
en
t 
Le
v
el
s 
n
o
t g
iv
en
 
D
u
ra
tio
n
: 
lo
n
g-
te
rm
 
 
N
o
t g
iv
en
,
 
bu
t l
o
n
g-
te
rm
 
ex
po
su
re
 
4 
pa
tie
n
ts
 
30
 
sh
ip
ya
rd
 
pa
in
te
rs
 
4 
pa
tie
n
ts
 
w
ith
 
m
o
re
 
ex
te
n
de
d 
he
ar
in
g 
lo
ss
 
th
an
 
co
u
ld
 
be
 
ex
pe
ct
ed
 
fro
m
 
N
 
hi
st
o
ry
.
 
 
≥
 
50
 
%
 
o
f s
hi
py
ar
d 
w
o
rk
er
s 
ha
d 
he
ar
in
g 
lo
ss
.
 
 
N
 
ex
po
su
re
 
w
as
 
lo
n
g 
bu
t i
n
te
ra
ct
io
n
s 
w
ith
 
M
IX
 
ex
po
su
re
 
n
o
t e
x
cl
u
de
d.
 
(23
) 
Ch
em
ic
al
 
de
pa
rt
m
en
t a
t p
ap
er
 
m
ill
 
fa
ct
o
ry
 
Le
v
el
s 
n
o
t g
iv
en
 
80
-
90
 
dB
 
(M
IX
) 
95
-
10
0 
dB
 
(N
) 
Pa
pe
r 
m
ill
 
fa
ct
o
ry
 
47
 
M
IX
 
16
4 
N
 
23
 
%
 
o
f t
he
 
M
IX
 
ex
po
se
d 
de
v
el
o
pe
d 
se
v
er
e 
he
ar
in
g 
lo
ss
 
af
te
r 
20
 
yr
s 
co
m
pa
re
d 
to
 
8 %
 
in
 
N
 
gr
o
u
p.
 
 
(30
) 
A
lip
ha
tic
 
an
d 
ar
o
m
at
ic
 
so
lv
en
ts
: 
N
o
 
cu
rr
en
t 
ex
po
su
re
.
 
D
u
ra
tio
n
: 
5-
40
 
yr
s 
 
Je
t f
u
el
: 
Le
v
el
s 
n
o
t g
iv
en
.
 
 
D
u
ra
tio
n
: 
15
-
41
 
yr
s 
N
o
t g
iv
en
 
23
 
M
IX
 
(co
n
fir
m
ed
/ 
su
sp
ec
te
d 
PO
S)
 
8 
jet
 
fu
el
 
>
 
50
 
%
 
o
f t
he
 
ex
po
se
d 
ha
d 
ab
n
o
rm
al
 
sp
ee
ch
 
di
sc
rim
in
at
io
n
,
 
CR
A
 
an
d 
ce
n
tr
al
 
v
es
tib
u
la
r 
dy
sf
u
n
ct
io
n
.
 
M
o
re
 
se
v
er
e 
re
su
lts
 
in
 
PO
S 
pa
tie
n
ts
.
 
(39
7) 
  79
 
Ta
bl
e 
20
.
 
O
cc
u
pa
tio
n
al
 
st
u
di
es
 
o
n
 
au
di
to
ry
 
ef
fe
ct
s 
o
f e
x
po
su
re
 
to
 
so
lv
en
t m
ix
tu
re
s 
(M
IX
), t
es
te
d 
w
ith
 
pu
re
-
to
n
e 
au
di
o
m
et
ry
,
 
u
n
le
ss
 
o
th
er
w
ise
 
st
at
ed
 
(in
 
o
rd
er
 
as
 
ap
pe
ar
in
g 
in
 
th
e 
te
x
t).
 
 
Ex
po
su
re
 
de
sc
rip
tio
n
 
M
IX
 
sp
ec
ifi
ca
tio
n
 
an
d 
ex
po
su
re
 
du
ra
tio
n
 
N
o
ise
 
(N
) 
N
o
.
 
o
f e
x
po
se
d 
 
an
d 
co
n
tr
o
ls 
R
es
u
lts
 
an
d 
co
m
m
en
ts
 
R
ef
er
en
ce
 
W
hi
te
 
sp
iri
ts
,
 
th
in
n
er
,
 
TO
L 
an
d 
X
Y
L 
Le
v
el
s 
n
o
t g
iv
en
 
 
D
u
ra
tio
n
: 
4-
45
 
yr
s 
N
o
t g
iv
en
 
60
 
M
IX
 
(su
sp
ec
te
d 
PO
S)
 
 
18
 
co
n
tr
o
ls 
9 
M
IX
 
(co
n
fir
m
ed
 
PO
S)
 
9 
co
n
tr
o
ls 
Lo
w
er
 
sc
o
re
s 
o
n
 
di
st
o
rt
ed
 
sp
ee
ch
 
an
d 
lo
n
ge
r 
la
te
n
ci
es
 
o
f t
he
 
CR
A
 
in
 
M
IX
 
ex
po
se
d.
 
 
(27
2,
 
27
8) 
Ex
po
su
re
s 
fro
m
 
w
o
rk
 
as
 
co
lo
u
r 
m
ix
er
s,
 
pa
in
te
rs
,
 
pr
in
te
rs
 
an
d 
pe
tr
o
l t
ru
ck
 
dr
iv
er
s 
Le
v
el
s 
n
o
t g
iv
en
.
 
D
u
ra
tio
n
: 
4-
25
 
yr
s 
N
o
t g
iv
en
 
53
 
M
IX
 
(su
sp
ec
te
d 
PO
S)
 
25
 
pa
tie
n
ts
 
ha
d 
ab
n
o
rm
al
 
v
al
u
es
 
in
 
o
n
e 
o
r 
m
o
re
 
v
es
-
tib
u
la
r 
te
st
.
 
31
 
pa
tie
n
ts
 
sh
o
w
ed
 
de
cr
ea
se
d 
di
sc
rim
i-
n
at
io
n
 
sc
o
re
s 
at
 
th
e 
in
te
rr
u
pt
ed
 
sp
ee
ch
.
 
N
o
rm
al
 
PT
A
.
 
(29
4) 
H
ist
o
ry
 
o
f e
x
po
su
re
 
to
 
pa
in
ts
,
 
v
ar
n
ish
,
 
gl
u
e,
 
ga
so
lin
e,
 
ST
Y
,
 
le
ad
.
 
Le
v
el
s 
n
o
t g
iv
en
 
 
D
u
ra
tio
n
: 
1-
20
 
yr
s 
N
o
t g
iv
en
 
33
 
M
IX
 
co
m
pa
re
d 
to
 
n
o
rm
al
 
cl
in
ic
al
 
v
al
u
es
 
M
ild
 
to
 
m
o
de
ra
te
 
he
ar
in
g 
lo
ss
 
in
 
so
m
e 
su
bje
ct
s.
 
A
bn
o
rm
al
 
re
su
lts
 
in
 
ce
n
tr
al
 
he
ar
in
g 
te
st
s 
as
 
fil
te
re
d 
sp
ee
ch
 
an
d 
co
gn
iti
v
e 
re
sp
o
n
se
s.
 
(21
4) 
EB
Z,
 
X
Y
L 
an
d 
TM
B
 
 
Cu
rr
en
t e
x
po
su
re
,
 
H
I 0
.
8-
1.
3 
(ra
n
ge
 
0.
4-
2.
9) 
Cu
m
u
la
tiv
e 
do
se
s 
u
se
d 
(cu
rr
en
t e
x
p ×
 
yr
s) 
D
u
ra
tio
n
: 
lo
n
g-
te
rm
 
 
60
-
75
 
dB
A
 
Le
q 
(cu
rr
en
t) 
61
 
M
IX
 
40
 
co
n
tr
o
ls,
 
ag
e-
m
at
ch
ed
 
Pr
ev
al
en
ce
 
o
f h
ea
rin
g 
lo
ss
: 
42
 
%
 
in
 
M
IX
 
co
m
pa
re
d 
to
 
5 %
 
in
 
co
n
tr
o
ls.
 
V
es
tib
u
la
r 
dy
sf
u
n
ct
io
n
: 
47
.
5 %
 
in
 
M
IX
 
co
m
pa
re
d 
to
 
5 %
 
in
 
co
n
tr
o
ls.
 
(35
7) 
TO
L 
≤
 
70
 
pp
m
,
 
X
Y
L 
≤
 
40
 
pp
m
 
 
Cu
rr
en
t e
x
po
su
re
,
 
H
I ≤
 
1.
53
 
<
 
85
 
dB
 
39
 
M
IX
 
(pa
in
te
rs
) 
50
 
co
n
tr
o
ls 
O
R
 
5 
(95
 
%
 
CI
 
1.
4-
17
.
5) 
fo
r 
he
ar
in
g 
lo
ss
 
in
 
pa
in
te
rs
.
 
(25
4) 
TO
L 
≤
 
18
 
pp
m
,
 
X
Y
L 
<
 
5 
pp
m
,
 
 
EB
Z 
<
 
1.
8 p
pm
,
 
cy
cl
o
H
EX
 
<
 
14
 
pp
m
 
Le
v
el
s 
be
lo
w
 
TL
V
s 
<
 
85
 
dB
A
 
TW
A
 
O
il 
re
fin
er
y 
43
8 
w
o
rk
er
s 
H
ea
rin
g 
lo
ss
: 
O
R
 
2.
4 
(95
 
%
 
CI
 
1.
0-
5.
7) 
fo
r 
w
o
rk
er
s 
ex
po
se
d 
to
 
ar
o
m
at
ic
s 
an
d 
pa
ra
ffi
n
s.
 
O
R
 
3.
0 
(95
 
%
 
CI
 
1.
3-
6.
9) 
fo
r 
N
 
ex
po
se
d 
fro
m
 
m
ai
n
te
n
an
ce
 
gr
o
u
p.
 
H
ea
rin
g 
lo
ss
 
as
se
ss
ed
 
by
 
PT
A
 
an
d 
im
m
ita
n
ce
 
au
di
o
-
m
et
ry
 
re
fle
x
es
 
su
gg
es
ts
 
al
so
 
ce
n
tr
al
 
in
v
o
lv
em
en
t. 
(25
5) 
M
ax
 
w
o
rk
-
lif
e 
av
er
ag
e:
 
X
Y
L 
25
 
pp
m
,
 
TO
L 
25
 
pp
m
,
 
w
hi
te
 
sp
iri
t 9
0 p
pm
 
an
d 
EB
Z 
20
 
pp
m
 
 
W
o
rk
-
lif
e 
ex
po
su
re
 
in
de
x
 
0.
3-
3.
0 
 
M
ea
n
 
du
ra
tio
n
: 
12
.
5 
yr
s 
(ra
n
ge
 
0.
5-
39
) 
>
 
85
 
dB
A
 
(M
IX
+
N
) 
≤
 
85
 
dB
A
 
(M
IX
) 
≤
 
80
 
dB
A
 
(su
bg
ro
u
p 
M
IX
) 
Pa
in
t a
n
d 
la
cq
u
er
 
96
 
M
IX
+
N
 
20
7 
M
IX
 
 
21
4 
co
n
tr
o
ls 
O
R
 
4.
4 
(95
 
%
 
CI
 
2.
3-
8.
1) 
fo
r 
he
ar
in
g 
lo
ss
 
fo
r 
su
b-
gr
o
u
p 
M
IX
 
(N
 
≤
 
80
 
dB
A
) c
o
m
pa
re
d 
to
 
N
 
m
at
ch
ed
 
co
n
tr
o
ls.
 
Po
o
re
r 
m
ea
n
 
he
ar
in
g 
th
re
sh
o
ld
s 
at
 
2-
4 
kH
z 
fo
r 
M
IX
+
N
 
gr
o
u
p 
th
an
 
fo
r 
M
IX
 
gr
o
u
p.
 
(34
8,
 
35
0) 
  80
 
Ta
bl
e 
20
.
 
O
cc
u
pa
tio
n
al
 
st
u
di
es
 
o
n
 
au
di
to
ry
 
ef
fe
ct
s 
o
f e
x
po
su
re
 
to
 
so
lv
en
t m
ix
tu
re
s 
(M
IX
), t
es
te
d 
w
ith
 
pu
re
-
to
n
e 
au
di
o
m
et
ry
,
 
u
n
le
ss
 
o
th
er
w
ise
 
st
at
ed
 
(in
 
o
rd
er
 
as
 
ap
pe
ar
in
g 
in
 
th
e 
te
x
t).
 
 
Ex
po
su
re
 
de
sc
rip
tio
n
 
M
IX
 
sp
ec
ifi
ca
tio
n
 
an
d 
ex
po
su
re
 
du
ra
tio
n
 
N
o
ise
 
(N
) 
N
o
.
 
o
f e
x
po
se
d 
 
an
d 
co
n
tr
o
ls 
R
es
u
lts
 
an
d 
co
m
m
en
ts
 
R
ef
er
en
ce
 
M
ai
n
 
so
lv
en
t X
Y
L,
 
m
in
o
r 
TO
L,
 
EB
Z,
 
 
w
hi
te
 
sp
iri
t, 
n
-
bu
ta
n
o
l  
Cu
rr
en
t H
I 6
.
3 
(0.
8-
23
.
2,
 
82
 
%
 
ha
d 
H
I >
 
1) 
 
W
o
rk
-
lif
e 
H
I 6
6 
(0.
1-
34
6) 
93
 
dB
 
(M
IX
+
N
) 
90
 
dB
 
(N
) 
D
o
ck
ya
rd
 
w
o
rk
er
s 
51
7 
M
IX
+
N
 
18
4 
N
 
20
5 
co
n
tr
o
ls 
H
ea
rin
g 
lo
ss
: 
O
R
 
4.
9 
(95
 
%
 
CI
 
3.
1-
7.
7) 
fo
r 
M
IX
+
N
 
gr
o
u
p,
 
O
R
 
3.
3 
(95
 
%
 
CI
 
2.
1-
5.
4) 
fo
r 
N
 
al
o
n
e 
gr
o
u
p 
(34
9) 
M
ai
n
 
co
m
po
n
en
t X
Y
L 
 
W
o
rk
-
lif
e 
H
I 4
.
8 
(0.
01
-
9.
9) 
H
EX
+
TO
L 
 
W
o
rk
-
lif
e 
H
I 1
.
6 
(0.
8-
4.
5) 
90
 
dB
A
 
(M
IX
) 
79
 
dB
A
 
(H
EX
+
TO
L)
 
78
 
dB
A
 
(co
n
tr
o
ls)
 
73
1 
M
IX
 
96
 
H
EX
+
TO
L 
 
22
3 
co
n
tr
o
ls 
Pr
ev
al
en
ce
 
o
f h
ea
rin
g 
lo
ss
: 
42
 
%
 
in
 
co
n
tr
o
l g
ro
u
p,
 
63
 
%
 
in
 
M
IX
 
gr
o
u
p 
(O
R
 
2.
4,
 
95
 
%
 
CI
 
1.
6-
3.
7),
 
73
 
%
 
in
 
H
EX
+
TO
L 
(O
R
 
5.
3,
 
95
 
%
 
CI
 
2.
6-
11
). 
(34
7) 
U
n
sp
ec
ifi
ed
 
Le
v
el
s 
n
o
t g
iv
en
 
 
D
u
ra
tio
n
: 
5-
15
 
yr
s 
81
.
5-
85
 
dB
A
 
(M
IX
+
m
o
d N
) 
81
.
5-
85
 
dB
A
 
(m
o
de
ra
te
 
N
) 
92
.
5-
10
7 
dB
A
 
(hi
gh
 
N
) 
Ca
r 
pa
in
te
rs
 
50
 
M
IX
+
 
m
o
de
ra
te
 
N
 
50
 
m
o
de
ra
te
 
N
 
 
60
 
hi
gh
 
N
 
M
IX
+
m
o
d 
N
 
gr
o
u
p 
ha
d 
sig
n
ifi
ca
n
tly
 
hi
gh
er
 
he
ar
in
g 
th
re
sh
o
ld
s 
th
an
 
m
o
de
ra
te
 
N
 
gr
o
u
p.
 
 
H
ea
rin
g 
lo
ss
 
in
 
M
IX
+
m
o
d 
N
 
th
e 
sa
m
e 
as
 
in
 
hi
gh
 
N
.
 
(95
) 
TO
L,
 
M
EK
,
 
TC
E,
 
CB
Z 
an
d 
o
th
er
s 
G
eo
m
et
ric
 
m
ea
n
s:
 
3.
2 
pp
m
 
TO
L,
 
5.
8 
pp
m
 
M
EK
 
(m
o
de
ra
te
) 
4.
8 
pp
m
 
TO
L,
 
12
.
5 
pp
m
 
M
EK
 
(hi
gh
) 
D
u
ra
tio
n
: 
20
 
yr
s 
 
74
-
84
 
dB
A
 
al
l g
ro
u
ps
 
 
(la
st
 
10
 
yr
s) 
Co
at
ed
 
fa
br
ic
s 
w
o
rk
er
s 
18
 
M
IX
 
(m
o
de
ra
te
)  
72
 
M
IX
 
(hi
gh
) 
20
 
co
n
tr
o
ls 
(lo
w
) 
M
IX
 
(hi
gh
) g
ro
u
p 
ha
d 
sig
n
ifi
ca
n
tly
 
hi
gh
er
 
he
ar
in
g 
th
re
sh
o
ld
s 
an
d 
w
o
rs
e 
re
su
lts
 
in
 
ce
n
tr
al
 
he
ar
in
g 
te
st
 
co
m
pa
re
d 
to
 
th
e 
co
n
tr
o
l g
ro
u
p.
 
So
lv
en
t e
x
po
su
re
 
gr
o
u
p 
pr
ed
ic
te
d 
he
ar
in
g 
lo
ss
 
o
u
tc
o
m
e.
 
(13
8) 
n
-
H
EX
,
 
pe
tr
o
le
u
m
 
an
d 
o
th
er
s 
n
-
H
EX
 
al
o
n
e 
≥
 
85
 
dB
A
 
(M
IX
+
N
) 
90
 
M
IX
+
N
 
 
24
 
N
 
10
 
n
-
H
EX
 
12
 
co
n
tr
o
ls 
 
A
u
di
to
ry
 
fu
n
ct
io
n
 
m
ea
su
re
d 
by
 
PT
A
 
an
d 
au
di
to
ry
 
ev
o
ke
d 
P3
00
.
 
A
 
do
se
-
re
sp
o
n
se
 
gr
ad
ie
n
t f
o
r 
sim
u
l-
ta
n
eo
u
s 
ex
po
su
re
 
to
 
M
IX
 
an
d 
N
 
an
d 
he
ar
in
g 
lo
ss
,
 
w
ith
 
a 
sig
n
ifi
ca
n
t a
ss
o
ci
at
io
n
 
fo
r 
m
ed
iu
m
 
o
r 
hi
gh
 
ex
po
su
re
s 
to
 
M
IX
 
an
d 
N
,
 
O
R
 
9.
5 
(95
 
%
 
CI
 
2-
44
.
5).
 
 
(32
) 
Je
t f
u
el
s 
Le
v
el
s 
34
 
%
 
o
f U
S 
O
SH
A
 
st
an
da
rd
s 
 
Cu
m
u
la
tiv
e 
ex
po
su
re
s 
to
 
N
 
an
d 
jet
 
fu
el
s 
u
se
d.
 
D
u
ra
tio
n
: 
at
 
le
as
t 3
 
yr
s 
≥
 
85
 
dB
A
 
at
 
le
as
t 3
 
yr
s 
M
ili
ta
ry
 
pe
rs
o
n
n
el
 
13
8 
jet
 
fu
el
 
an
d/
o
r 
N
 
H
ea
rin
g 
lo
ss
 
af
te
r 
ex
po
su
re
 
to
 
jet
 
fu
el
+
N
: 
 
O
R
 
1.
7 
(95
 
%
 
CI
 
1.
14
-
2.
5) 
af
te
r 
3 
yr
s 
o
f e
x
po
su
re
,
 
 
O
R
 
2.
4 
(95
 
%
 
CI
 
1.
04
-
5.
6) 
af
te
r 
12
 
yr
s 
o
f e
x
po
su
re
.
 
(18
9) 
  81
 
Ta
bl
e 
20
.
 
O
cc
u
pa
tio
n
al
 
st
u
di
es
 
o
n
 
au
di
to
ry
 
ef
fe
ct
s 
o
f e
x
po
su
re
 
to
 
so
lv
en
t m
ix
tu
re
s 
(M
IX
), t
es
te
d 
w
ith
 
pu
re
-
to
n
e 
au
di
o
m
et
ry
,
 
u
n
le
ss
 
o
th
er
w
ise
 
st
at
ed
 
(in
 
o
rd
er
 
as
 
ap
pe
ar
in
g 
in
 
th
e 
te
x
t).
 
 
Ex
po
su
re
 
de
sc
rip
tio
n
 
M
IX
 
sp
ec
ifi
ca
tio
n
 
an
d 
ex
po
su
re
 
du
ra
tio
n
 
N
o
ise
 
(N
) 
N
o
.
 
o
f e
x
po
se
d 
 
an
d 
co
n
tr
o
ls 
R
es
u
lts
 
an
d 
co
m
m
en
ts
 
R
ef
er
en
ce
 
M
EK
,
 
TO
L,
 
X
Y
L,
 
M
IB
K
 
Lo
w
 
le
v
el
s,
 
H
I <
 
1 
D
u
ra
tio
n
: 
lo
n
g-
te
rm
 
≤
 
80
 
dB
 
(M
IX
) 
81
-
92
 
dB
 
(M
IX
+
N
) 
85
-
10
1 
dB
 
(N
) 
≤
 
80
 
dB
 
(C
o
n
tr
o
ls)
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8. Auditory effects of metals  
8.1 Lead  
8.1.1 General 
Lead occurs naturally in the environment. It is a ubiquitous metal that has long 
been used by humans. Lead exposures can occur in mining and in polluted en-
vironments. Main industrial applications include the manufacture of car batteries, 
sheet metal, pipes and foil. Individuals employed in any of these occupations as 
well as professional shooters may bring lead dust on their bodies or clothing into 
their homes. Except in some developing countries, there is a declining use in 
paints, enamels and glazes. Hazard arises from inhalation of dust or fumes or 
certain motor vehicle emissions. Organic lead compounds can be absorbed 
through the skin (194). 
8.1.2 Effects in animals 
Several animal experiments have been conducted regarding the effects of lead 
exposure on the auditory system (Table 21).  
In guinea pigs, lead exposure induced dysfunction of the vestibulo-cochlear 
nerve but it did not induce dysfunction of the organ of Corti and the stria vascularis 
(388). In contrast, cochlear effects by lead were reported in studies with monkeys 
(204, 331). Auditory brainstem response latencies were less affected by stimulus 
intensity, stimulus rate and noise masking level in unexposed monkeys as com-
pared to humans (205).  
Three of six monkeys exposed for life-time to lead exhibited elevated thresholds 
for pure tones. The monkeys had high current blood lead concentrations between 
50 and 170 µg/dl with a history of moderate blood lead levels of 30 µg/dl. The 
relative contribution of current and long-term moderate blood lead concentrations 
to the observed results is unknown (331).  
In another study of long-term exposed monkeys, blood lead levels of 35 µg/dl 
did not cause significant effects on evoked potentials (NOAEL). At a level of 55 
µg/dl, these effects were significant (LOAEL) (221). 
Blood lead levels of 35-40 µg/dl in monkeys exposed from birth up to 2 years  
of age had no significant effects on auditory function (NOAEL) (202). Also in 
monkeys, concentrations in dams at or above 85 µg/dl during pregnancy and 122 
µg/dl during lactation were associated with cochlear dysfunction in 2/11 offspring. 
These 2 monkeys hade the highest blood levels at 0-6 months of age (46 and 70 
µg/dl) (204). Interaction with noise has not been studied.  
8.1.3 Observations in man  
8.1.3.1 Lead alone or combined with noise.  
Occupational studies have been conducted regarding the effects of lead exposure 
on the auditory system (Table 22). Noise levels were not always reported, 
particularly because most studies examined the effects of lead on the central 
auditory system, which is not considered to be affected by noise exposure. 
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However, due to the nature of the work performed, it is likely that the studied 
workers were also exposed to noise.  
Studies conducted with lead-exposed workers consistently report an association 
between lead exposure and central auditory effects. Chronic lead exposure im-
paired conduction in the auditory nerve and the auditory pathway in the lower 
brainstem. Blood lead concentrations correlated significantly with abnormalities  
in the recorded evoked potentials in several investigations.  
Farahat et al reported a significant correlation between current blood lead levels 
and hearing thresholds. The exposed workers (mean 37 µg/dl) had significantly 
elevated hearing thresholds compared to the controls (110). Also Forst et al 
reported a significant correlation between current blood lead levels and elevated 
hearing thresholds (defined as > 10 dB hearing loss) but only at 4 kHz (134). 
However, a hearing loss of 10 dB is not considered abnormal in workers 19-65 
years of age. 
Median blood lead levels of 30 µg/dl (range 10-64 µg/dl) was significantly 
associated with central auditory effects (evoked potentials and sensitised speech 
tests) but not peripheral ones (13, 177, 266). 
Bleecker et al reported an association between current mean (28 µg/dl) and life-
time weighted average (39 µg/dl) blood lead levels and auditory dysfunction (35). 
Several other studies have demonstrated auditory dysfunction at current mean 
blood lead levels of 42-57 µg/dl (70, 89, 90, 156, 386).  
The only study that tested for statistical interaction between lead and noise 
exposure showed no significant interaction. Long-term exposure to 57 µg/dl of 
lead significantly affected pure-tone thresholds (386).  
Studies on exposures outside the work environment are beyond the scope of  
the present document. However, in the case of lead, it is worth noting that several 
studies conducted with children have shown ototoxic effects (291-293, 340, 341), 
which were not seen in cases of extreme plumbism (40). 
8.1.4 Conclusion on lead 
In monkeys, a NOAEL of 35-40 µg/dl blood and a LOAEL of 55 µg/dl blood were 
identified (202, 221). Interaction with noise has not been studied in animals.  
In humans, central auditory effects have been associated with current exposures 
and life-time weighted average blood lead concentrations of approximately 28-57 
µg/dl (13, 35, 70, 89, 90, 110, 156, 177, 266, 386). Thus, auditory effects have 
been observed at blood lead levels found in the general population, e.g. in urban 
areas in Western Europe (37 µg/dl) (345). One study investigated but did not find 
any interaction between lead (57 µg/dl) and noise (386). 
International 8-hour OELs for elemental and inorganic lead are 0.05-0.15 mg/m3 
inhalable aerosol (Appendix 1). The EU SCOEL has recommended a health-based 
OEL of 0.1 mg/m3 and a biological exposure limit of 30 µg/dl blood to minimise 
the potential for adverse health effects including neurotoxicity, reproductive and 
developmental effects and carcinogenicity (99). 
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8.2 Mercury 
8.2.1 General 
Mercury is a naturally occurring element found in rocks and ores. Mercury is re-
leased into the atmosphere by evaporation from soils, from volcanic activity and 
from burning of fossil fuels such as coal, oil, petrol, asphalt, etc. (273). 
Exposure to mercury and mercury containing products may occur through con-
taminated air, water and food, or through the skin. Mercury released into the en-
vironment is converted into methyl mercury by aquatic bacteria. Methyl mercury 
bioaccumulates in the tissues of fish and shellfish, and humans (and other animals) 
may be poisoned by consumption of seafood (273). However, ototoxic effects 
reported following such environmental exposure, as well as from poisoning, will 
not be included in this document.  
Workers may be exposed to mercury and its compounds in mercury mines and 
refineries, chemical manufacturing, fluorescent light bulb manufacturing, dental/ 
health fields and metal smelting. Workers in fossil fuel power plants and in cement 
manufacturing may be exposed to mercury compounds if they are exposed to 
gaseous process emissions. The nervous system is very sensitive to all forms of 
mercury. Exposure to high levels of any types of mercury can permanently damage 
the brain, kidneys and developing foetus. Effects on the nervous system may result 
in irritability, tremors, changes in vision or hearing and memory problems. High 
exposures to mercury vapour may cause chest pain, shortness of breath, and pul-
monary oedema that can be fatal. Methyl mercury compounds and mercury metal 
vapours are especially harmful to the nervous system because more mercury 
reaches the brain. Mercury also accumulates in the body (192, 273).  
8.2.2 Effects in animals and in vitro studies 
8.2.2.1 Mercury alone 
Mercury is known to cause neurotoxicity and sensorineural hearing deficits. A few 
animal experiments assessed the effects of mercury and mercury compounds on 
the auditory system (Table 23).  
Cochlear effects were reported in studies with monkeys (332, 333). Monkeys 
exposed to methylmercuric chloride (CH3HgCl) (50 µg Hg/kg body weight and 
day) from birth to 7 years of age exhibited elevated pure-tone thresholds, in-
dicating a selective permanent high-frequency deficit, as measured at 14 years  
of age (333). In a later study by the same research team, monkeys were exposed to 
methylmercuric chloride (0, 10, 25 and 50 µg Hg/kg/day) throughout gestation and 
postnatally until 4 years of age. At 19 years of age, all exposed monkeys exhibited 
elevated pure-tone thresholds, generally across the full range of frequencies (332). 
In rats, exposure to 0.4 or 1.6 mg Hg/kg body weight as mercuric chloride 
(HgCl2), a soluble crystalline salt of mercury and one of its most toxic forms, daily 
for 12 weeks by gavage did not affect cortical auditory evoked potentials (112). 
Exposure of rats to 4 mg/m3 mercury vapour (Hg0) 2 hours/day on gestation days 
6-15 did not significantly alter evoked responses in adult offspring (154). 
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In vitro experiments (not in table) provided a description of mercury toxicity on 
central auditory structures. Gopal used microelectrode array recordings to evaluate 
acute and chronic neurotoxic effects of mercuric chloride on auditory cortex net-
works. Neurons dissociated from auditory cortices of 14-day-old mouse embryos 
were grown on photo-etched microelectrode arrays. For acute electrophysiological 
experiments, the spontaneous spiking and bursting activity from auditory cortex 
networks were compared before and after application of various concentrations of 
mercuric chloride. Results of acute experiments indicated that concentrations below 
75 mM of mercuric chloride had an excitatory effect of variable magnitude on the 
spontaneous activity of the auditory cortex networks. However, concentrations 
above 100 µM completely and irreversibly inhibited spike and burst activity. 
Chronic exposure to 10 mM mercuric chloride completely blocked the spontaneous 
activity. Morphological analysis indicated that 10 mM mercuric chloride caused 
neuronal cell death in 3 days (146).  
Liang et al used the whole cell patch clamp technique on freshly isolated outer 
hair cells of the guinea pig cochlea to record outward and inward potassium 
currents after treatment with mercuric chloride. Treatment affected potassium 
currents in a dose-dependent manner. The effects of mercuric chloride at 1.0-100 
mM were more pronounced on onset peak current than on steady-state end-current. 
Although the effect of mercuric chloride at 1.0 mM was partially washed out over 
several minutes, the effects at 10 and 100 mM were irreversible, also after wash-
out. Hearing sensitivity may thus result from dysfunction of hair cells, as their 
potassium channels are targets for mercuric chloride ototoxicity (219). 
8.2.2.2 Mercury combined with noise  
No studies were identified. 
8.2.3 Observations in man  
8.2.3.1 Mercury alone or combined with noise  
Occupational studies have been conducted regarding the effects of mercury 
exposure on the auditory system. Noise levels were not reported, particularly 
because most of the studies examined mercury’s central auditory effects, which 
are not considered to be affected by noise exposure. However, due to the nature  
of the tasks performed, it is likely that the workers were also exposed to noise.  
Discalzi et al used auditory brainstem responses to examine 22 workers exposed 
to lead, 8 exposed to mercury and 22 and 8 age- and sex-matched subjects, re-
spectively, never exposed to neurotoxic substances. All participants had normal 
audiometric thresholds (≤ 25 dBHL). Mean durations of exposure were 9.3 and 
11.7 years for lead and mercury, respectively. The urinary mercury content at the 
end of the previous working day was 325 µg/g creatinine. Both mercury and lead 
exposed workers showed a significant prolongation of wave I-V time (89). 
Counter et al measured mercury in blood and its auditory effects in children and 
adults in the remote Andean settlement of Nambija in Ecuador where mercury is 
used extensively in gold mining operations. The mean blood mercury level was 
17.5 µg/l in 75 inhabitants (36 children and 39 adults) versus 3.0 µg/l in a second 
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group of 34 subjects (15 children and 19 adults) in a non-gold mining area. Audio-
logical tests on 40 persons in the study area (21 children and 19 adults) showed 
hearing thresholds ranging from normal to mildly abnormal for children, and 
normal to severely abnormal for adults. Auditory brainstem evoked responses 
revealed a significant correlation between blood mercury levels and the I-III inter-
peak latencies on the right side. The results indicated that the study population had 
elevated blood mercury levels and may be at neurological risk from exposure to 
methyl mercury from the consumption of contaminated food and possibly from 
elemental mercury vapours inhaled during amalgam burning in the gold extraction 
process (71). 
More recently, Moshe et al also used auditory brainstem responses to examine 
the effects of industrial exposure to inorganic mercury and chlorinated hydro-
carbons on the auditory pathway. Forty workers were exposed to mercury, 37 
workers to chlorinated hydrocarbons and a control group of 36 subjects were  
never exposed to neurotoxic substances. The mean duration of exposure to mercury 
and chlorinated hydrocarbons was 15.5 and 15.8 years, respectively. The air con-
centration of current mercury exposure was 0.008 mg/m3. The current mean blood 
mercury level was inconsistently reported but was presumably 5 µg/l. A higher 
percentage of workers exposed to mercury and chlorinated hydrocarbons had 
abnormal prolongation of auditory brainstem response interpeak latencies I-III 
compared to control subjects (42 % and 34 % versus 18 %, respectively) (260).  
Thus, studies conducted with mercury exposed workers were consistent in 
reporting an association between mercury exposure and central auditory effects. 
Chronic mercury exposure impaired conduction in the auditory nerve and the 
auditory pathway in the lower brainstem.  
8.2.4 Conclusion on mercury 
In monkeys, ingestion (orally during gestation and postnatally for 4 years) of  
10 µg Hg/kg body weight/day as methylmercuric chloride was associated with 
permanent poorer hearing thresholds (LOAEL) (332). Interaction with noise was 
not studied. 
In humans, current mercury concentration in air of 0.008 mg/m3 and mean blood 
mercury levels of presumably 5 µg/l were significantly associated with effects as 
shown in central auditory tests (evoked potentials) (260). Higher concentrations 
were associated with similar outcomes (71, 89). Noise levels were not reported. 
International 8-hour OELs for elemental and inorganic mercury range from 0.02 to 
0.1 mg/m3 (Appendix 1). ACGIH has biological exposure limits for total inorganic 
mercury of 15 µg/l blood and 35 µg/g creatinine (7). In 2007, the EU SCOEL re-
commended biological limit values of 10 µg/l blood and 35 µg/g creatinine (101).  
All countries listed in Appendix 1 have OELs of 0.01 mg/m3 for organoalkyl 
mercury compounds. The ACGIH threshold limit values are primarily set to mini-
mise effects on the central and peripheral nervous system and kidney damage (4). 
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8.3 Organotins (trimethyltins) 
8.3.1 General 
Organotin compounds can be inhaled in commercial/industrial work environments 
where such compounds are produced or used, as in the production of plastics in 
the chemical industry and as biocides in antifouling boat bottom paints. Ingestion 
is considered an unlikely route of entry in these environments. Skin absorption 
may occur in direct contact with organotins (18). 
Alkyltins comprise a structurally related group of compounds that exhibit varied 
toxic effects. Trimethyltins and triethyltins have attracted considerable attention 
due to their close structural similarity and to the striking differences in their toxic 
actions (93). Trimethyltins have been extensively investigated for ototoxicity in 
animals. Trimethyltin is a neurotoxin, which damages areas of the limbic system, 
cerebral cortex and the brainstem. Instances of occupational exposure are rare but 
acute exposure to trimethyltin chloride may result in irritation of the eyes, skin, 
and mucous membranes, headache, blurred vision, facial flushing, excessive 
salivation, abdominal pain, nausea, vomiting, diarrhoea, vertigo and general 
malaise. Respiratory signs include coughing, shortness of breath and a burning 
sensation in the chest. Irregular heart rate, hypotension, cardiac arrhythmias and 
loss of consciousness may occur (18).  
8.3.2 Effects in animals and in vitro studies 
8.3.2.1 Trimethyltin alone  
The effects of trimethyltin on the auditory system have been studied in several 
animal experiments (Table 24). Trimethyltin disrupts auditory function at doses 
far below those shown to elicit general neurotoxicity (67, 393).  
Fechter et al investigated the development of ototoxicity in guinea pigs 6-48 
hours following a single intraperitoneal injection of 2 mg/kg body weight of 
trimethyltin. At all time interval studied, trimethyltin reduced compound action 
potential sensitivity and cochlear microphonics. No disruption in endocochlear 
potential was observed between 6 and 24 hours. Morphological examination 12 
hours following exposure showed permanent destruction of outer hair cells (128).  
In a later study by the same research group, trimethyltin was shown to disrupt 
the compound action potential sensitivity particularly between 8 and 24 kHz in a 
dose-related manner at doses as low as 0.2 mg/kg/body weight (guinea pigs, single 
intraperitoneal injection). A dose of 0.5 mg/kg body weight produced a loss of 
sensitivity which approached 30 dB (118).  
Young and Fechter investigated the ototoxicity in rats. A single intraperitoneal 
injection of trimethyltin chloride (2, 4 and 6 mg/kg) produced a frequency-specific 
dose-dependent auditory impairment, as well as decreased amplitude of the 
acoustically elicited startle response. At 2 mg/kg, no significant auditory effects 
were observed (393). In a later study by Crofton et al, rats were exposed to 3, 5  
or 7 mg/kg of trimethyltin (single intraperitoneal injection). Auditory brainstem 
responses were determined at 5, 40 and 80 kHz and acoustic startle response at 5 
and 40 kHz. The auditory brainstem response thresholds for 40-kHz tones were 
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elevated (30-50 dB) in the 5- and 7-mg/kg groups and for 80-kHz tones (17-31 
dB) in all dose groups. The acoustic startle response thresholds for 40-kHz tones 
were elevated (24-39 dB) in all groups. Morphological examination revealed a 
dose-dependent increase in outer hair cell loss preferentially in regions associated 
with high-frequency loss (79). 
The animal studies have consistently demonstrated cochlear effects of tri-
methyltin, which produces both hair cell and vascular damage in the cochlea. 
Trimethyltin disrupts function of the synapse between the inner hair cell and the 
Type 1 spiral ganglion cell. In all experiments with trimethyltin, the chemical  
was administrated by intraperitoneal injections in order to obtain information  
on ototoxic mechanisms rather than to evaluate potential risk to exposed 
populations. If extrapolations were made from dose levels in these experiments  
to the corresponding concentrations in air, the latter would be extremely high 
when compared to existing limits and human exposure to trimethyltin at these 
levels is unlikely.  
In vitro experiments (not in table) provided further descriptions of trimethyltin 
toxicity on the cochlea. Clerici et al examined 77 outer hair cells from 45 pig-
mented male guinea pigs. The cells were isolated in primary culture and exposed 
for 90 minutes to trimethyltin or triethyltin concentrations of 0.030-1.0 mM. 
Significant shortening of the outer hair cell body occurred at all doses to both 
organotins, with a mean reduction in length of 15 and 20 % for 1.0 mM trimethyl-
tin and triethyltin, respectively, compared to 3.4 % in control cells. The outer hair 
cells suffered a series of injuries, indicating that they represent one target of acute 
alkyltin ototoxicity (68). 
Fechter and Liu examined whether trimethyltin exerted direct toxic effects on 
the postsynaptic spiral ganglion cells and the role of extracellular calcium in such 
an effect. Trimethyltin induced a marked and sustained elevation in extracellular 
calcium levels in the spiral ganglion cells. The study indicated that extracellular 
calcium levels increased due to both increasing extracellular uptake and release  
of extracellular calcium from intracellular stores. Thus, trimethyltin ototoxicity 
appears to include a direct postsynaptic toxic event (119). In 1996, Liu and Fechter 
tested pigmented guinea pig outer hair cells and spiral ganglion cells in vitro to 
determine the role of enhanced intracellular calcium levels in trimethyltin oto-
toxicity. The study showed that trimethyltin elevates intracellular calcium levels  
in both types of cells. The elevation of trimethyltin in spiral ganglion cells is much 
more rapid and greater than that in the outer hair cells (227).  
8.3.2.2 Trimethyltin combined with noise  
No studies were identified. 
8.3.3 Observations in man  
No studies were identified.  
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8.3.4 Conclusion on trimethyltin 
In all animal studies, trimethyltin was administered by intraperitoneal injection.  
In guinea pigs, 0.2 mg/kg body weight resulted in auditory dysfunction (LOAEL) 
(118). In rats, 2 mg/kg body weight resulted in no effect on auditory function 
(NOAEL) (393), whereas 3 mg/kg resulted in auditory dysfunction and cor-
responding cochlear histopathology (LOAEL) (79). The reason for the difference 
between guinea pigs and rats is unknown, but it could possibly be explained by 
differences in uptake or metabolism between species. Interaction with noise was 
not studied. 
The auditory effects of trimethyltin in humans have not been studied. 
International 8-hour OELs for organotin compounds are 0.1 mg/m3 in all 
countries listed (Appendix 1). The ACGIH threshold limit value is set to prevent 
effects on immune function and the central nervous system (4). 
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9. Auditory effects of asphyxiants  
Asphyxiants are vapours or gases that can cause unconsciousness or death by 
suffocation (asphyxiation). They act by interfering with oxygen delivery or 
utilisation. Chemical asphyxiants reduce the blood’s ability to carry oxygen (like 
carbon monoxide) or interfere with the body’s utilisation of oxygen (like cyanide). 
The chemical asphyxiants that have been studied for their ototoxicity include 
carbon monoxide, hydrogen cyanide, acrylonitrile and 3,3'-iminodipropionitrile, 
each presented below. 
9.1 Carbon monoxide  
9.1.1 General 
Carbon monoxide, CO, is an odourless, tasteless, colourless, toxic gas. It occurs  
as a product of incomplete combustion of fuels, coal, oil and wood. It is present  
in petrol-powered engine exhaust and tobacco smoke. Carbon monoxide is co-
produced with hydrogen by steam reforming plants using methane or other hydro-
carbons as feedstock. It is a raw material for making monomers and other chemical 
products. Besides exposure via engine exhaust and tobacco smoke, which make 
exposure very common, other potential sources of carbon monoxide exposure 
include the process of forging, melting, pouring and welding metals, in farm 
operations, fire fighting, sewage and water treatment jobs (281). 
The carbon monoxide molecule consists of a carbon atom triply bonded to an 
oxygen atom. The toxicity of carbon monoxide results from its very tight binding 
to haemoglobin, the molecule carrying oxygen from the lungs to bodily tissues. 
Carbon monoxide readily combines with haemoglobin to form carboxyhaemo-
globin, thereby inhibiting haemoglobin from transporting oxygen. Excessive 
accumulations of carboxyhaemoglobin cause hypoxic stress as a result of the 
reduced oxygen-carrying capacity of the blood. In essence, victims are slowly 
suffocated because their haemoglobin is consumed (281). 
9.1.2 Effects in animals 
9.1.2.1 Carbon monoxide alone and combined with noise and other agents 
The auditory effects of carbon monoxide in combination with noise have been 
examined in numerous animal experiments (Table 25). The majority of studies 
were performed on rats. This species demonstrates a much higher resistance to 
acute carbon monoxide intoxication than humans. In rats, a lethal dose for a 30-
minute exposure is 5 000 ppm, in humans, the lethal dose is 1 500 ppm (320). The 
experiments in rats show that carbon monoxide does not alter auditory function by 
itself (up to 1 500 ppm) (61). Alone or combined with toluene, carbon monoxide 
exposure may potentiate noise-induced hearing loss (233). 
Carbon monoxide can potentiate noise-induced hearing loss at noise exposure 
conditions that have limited effects on auditory function alone as shown by e.g. 
Fechter et al (122) and Young et al (394). Studies by Chen et al (62) and Rao and 
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Fechter (320) indicate that under intermittent noise exposure with long quiet 
periods, carbon monoxide exposure may produce unexpectedly large, permanent 
threshold shifts. Surprisingly, the data did not validate the anticipated relation- 
ship between the percentage of time that noise is present (noise duty cycle) and 
increasing hearing loss. Instead, the mildest noise duty cycle (noise exposure inter-
rupted with quiet breaks) produced maximal hearing loss when carbon monoxide 
was also present. Otherwise, when carbon monoxide was absent, hearing loss was 
reduced due to the quiet breaks.  
Auditory function was compared in rats exposed 4 weeks earlier to carbon 
monoxide alone, noise alone, combined exposure to carbon monoxide and noise, 
or air in a chamber. The compound action potential threshold evoked by pure-tone 
stimuli was used as a measure of auditory sensitivity. The experimental NOAEL 
with respect to potentiation of noise-induced hearing loss was found to be 300 
ppm carbon monoxide. Potentiation of noise-induced hearing loss by carbon 
monoxide increased linearly as the concentration increased between 500 and 1 500 
ppm (experimental LOAEL 500 ppm) (61, 130). Benchmark dose software from 
the US Environmental Protection Agency (EPA) was employed to determine a 
benchmark concentration of carbon monoxide that produced either an increase in 
auditory threshold equivalent to 10 % of the effect of noise alone or produced a 5-
dB potentiation of noise-induced hearing loss. The lower bounds for these bench-
mark concentrations were 194 and 320 ppm (LOAELs), respectively (130). In a 
later study, the experimental NOAEL (300 ppm) and LOAEL (500 ppm) for com-
bined exposure to carbon monoxide and noise (impulsive noise, for 10 days, Leq 
8h of 84 dB SPL) were confirmed (233). Without exposure to carbon monoxide, 
the noise effect was not significant, but in the combined exposure scenarios, 
responses were significantly poorer.  
9.1.2.2 Carbon monoxide combined with anti-oxidants 
Rao and Fechter explored the ability of phenyl-N-tert-butylnitrone (PBN), a spin 
trap agent that forms adducts with free radicals, to protect against the combined 
effects of noise and carbon monoxide on auditory function in rats. Intraperitoneal 
injection of PBN both pre- and post-exposure to carbon monoxide and noise 
protected against the permanent hearing loss. Protection did not occur when PBN 
was given only post-exposure (319). Thus, while these results help to establish a 
role for oxidative stress in the interaction between carbon monoxide and noise, 
PBN does not offer an effective therapeutic treatment strategy. 
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9.1.3 Observations in man 
9.1.3.1 Carbon monoxide alone or combined with noise 
In humans, several reports have documented that hearing loss is one of the out-
comes associated with acute carbon monoxide poisoning. Unlike the findings in 
animal studies, noise exposure was not a necessary factor for the auditory problems 
to occur. Only studies on the effects of occupational exposures to carbon monoxide 
are included in the present document.  
In an early study, Lumio examined 700 patients suspected of having carbon 
monoxide poisoning. With the exception of a small part of the study population 
(6 % who worked in factories), most of the participants were from occupations  
in which workers were exposed to carbon monoxide from gas generators used in 
automobiles (56 % were drivers). The participants’ mean exposure duration was  
6 years, and 92 % of the participants’ age ranged from 21 to 50 years (44 % being 
31-40 years old). Occupational noise exposure and health indicators that could 
contribute to hearing loss were accounted for through a general medical ex-
amination and interview. Two hundred and sixty three participants (38 %) were 
diagnosed with chronic carbon monoxide poisoning. Among those, 78 % had 
hearing loss. Once participants with other risk factors for hearing loss were 
excluded from the sample, the percentage of cases of hearing loss decreased to 
68 %. The hearing disorders were evident in the extended high-frequency region  
of the audiogram and 63 % of the workers with hearing loss reported tinnitus. 
Among the workers exposed to carbon monoxide that were not diagnosed as cases 
of chronic poisoning, 27 % had hearing loss, a percentage that was reduced to 14 % 
once subjects with other risk factors were excluded. In 11 % of the cases of mild 
hearing loss, there was some improvement in their hearing thresholds. Lumio 
(1948) concluded that carbon monoxide poisoning was associated with hearing 
loss, despite the lack of excessive noise exposure (232). The presence of other risk 
factors does not exclude the possibility that carbon monoxide did contribute to the 
observed hearing deficits.  
Among 78 workers with a history of carbon monoxide exposure likely to have 
occurred in combination with noise (no exposure measurements), 66 % showed 
hearing loss while 76 % presented vestibular disorders (195). 
A database containing workers’ charts collected by the Quebec National Public 
Health Institute between 1983 and 1996 was examined. The database provided 
information on occupation, noise level (Leq8 hours), number of years of noise 
exposure for the current occupation, audiometric data and medical history. Carbon 
monoxide exposure status (yes or no) was determined for each occupation by a 
panel of 5 experienced assessors (2 industrial hygienists and 3 audiologists). Data 
from 6 812 audiometric assessments were retained for analysis and were divided 
among 4 groups: 1) carbon monoxide + noise ≥ 90 dBA, n = 1 872, 2) noise alone 
≥ 90 dBA, n = 2 383, 3) carbon monoxide + noise < 90 dBA, n = 1 031, and 4) 
noise alone < 90 dBA, n = 1 526. The effect of carbon monoxide with noise ex-
posure below 90 dBA was not significant at any frequency (0.5, 1, 2, 3, 4, 6 kHz). 
Workers who were exposed to carbon monoxide and to noise levels above 90 dBA 
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displayed significantly poorer hearing thresholds at high frequencies (3, 4, and 6 
kHz) than workers without carbon monoxide exposure but with equivalent noise 
exposure. The magnitude of the shift in hearing thresholds was influenced by the 
number of noise exposure years. The results indicate that carbon monoxide ex-
posure increases the magnitude of the hearing loss due to noise exposure. The  
ORs for a hearing deficit at least at one frequency were 1.4 (95 % CI 1.2-1.5)  
for the carbon monoxide plus noise ≥ 90-dBA group, 1.2 (95 % CI 1.0-1.3) for  
the noise ≥ 90-dBA group and 1.1 (1.0-1.3) for the carbon monoxide plus noise  
< 90-dBA group compared to the noise < 90-dBA group (presented as conference 
proceedings) (200, 217).    
Studies conducted by the same team in Canada also examined if a combined, 
non-occupational exposure to noise and carbon monoxide could affect the hearing 
thresholds of workers with occupational noise exposure. Data from 6 395 audio-
grams obtained from noise-exposed workers were retained for analysis and di-
vided into two groups: 1) 3 306 workers exposed to noise and carbon monoxide  
in their non-occupational activities and 2) 3 089 workers exposed only to noise in 
their non-occupational activities. Information was available on their occupational 
noise exposure levels but were estimated for their non-occupational exposures. 
Results indicated a significant interaction between audiometric results of a  
specific test frequency and non-occupational carbon monoxide exposure, years  
of occupational noise exposure and current occupational noise exposure level. 
Non-occupational noise exposure had a marginal effect on hearing thresholds 
when compared to non-occupational noise and carbon monoxide exposure (which 
had a larger effect on hearing thresholds). However, these effects were only 
observed in the group with at least 15 years of occupational noise exposure 
associated with concurrent non-occupational exposure to carbon monoxide  
and noise (presented as conference proceedings) (200, 217).  
Further, the effects of occupational exposure to low concentrations of carbon 
monoxide and noise on hearing status of a small subsample of workers (n = 28) 
were explored. Participants were subdivided in 4 groups: carbon monoxide only  
(n = 2), carbon monoxide and noise (n = 2, 85-90 dBA), noise only (n = 3, 90-91 
dBA) and unexposed controls (n = 21, < 80 dB). The environmental carbon 
monoxide levels ranged between 16 and 35 ppm and the biological (carboxy-
haemoglobin) levels were 2-3 %. The audiometric data indicated that combined 
carbon monoxide and noise exposure had an effect on hearing at 8 kHz as 
measured via both pure-tone audiometry and distortion product otoacoustic 
emissions, but this was based on only two individuals (199). 
Ahn et al conducted a nested case-control study in a cohort of male iron and 
steel workers exposed to low concentrations of carbon monoxide. The study  
group comprised 770 cases and 2 574 incidence density age-matched controls. 
Quantitative carbon monoxide or noise exposure data were available from a job-
exposure matrix. The OR for hearing loss (4 kHz threshold ≥ 35 dB) was 2.5 
(95 % CI 1.2-5.0) for exposure levels greater than 20 ppm of carbon monoxide, 
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after controlling for noise exposure level, body mass index, smoking, hypertension 
and diabetes (presented as an abstract) (9). 
9.1.3.2 Interactions between smoking and noise exposure 
Studies on the interaction between hearing loss and smoking offer some support 
for an ototoxic potential of carbon monoxide. According to recent studies, heavy 
smoking can affect hearing (41, 343, 383) and interact with noise, thus causing  
a more severe hearing loss (176, 247, 314, 372). In the study by Ahn et al (9), 
smoking was a variable significantly associated with hearing loss but with an OR 
for hearing loss barely above 1 (OR 1.01, 95 % CI 1.003-1.021) (data not shown, 
personal communication Thais Morata). 
9.1.4 Conclusion on carbon monoxide 
In rat inhalation studies, carbon monoxide alone did not affect the auditory system 
at concentrations up to 1 500 ppm (NOAEL) (61). However, it can potentiate the 
effects of noise even when noise levels alone would not cause a change in hearing. 
In combination with noise (95 or 100 dB at 13.6 kHz OBN), the experimental 
NOAEL was 300 ppm and the LOAEL 500 ppm (61, 130, 233). The calculated 
lower bounds for benchmark doses that affected the auditory thresholds were 194 
and 320 ppm (LOAELs, for details, see Section 9.1.2.1) (130).  
Acute human carbon monoxide poisoning has been associated with hearing loss, 
despite lack of excessive noise exposure. Most field studies lack noise exposure 
estimates. It is therefore not clear if noise exposure is a prerequisite for the audi-
tory effects seen following long-term occupational exposure to carbon monoxide.  
In a study analysing 6 812 audiograms, exposure to carbon monoxide and noise 
levels below 90 dBA had no effect on hearing thresholds, whereas workers who 
were exposed to carbon monoxide and to noise levels above 90 dBA displayed 
significantly poorer hearing thresholds at high frequencies (conference pro-
ceedings) (200, 217). In a small subset, the adjusted ORs for audiometric hearing 
loss were significant for exposures in the 16 to 35 ppm range in combination with 
noise exposure (two subjects) (199).  
International OELs for carbon monoxide range from 25 to 50 ppm (Appendix 1). 
The ACGIH threshold limit value of 25 ppm is intended to maintain blood 
carboxyhaemoglobin levels below 3.5 %, to prevent neurobehavioural effects  
and to maintain cardiovascular work and exercise capacities (4). 
9.2 Hydrogen cyanide 
9.2.1 General 
Cyanides are chemical compounds that contain a cyano functional group, CN−. 
The cyanide ion has a single negative charge and consists of a carbon that is triply 
bonded to a nitrogen atom. Cyanide is often used as shorthand term for hydrogen 
cyanide. 
Hydrogen cyanide, HCN, is a colourless and highly volatile liquid that boils 
slightly above room temperature at 26 °C, thereby generating hydrogen cyanide 
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gas. Hydrogen cyanide has a faint, bitter, almond-like odour. Hydrogen cyanide 
may be synthesised directly from ammonia and carbon monoxide or from 
ammonia, oxygen (or air) and natural gas. It is a by-product of the production of 
coke from coal and is recovered (along with hydrogen sulphide) from coke-oven 
exhaust gases. It may also be prepared by reacting a cyanide salt, e.g. calcium 
cyanide, with a strong acid, e.g. sulphuric acid, or by thermal decomposition of 
formamide (164). 
Cyanide is used in tempering steel, dyeing, explosives, engraving, the pro-
duction of acrylic resin plastic and other organic chemical products. Hydrogen 
cyanide is contained in the exhaust of vehicles, in tobacco smoke, and in the 
smoke of burning nitrogen-containing plastics. 
A hydrogen cyanide air concentration of 300 ppm will kill a human within  
a few minutes. The toxicity is caused by the cyanide ion, which prevent cellular 
respiration (164).  
9.2.2 Effects in animals 
9.2.2.1 Hydrogen cyanide alone and combined with noise   
One single investigation on the auditory effects of hydrogen cyanide in animals 
has been identified (Table 26) (126). Rats were exposed to 10, 30 or 50 ppm 
hydrogen cyanide alone for 3.5 hours or in combination with 2 hours of octave 
band noise exposure (100 dB, linear scale). Additional groups received noise 
exposure alone and no treatment other than placement in a quiet inhalation 
chamber with clean air. Hydrogen cyanide alone did not cause significant hearing 
loss or hair cell loss. Noise exposure alone impaired compound action potential 
(CAP) thresholds by about 10 dB (averaged across frequencies 12-40 kHz) and 
produced a 5 % loss of outer hair cells at the base of the cochlea, but no inner hair 
cell loss. The combined exposure to noise and hydrogen cyanide caused a cyanide 
dose-dependent CAP threshold impairment and outer hair cell loss that exceeded 
the noise exposure alone. At 30 ppm, the potentiation of noise-induced hearing 
loss achieved statistical significance. A risk assessment analysis was conducted for 
the auditory threshold data using benchmark dose software (from US EPA). A 
continuous model showed that the data could be described by a linear function. 
For a benchmark response corresponding to a 5-dB increase in the auditory 
threshold above the effect of noise alone, the lower bound of the 95 % CI for the 
benchmark dose was 9 ppm. The benchmark dose that impaired the auditory 
threshold 10 % above the effect of noise alone had a lower bound of 2 ppm. The 
lower bound of the hydrogen cyanide dose that produced a one standard deviation 
elevation in noise-induced hearing loss was 16 ppm (126). 
9.2.3 Observations in man 
No studies were identified.  
9.2.4 Conclusion on hydrogen cyanide 
In the only study available, hydrogen cyanide alone (up to 50 ppm) did not 
significantly affect the auditory system in rats (NOAEL). However, it can 
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potentiate the auditory effects of noise. At 30 ppm, the potentiation of noise-
induced hearing loss achieved statistical significance (LOAEL). Exposure to 10 
ppm and noise did not produce significant potentiation or pronounced outer hair 
cell loss (NOAEL). The lower bounds for benchmark doses that affected the 
auditory thresholds were 2, 9 and 16 ppm (LOAELs) (126). 
Auditory effects of hydrogen cyanide in humans have not been studied. 
International OELs for hydrogen cyanide vary from 0.9 to 10 ppm (Appendix 1). 
The ACGIH threshold limit value is set to prevent upper respiratory irritation, 
headache, nausea and symptoms of chronic exposure such as thyroid enlargement, 
and in addition to provide a sufficient margin of safety against acute poisoning (4). 
9.3 Acrylonitrile 
9.3.1 General 
A nitrile is any organic compound that has a carbon atom and a nitrogen atom 
triply bonded together, i.e. a -C≡N functional group. The prefix cyano is used in 
chemical nomenclature to indicate the presence of a nitrile group in a molecule.  
Acrylonitrile is a colourless, liquid, man-made chemical with a sharp, onion-  
or garlic-like odour. It dissolves in water and evaporates quickly. Acrylonitrile is 
used in the production of other chemicals such as plastics, synthetic rubber and 
acrylic fibres, and is one of the 50 most commonly produced industrial chemicals. 
Metabolism of ingested, inhaled or topically applied acrylonitrile releases cyanide 
that can produce acute respiratory arrest and central nervous system toxicity (16).  
9.3.2 Effects in animals 
9.3.2.1 Acrylonitrile alone and combined with noise and anti-oxidants 
Four animal experiments on the effects of acrylonitrile on the auditory system 
have been conducted (Table 26) (127, 131, 297, 299). Acrylonitrile potentiates 
noise-induced hearing loss as a consequence of oxidative stress. The metabolism 
of acrylonitrile involves conjugation with glutathione, resulting in rapid and 
pronounced depletion of this antioxidant in many organs including brain, liver, 
and kidney. It also results in cyanide formation through a secondary oxidative 
pathway. The studies indicate that the outer hair cells are the main target of 
toxicity.  
Acrylonitrile alone (50 mg/kg body weight, 1-2 subcutaneous injections) 
elevated auditory thresholds temporarily in rats. No effects were seen after 3 
weeks. Acrylonitrile (50 mg/kg body weight, 1-2 subcutaneous injections) in 
combination with noise (108 dB octave band noise, 8 hours) increased auditory 
threshold impairment relative to rats receiving noise only when measured 3 weeks 
following exposure (131). Combined exposure for 5 days to acrylonitrile (50 
mg/kg body weight, subcutaneous injections) and moderate noise (95 or 97 dB 
octave band noise, 4 hours) caused permanent hearing loss and outer hair cell loss 
in rats. Individually, neither acrylonitrile nor noise caused these effects (297).  
Rats treated daily with phenyl-N-tert-butylnitrone (PBN, spin-trap agent that 
sequesters ROS) prior to and again following acrylonitrile (50 mg/kg body weight, 
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subcutaneous injection) and noise (105 dB octave band noise, 4 hours) treatment 
for 5 consecutive days showed approximately the same auditory impairment as did 
rats receiving noise only. Thus, PBN blocked the potentiation of noise-induced 
hearing loss (127). Pre-treatment of rats with L-N-acetylcysteine (antioxidant, pro-
glutathione drug) decreased auditory loss and hair cell loss resulting from com-
bined exposure to acrylonitrile (50 mg/kg, subcutaneous injection) and moderate 
noise (97 dB octave band noise, 4 hours, 5 days) (299). 
All studies show that acrylonitrile exposure alone does not cause damage to the 
auditory system of the rat, however, it potentiates noise-induced hearing loss at 
noise levels that are realistic in terms of human exposure. However, the acrylo-
nitrile exposure route used in the animal studies (subcutaneous injection) differs 
from that experienced by workers and the doses of acrylonitrile in the animal 
studies were greater. Because the widespread use of acrylonitrile in industry 
occurs in settings where noise exposure is also present, the identified synergistic 
mechanism may be of importance for occupational health. 
9.3.3 Observations in man 
No studies were identified.  
9.3.4 Conclusion on acrylonitrile  
In rat studies using subcutaneous injection, acrylonitrile (50 mg/kg body weight, 
only dose tested) did not induce permanent auditory effects (NOAEL). However 
acrylonitrile can potentiate noise-induced hearing loss. Combined exposure to 
acrylonitrile (50 mg/kg, only dose tested) and noise (≥ 95 dB) caused permanent 
hearing loss and outer hair cell loss (LOAEL) (127, 131, 297, 299).  
Auditory effects of acrylonitrile in humans have not been studied. 
International 8-hour OELs for acrylonitrile vary from 1 to 30 ppm (Appendix 1). 
The ACGIH threshold limit value is set to minimise the potential for headache, 
nausea, respiratory difficulties, central nervous system effects and cancer (4). 
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9.4 3,3'-Iminodipropionitrile (IDPN)  
9.4.1 General  
3,3'-Iminodipropionitrile, IDPN, is a colourless liquid, which has been extensively 
used as neurotoxic agent in animal experiments. Synonyms include 3,3'-iminobis-
propionitrile, ββ'-iminodipropionitrile, and N, N-bis(2-cyanoethyl)amine. No re-
ports on occupational exposures to IDPN were identified (69).  
9.4.2 Effects in animals 
Four animal experiments have been conducted on the effects of IDPN on the 
auditory system (Table 27) (73, 77, 80, 144). These studies show that IDPN 
(administrated by intraperitoneal injection) alone causes extensive hearing loss 
and loss of neural structures in the cochlea of the rat.  
No significant effects were registered after intraperitoneal injection of 100 mg/ 
kg body weight/day for 3 days, but decreased acoustic startle response amplitude 
were registered in rats following 150 mg/kg body weight/day (LOAEL). Elevated 
auditory thresholds were reported for 5- and 40-kHz tones for the 200-mg/kg 
group, representing approximate increases of 25 dB and 50 dB, respectively. The 
onset of this auditory dysfunction in the 200-mg/kg group, as demonstrated by a 
loss of reflex inhibition, was 2 days for the 40-kHz tone and 4 days for the 5-kHz 
tone (73).  
Exposure of rats to 167 and 200 mg/kg body weight of IDPN for 3 consecutive 
days caused elevated auditory thresholds (as measured by reflex modification 
audiometry and/or auditory brainstem response) over a broad range of frequencies 
while no such effects were observed at 133 and 150 mg/kg body weight. Histology 
made on rats dosed with 200 mg/kg body weight showed loss of hair cells and 
spiral ganglion cells, and damage to the cochlear nerve in a basal-to-apical fashion. 
At 100 mg/kg body weight, IDPN had virtually no effect on structure (80).  
The interaction with noise has not been studied. 
9.4.3 Observations in man 
No studies were identified.  
9.4.4 Conclusion on IDPN 
In rat studies, intraperitoneal injections of 150 mg/kg body weight/day for 3 
consecutive days caused auditory changes (LOAEL). No auditory effects were 
observed at 100 mg/kg (NOAEL) (73). The interaction with noise has not been 
studied. Auditory effects of IDPN in humans have not been studied. 
No OELs for IDPN were identified.  
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10. Auditory effects of other substances 
10.1 Pesticides 
10.1.1 General 
The term “pesticide” has been used to represent any chemical substance used to 
prevent, destroy, repel or mitigate pests of weeds. The major classes of pesticides 
include herbicides, insecticides, fungicides and fumigants. Pesticides vary in their 
uptake, mode of action, metabolism, toxicity and elimination from the body. People 
can be exposed to pesticides in agriculture but also through the contamination  
of food, air, drinking water and dust. Epidemiological studies have discovered 
associations between pesticide exposure and long-term effects on health in three 
main areas, cancer, reproductive disorders and neurotoxic effects (22). 
In this document, the term pesticide refers to the active ingredient of a pesticide 
product or formulation. A pesticide product applied by farmers usually contains 
one or more active pesticidal ingredients and ingredients which can enhance the 
effect of the active ingredient. The pesticides that have been studied for their 
auditory effects include organophosphates (paraoxon, parathion), pyrethroids, 
pyridyliums (paraquat) and hexachlorobenzene. Paraquat was banned in Sweden 
in 1983. The substance has also been banned in several other countries including 
Denmark, Finland and Norway. The EU allowed paraquat in 2004. Sweden 
supported by Denmark, Finland and Austria brought the EU to court. In 2007,  
the court annulled the directive authorising paraquat as an active plant protection 
substance. In the US, paraquat is available for use only by commercially licensed 
users (56, 284, 359). 
10.1.2 Effects in animals 
Few studies on the auditory effects of pesticides in laboratory animals were 
identified (Table 28) (28, 33, 148, 276, 330). Two of five studies were conducted 
with paraquat and reported irreversible cochlear effects (33, 276). One study on 
the organophosphorus compound paraoxon reported only reversible effects (28). 
The only study on hexachlorobenzene noted irreversible threshold shifts but no 
hair cell loss (148). Interaction with noise was not studied.  
10.1.3 Observations in man 
10.1.3.1 Pesticides alone or combined with noise 
Few occupational studies have been conducted regarding the effects of pesticide 
exposures on the auditory system (Table 29) (26, 27, 72, 98, 150, 315, 369). Noise 
levels have not always been reported in these studies. However, due to the nature 
of the work performed, it is likely that the studied workers were also exposed to 
hazardous noise.  
10.1.4 Conclusion on pesticides 
Risk evaluation is not attempted, because of the lack of exposure information in 
the few experiments conducted. 
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10.2 Polychlorinated biphenyls (PCBs) 
10.2.1 General  
Polychlorinated biphenyls (PCBs) are synthetic organic chemicals, which are 
either oily liquids or solids and are colourless to light yellow. They have high 
boiling points and are practically non-flammable except at high temperatures. 
Some PCBs are volatile and may exist as vapour in air. PCB production started  
in the late 1920s (174) and PCBs were used extensively in the manufacture of 
transformers, capacitors and other heat transfer devices through the late 1970s.  
In 1979, their manufacture and importation was banned in the US based on 
mounting evidence that they were toxic to humans and wildlife. In Sweden, the 
use of PCBs was restricted in 1972 to only allow PCBs in closed systems. New 
equipment containing PCBs was not allowed for use from 1978, whereas old 
installations containing PCBs were allowed until 1995 (8, 29). No new PCB-
containing products have been allowed in Norway since 1980, in Finland since 
1985, in Denmark since 1986 and in Iceland since 1988 (8).  
Occupational exposure to PCBs can take place during the renovating and 
demolishing of buildings, repair and maintenance of PCB transformers, accidents, 
fires, or spills involving PCB transformers and older computers and instruments, 
and disposal of PCB materials. In addition to older electrical instruments and 
fluorescent lights that contain PCB-filled capacitors, also caulking materials, 
elastic sealants and heat insulation have been known to contain PCBs. Exposure  
in the contaminated workplace occurs mostly by breathing air containing PCBs 
and by touching substances that contain PCBs (223). 
PCBs are classified as probable human carcinogens and are listed in the top 
10 % of the US EPA’s most toxic chemicals (17, 167). Reproductive and de-
velopmental effects may also be related to consumption of PCB contaminated fish 
and possibly occupational exposure to PCBs. Skin conditions, such as acne and 
rashes, may occur in people exposed to high levels of PCBs.  
The Nordic Expert Group for Criteria Documentation of Health Risks from 
Chemicals (NEG) is presently preparing a criteria document on PCBs (223). 
10.2.2 Effects of PCBs 
Aroclor 1254 is the PCB mixture most investigated for its auditory effects but  
also other PCB mixtures as well as the individual congener PCB 126 (3,3',4,4',5-
pentachlorobiphenyl) have been studied for their ototoxicity in the offspring of 
rats (Table 30). All studied PCBs were found to be ototoxic with a suggested 
cochlear and/or auditory nerve site of lesion. Aroclor has also been shown to affect 
development of the hearing organ through induction of hypothyroidism (145, 300). 
PCB 126 administrated by feed (35 days prior to breeding to postnatal day 21) 
caused no significant auditory effects at 0.25 µg/kg body weight/day (NOAEL), 
whereas elevated hearing thresholds were observed at 1 µg/kg body weight 
(LOAEL) (76).  
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Aroclor 1254 administered by oral gavage (from gestation day 6 to postnatal  
day 21) caused permanent auditory deficits at 1 mg/kg body weight/day (LOAEL, 
lowest dose tested) (153).  
Oral gavage of a mixture of PCBs containing 35 % Aroclor 1242, 35 % Aroclor 
1248, 15 % Aroclor 1254 and 15 % Aroclor 1260 (28 days prior to breeding to 
postnatal day 21) caused no auditory effects at 1 mg/kg body weight/day (NOAEL) 
but auditory deficits at 3 mg/kg (LOAEL) (300).  
Interaction with noise has not been studied in animals nor have auditory effects 
of PCBs in humans. 
10.2.3 Conclusion on PCBs 
PCB mixtures as well as the individual congener PCB 126 were ototoxic with a 
suggested cochlear and/or auditory nerve site of lesion in the offspring of rats. 
Interaction with noise was not studied. No human studies were identified. 
International OELs for PCBs range from 0.001 to 0.5 mg/m3 (Appendix 1). 
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11. Dose-effect and dose-response relationships 
The chemicals examined in the present document have been associated with 
auditory effects in animals. They are substances with diverse chemical structures. 
This implies multiple targets for injury within the auditory system and multiple 
possible underlying mechanisms. This complexity represents an obstacle in 
identifying the features necessary for a chemical to be ototoxic (113, 116).  
Another complexity is that different species respond differently to the same 
chemical, basically due to metabolic differences. On the other hand, this has 
offered some clues as to the toxic action (84, 117, 213). Since noise is often 
present in the occupational arena, there is a need to incorporate noise exposure  
in the investigations of ototoxicity of industrial chemicals. This adds to the com-
plexity of the problem. Little is known about combined chemical exposures, and 
even less is known about mechanisms for interaction between a chemical and  
a physical agent, in this case noise, which makes prediction of the outcome 
challenging.  
At this writing, the existing human studies were designed to generate or test 
hypotheses instead of examining dose-response relationships. Limitations of the 
reviewed studies (study designs, insufficient characterisation of the exposure 
levels of chemicals and noise, lack of details on if and how other risk factors were 
accounted for, etc.) preclude the use of their results in estimating dose-response 
relationships and in identifying NOAELs or LOAELs for the chemicals covered in 
the present document. 
Overall, studies conducted with experimental animals provide the most robust 
evidence regarding mechanisms and dose-effect relationships between agents and 
effects on the auditory function or physiology.  
Styrene, toluene, lead and carbon monoxide are the substances that have been 
more extensively studied to date, due to the relevance to occupational health and 
evidence of their general toxicity or neurotoxicity.  
NOAELs and LOAELs for auditory effects in animals for the chemicals covered 
in this document are summarised in Table 31. If a chemical exposure has not been 
shown to potentiate noise-induced hearing loss, the level given is considered as 
the NOAEL for the substance in the combined exposure scenario.  
Table 32 presents the most relevant human studies indicating auditory effects by 
chemical exposure.  
Styrene  
The ototoxicity of styrene has been confirmed in numerous studies and 300 ppm 
was found to be the LOAEL in inhalation experiments with rats forced to be active 
(210). A more recent study using gavage exposure of non-active rats showed effects 
at 200 mg/kg body weight (corresponding to approximately 250 ppm) (64). Syner-
gistic interaction between styrene and noise was manifested only at concentrations 
above the LOAEL for styrene alone, i.e. at and above 400 ppm (208, 210, 269).  
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Several occupational studies were also conducted and the preponderance of the 
evidence indicates that workers exposed to styrene are at increased risk of hearing 
loss. This was demonstrated not only by increased prevalences of cases of hearing 
loss, but also by significant differences in hearing thresholds and in other tests 
evaluating central auditory function compared to control populations. Such tests 
allowed for a distinction between the effects of the solvent and effects of noise. A 
limitation of the occupational studies is the incomplete historical characterisation 
of the exposure to styrene. This calls for caution when interpreting dose-effect 
relationships from human studies. The lowest current average exposures among 
styrene-only and styrene and noise exposed workers exhibiting hearing loss (com-
pared to noise-only or no noise-no styrene workers) were 2.8-3.5 ppm. However, 
neither current nor life-time (average 14-18 ppm) styrene air concentrations cor-
related with hearing loss, whereas current urinary MA levels were positively 
correlated with hearing thresholds (187, 256). Other studies have, on the other 
hand, demonstrated hearing loss in workers currently exposed to average styrene 
air levels of 5-22 ppm and noise below 85 dB (240, 258, 259). Śliwińska-Kowalska 
et al found a significant positive correlation between the styrene exposure (work-
life average 14 ppm) and hearing loss (346, 347). However, more recently, Triebig 
et al observed hearing loss in workers exposed to styrene only after exposure 
during at least 10 years to levels around 30-50 ppm styrene, with higher levels in 
the past (374).  
Toluene 
In studies with rats, 900 ppm was identified as the NOAEL for toluene (308).  
In studies of combined exposure to toluene and noise, a NOAEL of 500 ppm  
was identified (39, 234). Synergistic interaction between toluene and noise  
was manifested at the same concentration as the LOAEL for toluene alone, i.e.  
at and above 1 000 ppm (39, 186).  
Several occupational studies were conducted and the preponderance of the evi-
dence indicates that workers exposed to toluene are at increased risk for auditory 
disorders. One human study did not find significant effects that could be attributed 
to life-time weighted average toluene exposure at around 50 ppm (342). Other 
observations suggested that the lowest current exposures associated with significant 
hearing loss were 10-50 ppm (31, 257, 384). Historic toluene and/or noise exposure 
levels were not well characterised and some groups of workers were co-exposed to 
other solvents. It is likely that participants were exposed to higher concentrations 
in the past, as well as to peaks of high exposure in the present that could explain 
the observed effects. In one study, chronic exposure (12-14 years) to an average  
of 97 ppm caused hearing loss but noise levels were not given (2).  
Carbon disulphide 
Most investigations on the neurotoxicant carbon disulphide have focused on its 
central auditory effects but cochlear effects have also been reported. In rats, 500 
ppm was identified as the NOAEL, while significant effects were observed at 800 
ppm (LOAEL) as measured by auditory brainstem response (66, 157, 323). 
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Interaction with noise was not studied. In humans, the age-adjusted risk for audio-
metric hearing loss was significantly increased for exposures above 14 ppm in 
combination with noise in the range 80-91 dBA (58). Auditory effects (evoked 
potentials) were also observed in workers exposed to carbon disulphide (current 
exposure levels 3-8 ppm and higher exposure in the past) for at least 20 years. 
Noise levels were not reported (158). The workers were weavers, and thus a rather 
high noise level could be expected.  
Other solvents 
Xylene, ethylbenzene, chlorobenzene, trichloroethylene, n-hexane and n-heptane 
have been less studied for ototoxicity than styrene and toluene, but the existing 
animal data indicate that they cause auditory effects. A synergistic interaction has 
been shown between noise and exposure to ethylbenzene and trichloroethylene, 
respectively (the only substances investigated). No or limited human data were 
identified concerning auditory effects of these solvents.  
Solvent mixtures  
Solvent mixtures are important even if risk assessment is impossible due to the 
different nature of mixtures used at workplaces. However, some studies indicate 
that exposure to solvent mixtures containing ototoxic solvents (e.g. styrene, 
toluene, xylenes, ethylbenzene, trichloroethylene, n-hexane and jet fuels) and  
with a hazard index exceeding 1 may cause auditory effects.  
Lead 
Most investigations on lead have focused on its central auditory effects but also 
cochlear effects have been reported. In monkeys, blood concentrations of 35-40 
µg/dl (NOAEL) did not cause significant changes in evoked potentials, whereas 
55 µg/dl did (LOAEL) (202, 221). In humans, mean/median and life-time 
weighted average blood lead concentrations of 28-57 µg/dl were significantly 
associated with auditory effects (13, 35, 70, 89, 90, 110, 156, 177, 266, 386). 
Noise exposure was not reported in most studies, since they focused on central 
auditory effects. However, the only study that controlled for noise did not detect 
an interaction between the two agents. Peripheral auditory effects were associated 
with a mean blood lead level of 57 µg/dl (386). 
Mercury 
Mercury is known to cause neurotoxicity and sensorineural hearing deficits. In 
monkeys, ingestion (orally during gestation and postnatally for 4 years) of methyl-
mercuric chloride at 10 Hg µg/kg body weight/day was associated with permanent-
ly poorer hearing thresholds (LOAEL) (332). Interaction with noise was not studied. 
In humans, current mercury concentration in air of 0.008 mg/m3 and mean blood 
mercury levels of presumably 5 µg/l were significantly associated with effects as 
shown in central auditory tests (evoked potentials) (260). Higher concentrations 
were associated with similar outcomes (71, 89). Noise levels were not reported.  
  121 
Trimethyltins 
Intraperitoneally injected trimethyltin caused auditory effects in both guinea pigs 
and rats. Interaction with noise was not studied. No human studies were identified. 
Carbon monoxide 
In rats exposed to noise and carbon monoxide, the calculated LOAELs (lower 
bounds for the benchmark concentrations) were 320 ppm for a 5-dB potentiation  
of noise-induced hearing loss and 194 ppm for an increase in auditory threshold 
equivalent to 10 % of the effect of noise alone (100-dB octave band noise for 8 
hours) (130). Without concomitant noise exposure, no auditory effects of carbon 
monoxide were reported in rats (130, 233). A more serious implication is that in 
scenarios in which noise exposure alone did not have a significant effect, noise  
in combination with carbon monoxide exposure produced unexpectedly large, 
permanent threshold shifts (61, 62, 130, 320). The data did not validate the anti-
cipated positive relationship between the percentage of time that noise is present 
(noise duty cycle) and hearing loss. Instead, the mildest noise duty cycle (short 
duration exposures interspersed by quiet periods) produced maximal hearing  
loss when carbon monoxide was also present. The potentiation was more likely to 
occur with moderate noise exposure levels (octave band noise: 100 dB for 2 hours 
or 105 dB for 1 hour) than more severe noise exposures. Rao and Fechter used the 
US OSHA’s 5-dB time-intensity exchange rate to manipulate their noise exposures. 
The greatest potentiation by carbon monoxide occurred at levels equivalent to the 
US permissible exposure level of 90 dB for 8 hours (320). Their observations raise 
the issue of the appropriateness of the time-intensity paradigm in combined ex-
posure circumstances.  
Most field studies lack noise exposure estimates. It is therefore not clear if  
noise exposure is a prerequisite for the auditory effects seen following long-term 
occupational exposure to carbon monoxide. In a study analysing 6 812 audiograms, 
exposure to carbon monoxide and noise levels below 90 dBA had no effect on 
hearing thresholds, whereas workers who were exposed to carbon monoxide and 
to noise levels above 90 dBA displayed significantly poorer hearing thresholds at 
high frequencies (conference proceedings) (200, 217). In humans, the only dose-
response data available is based on two individuals for which audiometric data in-
dicated a significant effect for exposures in the 16-35 ppm range when combined 
with noise (85-90 dBA) (199).  
Other asphyxiants 
Hydrogen cyanide (inhalation) and acrylonitrile (subcutaneous injection) alone 
were not ototoxic in rats but potentiated the effects of noise. IDPN (intraperitoneal 
injection) alone caused auditory changes in rats. Interaction with noise was not 
studied. No human studies on auditory effects by these agents were identified. 
 
Pesticides 
Results from animal studies as well as human data indicate that pesticides (e.g. 
organophosphorus compounds, paraquat and hexachlorobenzene) may affect 
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auditory function. Interaction with noise was not studied. Due to the sparse 
amount of data on this diverse group of chemicals, no hazard assessment can be 
performed.  
 
PCB 
PCB mixtures (including Aroclor 1254) as well as the individual congener PCB 
126 were ototoxic with a suggested cochlear and/or auditory nerve site of lesion in 
the offspring of rats. Interaction with noise was not studied. No human studies 
were identified. 
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XY
L 
a
n
d 
EB
Z)
 
45
0 
p-
X
Y
L 
90
0 
p-
X
Y
L 
-
 
In
ha
la
tio
n
: 
6 
h/
d,
 
6 
d/
w
,
 
13
 
w
 
R
at
s 
A
B
R
 
M
E 
O
H
C 
lo
ss
 
(o-
 
an
d 
m
-
x
yl
en
e 
n
o
t o
to
to
x
ic
). 
(14
0) 
-
 
1 
80
0 
p-
X
Y
L 
-
 
In
ha
la
tio
n
: 
6 
h/
d,
 
5-
6 
d/
w
,
 
3 o
r 
13
 
w
 
R
at
s 
A
B
R
 
M
E 
H
ea
rin
g 
lo
ss
 
an
d 
O
H
C 
lo
ss
 
(o-
 
an
d 
m
-
x
yl
en
e 
n
o
t 
o
to
to
x
ic
,
 
o
n
ly
 
do
se
 
te
st
ed
).  
(14
0,
 
23
8) 
-
 
80
0 
m
ix
ed
 
X
Y
L 
 
-
 
In
ha
la
tio
n
: 
14
 
h/
d,
 
7 
d/
w
,
 
6 
w
 
R
at
s 
A
B
R
 
 
B
A
 
 
CA
R
 
H
ea
rin
g 
lo
ss
 
(lo
w
es
t d
o
se
 
te
st
ed
).  
(30
6) 
 
-
 
25
0 
M
ix
tu
re
 
 
(~
50
 
p-
X
Y
L+
50
 
EB
Z)
 
 
 
 
-
 
In
ha
la
tio
n
: 
6 
h/
d,
 
5 
d/
w
,
 
13
 
w
 
R
at
s 
A
B
R
 
M
E 
O
H
C 
lo
ss
 
(sy
n
er
gi
sm
,
 
lo
w
es
t d
o
se
 
te
st
ed
).  
H
ea
rin
g 
lo
ss
 
at
 
1 0
00
 
pp
m
 
m
ix
tu
re
 
(sy
n
er
gi
sm
). 
(14
1) 
XY
L 
co
m
bi
n
ed
 
w
ith
 
n
o
ise
 
(N
) 
N
o
 
da
ta
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Cr
iti
ca
l s
tu
di
es
 
o
n
 
au
di
to
ry
 
ef
fe
ct
s 
in
 
an
im
al
s 
w
ith
 
co
rr
es
po
n
di
n
g 
N
O
A
EL
s 
an
d 
LO
A
EL
s 
(in
 
pp
m
,
 
if 
n
o
t o
th
er
w
ise
 
st
at
ed
) f
o
r 
th
e 
su
bs
ta
n
ce
s 
re
v
ie
w
ed
 
in
 
th
e 
pr
es
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t d
o
cu
m
en
t. 
Fo
r 
ab
br
ev
ia
tio
n
s,
 
se
e 
en
d 
o
f t
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.
 
 
N
O
A
EL
 
LO
A
EL
 
N
o
ise
 
(N
) 
Ex
po
su
re
 
re
gi
m
en
 
Sp
ec
ie
s 
A
u
di
to
ry
 
te
st
 
 
A
u
di
to
ry
 
ef
fe
ct
 
R
ef
er
en
ce
 
Et
hy
lb
en
ze
n
e 
(E
BZ
)  
EB
Z 
a
lo
n
e 
a
n
d 
in
 
m
ix
tu
re
 
(E
BZ
 
a
n
d 
o
-
,
 
m
-
 
a
n
d 
p-
XY
L)
 
-
 
20
0 
-
 
In
ha
la
tio
n
: 
6 
h/
d,
 
5 
d/
w
,
 
13
 
w
 
R
at
s 
A
B
R
 
 
M
E 
 
O
H
C 
lo
ss
 
(lo
w
es
t d
o
se
 
te
st
ed
). 
H
ea
rin
g 
lo
ss
 
at
 
40
0 
pp
m
.
 
(14
1) 
30
0 
40
0 
-
 
In
ha
la
tio
n
: 
6 
h/
d,
 
5 
d 
R
at
s 
CA
P 
 
M
E 
H
ea
rin
g 
lo
ss
 
an
d 
O
H
C 
lo
ss
.
 
(51
) 
-
 
25
0 
M
ix
tu
re
 
 
(~
 
50
 
EB
Z+
50
 
p-
X
Y
L)
 
-
 
In
ha
la
tio
n
: 
6 
h/
d,
 
5 
d/
w
,
 
13
 
w
 
R
at
s 
A
B
R
 
 
M
E 
O
H
C 
lo
ss
 
(sy
n
er
gi
sm
,
 
lo
w
es
t d
o
se
 
te
st
ed
).  
H
ea
rin
g 
lo
ss
 
at
 
1 0
00
 
pp
m
 
m
ix
tu
re
 
(sy
n
er
gi
sm
). 
(14
1) 
EB
Z 
co
m
bi
n
ed
 
w
ith
 
n
o
ise
 
(N
) 
-
 
30
0 
95
 
o
r 
10
5 
dB
 
SP
L 
br
o
ad
ba
n
d 
1.
5-
12
.
5 
kH
z 
In
ha
la
tio
n
: 
6 
h/
d,
 
5 
d 
N
: 
8 
h/
d,
 
5 
d 
R
at
s 
CA
P 
 
D
PO
EA
 
M
E 
O
H
C 
lo
ss
 
(w
he
n
 
co
m
bi
n
ed
 
w
ith
 
10
5 
dB
), 
(sy
n
er
gi
sm
,
 
lo
w
es
t d
o
se
 
te
st
ed
).  
H
ea
rin
g 
lo
ss
 
n
o
t d
iff
er
en
t f
ro
m
 
N
 
at
 
40
0 
pp
m
.
 
(52
) 
Ch
lo
ro
be
n
ze
n
e 
(C
BZ
)  
CB
Z 
a
lo
n
e 
-
 
2 
00
0 
-
 
In
ha
la
tio
n
: 
6 
h/
d,
 
5 
d 
R
at
s 
A
B
R
 
at
 
16
 
kH
z 
o
n
ly
 
H
ea
rin
g 
lo
ss
 
(lo
w
es
t d
o
se
 
te
st
ed
). T
he
 
o
n
ly
 
st
u
dy
 
id
en
tif
ie
d.
 
(32
8) 
CB
Z 
co
m
bi
n
ed
 
w
ith
 
n
o
ise
 
(N
) 
N
o
 
da
ta
 
Tr
ic
hl
o
ro
et
hy
le
n
e 
(T
CE
) 
TC
E 
a
lo
n
e 
-
 
2 
00
0 
-
 
In
ha
la
tio
n
: 
12
 
h/
d,
 
7 
d/
w
,
 
3 
w
 
R
at
s 
A
B
R
 
H
ea
rin
g 
lo
ss
 
(m
id
-
fre
qu
en
cy
,
 
lo
w
es
t d
o
se
 
te
st
ed
). 
(32
7) 
1 
60
0 
2 
40
0 
1 
70
7 
(B
M
C)
 
-
 
In
ha
la
tio
n
: 
6 
h/
d,
 
5 
d/
w
,
 
13
 
w
 
R
at
s 
R
M
A
 
at
 
16
 
kH
z 
o
n
ly
 
H
ea
rin
g 
lo
ss
 
(m
id
-
fre
qu
en
cy
). 
B
M
C:
 
15
-
dB
 
in
cr
ea
se
 
in
 
he
ar
in
g 
th
re
sh
o
ld
.
 
(75
) 
2 
40
0 
3 
20
0 
1 
41
8 
(B
M
C)
 
-
 
In
ha
la
tio
n
: 
6 
h/
d,
 
5 
d/
w
,
 
4 
w
 
R
at
s 
R
M
A
 
at
 
16
 
kH
z 
o
n
ly
 
H
ea
rin
g 
lo
ss
 
(m
id
-
fre
qu
en
cy
).  
B
M
C:
 
15
-
dB
 
in
cr
ea
se
 
in
 
he
ar
in
g 
th
re
sh
o
ld
.
 
 
(75
) 
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.
 
Cr
iti
ca
l s
tu
di
es
 
o
n
 
au
di
to
ry
 
ef
fe
ct
s 
in
 
an
im
al
s 
w
ith
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rr
es
po
n
di
n
g 
N
O
A
EL
s 
an
d 
LO
A
EL
s 
(in
 
pp
m
,
 
if 
n
o
t o
th
er
w
ise
 
st
at
ed
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n
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.
 
 
N
O
A
EL
 
LO
A
EL
 
N
o
ise
 
(N
) 
Ex
po
su
re
 
re
gi
m
en
 
Sp
ec
ie
s 
A
u
di
to
ry
 
te
st
 
 
A
u
di
to
ry
 
ef
fe
ct
 
R
ef
er
en
ce
 
1 
60
0 
3 
20
0 
-
 
In
ha
la
tio
n
: 
12
 
h/
d,
 
7 
d/
w
,
 
12
 
w
 
R
at
s 
A
B
R
 
H
ea
rin
g 
lo
ss
 
(m
id
-
fre
qu
en
cy
). 
(32
7) 
TC
E 
co
m
bi
n
ed
 
w
ith
 
n
o
ise
 
(N
) 
-
 
3 
00
0 
95
 
dB
 
SP
L 
In
ha
la
tio
n
: 
18
 
h/
d,
 
5 
d/
w
,
 
3 
w
 
R
at
s 
R
M
A
 
H
ea
rin
g 
lo
ss
 
(m
id
-
fre
qu
en
cy
,
 
o
n
ly
 
do
se
 
te
st
ed
). 
G
en
er
al
ly
 
ad
di
tiv
e 
ef
fe
ct
.
 
Sy
n
er
gi
sm
 
at
 
4 
kH
z.
 
(26
2) 
n
-
H
ex
a
n
e 
(n-
H
EX
)  
n
-
H
EX
 
a
lo
n
e 
1 
00
0 
-
 
-
 
In
ha
la
tio
n
: 
18
-
21
 
h/
d,
 
7 
d/
w
,
 
28
 
o
r 
61
 
d 
R
at
s 
A
B
R
 
N
o
 
au
di
to
ry
 
ef
fe
ct
s 
(on
ly
 
do
se
 
te
st
ed
). 
(28
6,
 
28
7) 
1 
00
0 
-
 
-
 
In
ha
la
tio
n
: 
24
 
h/
d,
 
6 
d/
w
,
 
11
 
w
 
R
at
s 
A
B
R
 
R
ev
er
sib
le
 
au
di
to
ry
 
ef
fe
ct
s 
(on
ly
 
do
se
 
te
st
ed
). 
(16
3) 
-
 
1 
00
0 
-
 
In
ha
la
tio
n
: 
24
 
h/
d,
 
5 
d/
w
,
 
11
 
w
 
R
at
s 
A
B
R
 
A
u
di
to
ry
 
ef
fe
ct
s 
(pr
o
lo
n
ge
d 
la
te
n
ci
es
 
an
d 
de
cr
ea
se
d 
A
B
R
 
am
pl
itu
de
s,
 
o
n
ly
 
do
se
 
te
st
ed
). 
(32
5) 
n
-
H
EX
 
co
m
bi
n
ed
 
w
ith
 
n
o
ise
 
(N
) 
N
o
 
da
ta
 
n
-
H
ep
ta
n
e 
(n-
H
EP
) 
n
-
H
EP
 
a
lo
n
e 
 
 
 
 
 
 
 
80
0 
4 
00
0 
-
 
In
ha
la
tio
n
: 
6 
h/
d,
 
7 
d/
w
,
 
28
 
d 
R
at
s 
A
B
R
 
A
u
di
to
ry
 
ef
fe
ct
s 
(de
cr
ea
se
d 
A
B
R
 
am
pl
itu
de
s).
 
 
Th
e 
o
n
ly
 
st
u
dy
 
id
en
tif
ie
d.
 
(34
4) 
n
-
H
EP
 
co
m
bi
n
ed
 
w
ith
 
n
o
ise
 
(N
) 
N
o
 
da
ta
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Cr
iti
ca
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tu
di
es
 
o
n
 
au
di
to
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ef
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s 
in
 
an
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al
s 
w
ith
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rr
es
po
n
di
n
g 
N
O
A
EL
s 
an
d 
LO
A
EL
s 
(in
 
pp
m
,
 
if 
n
o
t o
th
er
w
ise
 
st
at
ed
) f
o
r 
th
e 
su
bs
ta
n
ce
s 
re
v
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w
ed
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e 
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t d
o
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m
en
t. 
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ab
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tio
n
s,
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.
 
 
N
O
A
EL
 
LO
A
EL
 
N
o
ise
 
(N
) 
Ex
po
su
re
 
re
gi
m
en
 
Sp
ec
ie
s 
A
u
di
to
ry
 
te
st
 
 
A
u
di
to
ry
 
ef
fe
ct
 
R
ef
er
en
ce
 
Ca
rb
o
n
 
di
su
lp
hi
de
 
(C
S 2
) 
CS
2 
a
lo
n
e 
20
0 
80
0 
-
 
In
ha
la
tio
n
: 
6 
h/
d,
 
5 
d/
w
,
 
15
 
w
 
R
at
s 
A
B
R
 
A
u
di
to
ry
 
ef
fe
ct
s 
(re
v
er
sib
le
 
de
la
ye
d 
A
B
R
 
in
te
rp
ea
k 
la
te
n
ci
es
). 
(15
7) 
40
0 
80
0 
-
 
In
ha
la
tio
n
: 
7 
h/
d,
 
7 
d/
w
,
 
11
 
w
 
R
at
s 
A
B
R
 
 
A
u
di
to
ry
 
ef
fe
ct
s 
(ef
fe
ct
s 
o
n
 
A
B
R
 
la
te
n
ci
es
). 
(32
3) 
50
0 
 
-
 
-
 
In
ha
la
tio
n
: 
6 
h/
d,
 
5 
d/
w
,
 
12
 
w
 
 
R
at
s 
R
M
A
 
N
o
 
he
ar
in
g 
lo
ss
 
(on
ly
 
do
se
 
te
st
ed
).  
(66
) 
CS
2 
co
m
bi
n
ed
 
w
ith
 
n
o
ise
 
(N
) 
N
o
 
da
ta
 
So
lv
en
t m
ix
tu
re
 
(pe
r 
se
) (
M
IX
) 
W
hi
te
 
sp
iri
t (
de
a
ro
m
a
tis
ed
) a
lo
n
e 
80
0 
pp
m
 
 
-
 
-
 
In
ha
la
tio
n
: 
6 
h/
d,
 
5d
/w
,
 
6 
m
 
R
at
s 
A
B
R
 
N
o
 
he
ar
in
g 
lo
ss
.
 
 
(23
6) 
Je
t fu
el
 
(JP
-
8) 
a
lo
n
e 
-
 
1 
00
0 
m
g/
m
3  
 
-
 
In
ha
la
tio
n
: 
4 
h/
d,
 
1 
o
r 
5 
d 
R
at
s 
CA
P 
 
D
PO
EA
 
M
E 
H
ea
rin
g 
lo
ss
 
(de
cr
ea
se
 
in
 
D
PO
A
E 
am
pl
itu
de
) a
fte
r 
re
pe
at
ed
 
ex
po
su
re
.
 
N
o
 
O
H
C 
lo
ss
.
 
O
n
ly
 
do
se
 
te
st
ed
.
 
(13
2) 
Je
t fu
el
 
(JP
-
8) 
co
m
bi
n
ed
 
w
ith
 
n
o
ise
 
(N
) 
-
 
1 
00
0 
m
g/
m
3 
 
 
97
,
 
10
2 
o
r 
10
5 
dB
 
O
B
N
 
8 
kH
z 
In
ha
la
tio
n
: 
4 
h/
d,
 
1 
o
r 
5 
d 
N
: 
4 
h 
(10
5 
dB
), 
1 
h/
d,
 
5 
d 
(10
2 
dB
) o
r 
4 
h/
d,
 
5 
d 
(97
 
dB
) 
R
at
s 
CA
P 
 
D
PO
EA
 
 
M
E 
H
ea
rin
g 
lo
ss
 
(de
cr
ea
se
 
in
 
D
PO
A
E 
am
pl
itu
de
) a
n
d 
O
H
C 
lo
ss
 
gr
ea
te
r 
th
an
 
by
 
N
.
 
O
H
C 
lo
ss
 
o
n
ly
 
af
te
r 
re
pe
at
ed
 
ex
po
su
re
.
 
O
n
ly
 
do
se
 
te
st
ed
.
 
(13
2) 
  
12
8  
Ta
bl
e 
31
.
 
Cr
iti
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tu
di
es
 
o
n
 
au
di
to
ry
 
ef
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s 
in
 
an
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s 
w
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rr
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po
n
di
n
g 
N
O
A
EL
s 
an
d 
LO
A
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s 
(in
 
pp
m
,
 
if 
n
o
t o
th
er
w
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) f
o
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th
e 
su
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ta
n
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m
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.
 
 
N
O
A
EL
 
LO
A
EL
 
N
o
ise
 
(N
) 
Ex
po
su
re
 
re
gi
m
en
 
Sp
ec
ie
s 
A
u
di
to
ry
 
te
st
 
 
A
u
di
to
ry
 
ef
fe
ct
 
R
ef
er
en
ce
 
Le
a
d 
(P
b) 
(bl
o
o
d 
le
ve
l) 
Pb
 
a
lo
n
e 
35
 
µg
/d
l 
55
 
µg
/d
l 
-
 
In
 
di
et
: 
pr
en
at
al
 
to
 
 
~
 
10
 
yr
s 
o
f a
ge
 
M
o
n
ke
ys
 
A
B
R
 
A
u
di
to
ry
 
ef
fe
ct
s 
(pr
o
lo
n
ga
tio
n
s 
o
f A
B
R
 
la
te
n
ci
es
).  
(22
1) 
35
-
40
 
µg
/d
l 
-
 
-
 
In
 
m
ilk
: 
bi
rt
h 
to
 
1 
 
o
r 
2 
yr
s 
o
f a
ge
 
M
o
n
ke
ys
 
 
A
B
R
,
 
D
PO
A
E,
 
Ty
m
pa
n
o
-
m
et
ry
 
N
o
 
au
di
to
ry
 
ef
fe
ct
s.
 
(20
2) 
Pb
 
co
m
bi
n
ed
 
w
ith
 
n
o
ise
 
(N
) 
N
o
 
da
ta
 
 
 
 
 
 
 
 
M
er
cu
ry
 
(H
g) 
 
 
 
 
 
 
 
H
g 
a
lo
n
e 
-
 
10
 
µg
 
H
g/
kg
 
bw
/d
 
as
 
CH
3H
gC
l 
-
 
O
ra
lly
: 
ge
st
at
io
n
 
to
 
4 
yr
s 
o
f a
ge
 
M
o
n
ke
ys
 
PT
A
 
H
ea
rin
g 
lo
ss
 
in
 
al
l a
n
im
al
s 
at
 
19
 
yr
s 
o
f a
ge
.
 
Th
e 
de
te
rio
ra
tio
n
 
in
 
he
ar
in
g 
be
tw
ee
n
 
11
 
an
d 
19
 
yr
s 
 
w
as
 
m
o
re
 
pr
o
n
o
u
n
ce
d 
in
 
ex
po
se
d 
th
an
 
in
 
co
n
tr
o
l 
m
o
n
ke
ys
.
 
Lo
w
es
t d
o
se
 
te
st
ed
.
 
(33
2) 
H
g 
co
m
bi
n
ed
 
w
ith
 
n
o
ise
 
(N
) 
N
o
 
da
ta
 
 
 
 
 
 
 
 
Tr
im
et
hy
lti
n
s 
(T
M
T)
 
TM
T 
a
lo
n
e 
-
 
0.
2 
m
g/
kg
 
bw
 
-
 
Si
n
gl
e 
ip
.
 
in
jec
tio
n
 
G
u
in
ea
 
pi
gs
 
CA
P,
 
CM
,
 
 
SP
 
A
u
di
to
ry
 
ef
fe
ct
s 
(la
te
n
cy
 
de
la
ys
 
in
 
CA
P,
 
lo
w
es
t  
do
se
 
te
st
ed
). 
(11
8) 
2 
m
g/
kg
 
bw
 
4 
m
g/
kg
 
bw
 
-
 
Si
n
gl
e 
ip
.
 
in
jec
tio
n
 
R
at
s 
A
SR
 
H
ea
rin
g 
lo
ss
.
 
(39
3) 
-
 
3 
m
g/
kg
 
bw
 
-
 
Si
n
gl
e 
ip
.
 
in
jec
tio
n
 
R
at
s 
A
B
R
,
 
A
SR
,
 
M
E 
H
ea
rin
g 
lo
ss
 
(A
B
R
 
th
re
sh
o
ld
s) 
an
d 
O
H
C 
lo
ss
.
 
Lo
w
es
t d
o
se
 
te
st
ed
.
 
(79
) 
TM
T 
co
m
bi
n
ed
 
w
ith
 
n
o
ise
 
(N
) 
N
o
 
da
ta
 
 
 
 
 
 
 
 
  
12
9  
Ta
bl
e 
31
.
 
Cr
iti
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o
n
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w
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es
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n
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n
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N
O
A
EL
s 
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LO
A
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(in
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m
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if 
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o
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er
w
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n
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v
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w
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e 
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t d
o
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m
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t. 
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.
 
 
N
O
A
EL
 
LO
A
EL
 
N
o
ise
 
(N
) 
Ex
po
su
re
 
re
gi
m
en
 
Sp
ec
ie
s 
A
u
di
to
ry
 
te
st
 
 
A
u
di
to
ry
 
ef
fe
ct
 
R
ef
er
en
ce
 
Ca
rb
o
n
 
m
o
n
o
xi
de
 
(C
O
) 
CO
 
a
lo
n
e 
1 
50
0 
-
 
-
 
3.
5-
9.
5 
h 
R
at
s 
CA
P 
 
CM
 
N
o
 
au
di
to
ry
 
ef
fe
ct
s.
 
(61
) 
CO
 
co
m
bi
n
ed
 
w
ith
 
n
o
ise
 
(N
) 
30
0 
50
0 
11
0 
o
r 
11
5 
dB
 
Li
n
,
 
4 
kH
z 
O
B
N
 
In
ha
la
tio
n
: 
9.
5 
h 
N
: 
8 
h 
R
at
s 
CA
P 
CM
 
Po
te
n
tia
tio
n
 
o
f N
IH
L 
(sy
n
er
gi
sm
). 
(61
) 
30
0 
50
0 
19
4,
 
32
0 
(B
M
Cs
) 
10
0 
dB
 
Li
n
,
 
13
.
6 
kH
z 
O
B
N
 
In
ha
la
tio
n
: 
9.
5 
h 
 
N
: 
8 
h 
R
at
s 
CA
P 
Po
te
n
tia
tio
n
 
o
f N
IH
L 
in
cr
ea
se
d 
lin
ea
rly
 
as
 
CO
 
in
cr
ea
se
d 
be
tw
ee
n
 
50
0 
an
d 
1 
50
0 
pp
m
 
(sy
n
er
gi
sm
).  
B
M
Cs
 
(lo
w
er
 
bo
u
n
ds
): 
In
cr
ea
se
 
in
 
au
di
to
ry
 
th
re
s-
ho
ld
 
eq
u
iv
al
en
t t
o
 
10
 
%
 
o
f t
he
 
ef
fe
ct
 
by
 
N
 
at
 
19
4 
pp
m
 
an
d 
5-
dB
 
po
te
n
tia
tio
n
 
o
f N
IH
L 
at
 
32
0 
pp
m
.
 
 
(13
0) 
30
0 
50
0 
84
 
dB
 
SP
L 
Le
q8
h,
 
im
pu
lsi
v
e 
In
ha
la
tio
n
: 
8 
h/
d,
 
10
 
d 
N
: 
6 
h/
d,
 
10
 
d 
R
at
s 
A
B
R
 
 
D
PO
A
E 
Po
te
n
tia
tio
n
 
o
f N
IH
L 
(sy
n
er
gi
sm
). 
(23
3) 
H
yd
ro
ge
n
 
cy
a
n
id
e 
(H
CN
) 
H
CN
 
a
lo
n
e 
50
 
 
-
 
-
 
In
ha
la
tio
n
: 
3.
5 
h 
R
at
s 
CA
P 
 
M
E 
N
o
 
he
ar
in
g 
lo
ss
 
o
r 
O
H
C 
lo
ss
.
 
Th
e 
o
n
ly
 
st
u
dy
 
id
en
tif
ie
d.
 
(12
6) 
H
CN
 
co
m
bi
n
ed
 
w
ith
 
n
o
ise
 
(N
) 
10
 
 
30
 
 
2-
16
 
(B
M
Cs
) 
10
0 
dB
 
Li
n
,
 
O
B
N
 
In
ha
la
tio
n
: 
3.
5 
h 
N
: 
2 
h 
R
at
s 
CA
P 
M
E 
Po
te
n
tia
tio
n
 
o
f N
IH
L 
an
d 
O
H
C 
lo
ss
.
 
 
B
M
Cs
 
(lo
w
er
 
bo
u
n
ds
): 
Im
pa
ire
d 
au
di
to
ry
 
th
re
s-
 
ho
ld
 
10
 
%
 
ab
o
v
e 
th
e 
ef
fe
ct
 
by
 
N
 
at
 
2 
pp
m
,
 
5-
dB
 
po
te
n
tia
tio
n
 
o
f N
IH
L 
at
 
9 
pp
m
 
an
d 
1 
SD
 
el
ev
at
io
n
 
 
o
f N
IH
L 
at
 
16
 
pp
m
.
 
Th
e 
o
n
ly
 
st
u
dy
 
id
en
tif
ie
d.
 
(12
6) 
  
13
0  
Ta
bl
e 
31
.
 
Cr
iti
ca
l s
tu
di
es
 
o
n
 
au
di
to
ry
 
ef
fe
ct
s 
in
 
an
im
al
s 
w
ith
 
co
rr
es
po
n
di
n
g 
N
O
A
EL
s 
an
d 
LO
A
EL
s 
(in
 
pp
m
,
 
if 
n
o
t o
th
er
w
ise
 
st
at
ed
) f
o
r 
th
e 
su
bs
ta
n
ce
s 
re
v
ie
w
ed
 
in
 
th
e 
pr
es
en
t d
o
cu
m
en
t. 
Fo
r 
ab
br
ev
ia
tio
n
s,
 
se
e 
en
d 
o
f t
ab
le
.
 
 
N
O
A
EL
 
LO
A
EL
 
N
o
ise
 
(N
) 
Ex
po
su
re
 
re
gi
m
en
 
Sp
ec
ie
s 
A
u
di
to
ry
 
te
st
 
 
A
u
di
to
ry
 
ef
fe
ct
 
R
ef
er
en
ce
 
Ac
ry
lo
n
itr
ile
 
(A
CN
) 
AC
N 
a
lo
n
e 
50
 
m
g/
kg
 
bw
 
-
 
-
 
Sc
.
 
in
jec
tio
n
: 
1,
 
2 
o
r 
 
5 
d 
R
at
s 
CA
P 
N
o
 
he
ar
in
g 
lo
ss
 
(tr
an
sie
n
t l
o
ss
 
o
f a
u
di
to
ry
 
th
re
sh
o
ld
 
se
n
sit
iv
ity
 
im
m
ed
ia
te
ly
 
af
te
r 
ex
po
su
re
). O
n
ly
 
do
se
 
te
st
ed
.
 
(12
7,
 
13
1) 
50
 
m
g/
kg
 
bw
 
-
 
-
 
Sc
.
 
in
jec
tio
n
: 
5 
d 
R
at
s 
CA
P 
D
PO
EA
 
M
E 
N
o
 
he
ar
in
g 
lo
ss
 
o
r 
O
H
C 
lo
ss
.
 
O
n
ly
 
do
se
 
te
st
ed
.
 
(29
7) 
AC
N 
co
m
bi
n
ed
 
w
ith
 
n
o
ise
 
(N
) 
-
 
50
 
m
g/
kg
 
bw
 
10
8 
dB
 
O
B
N
 
Sc
.
 
in
jec
tio
n
: 
1 
o
r 
2 
d 
N
: 
8 
h/
d,
 
1 
d 
R
at
s 
CA
P 
Po
te
n
tia
tio
n
 
o
f N
IH
L 
(pe
rm
an
en
t l
o
ss
 
o
f a
u
di
to
ry
 
th
re
sh
o
ld
 
se
n
sit
iv
ity
). O
n
ly
 
do
se
 
te
st
ed
.
 
(13
1) 
-
 
50
 
m
g/
kg
 
bw
 
10
5 
dB
 
Li
n
 
O
B
N
 
Sc
.
 
in
jec
tio
n
: 
1 
o
r 
5 
d 
N
: 
4 
h/
d,
 
1 
o
r 
5 
d 
R
at
s 
CA
P 
Po
te
n
tia
tio
n
 
o
f N
IH
L 
(pe
rm
an
en
t l
o
ss
 
o
f a
u
di
to
ry
 
th
re
sh
o
ld
 
se
n
sit
iv
ity
). O
n
ly
 
do
se
 
te
st
ed
.
 
(12
7) 
-
 
50
 
m
g/
kg
 
bw
 
95
 
o
r 
97
 
dB
 
O
B
N
 
Sc
.
 
in
jec
tio
n
: 
5 
d 
N
: 
4 
h/
d,
 
5 
d 
R
at
s 
CA
P 
D
PO
EA
 
M
E 
H
ea
rin
g l
o
ss
 
(pe
rm
an
en
t t
hr
es
ho
ld
 
sh
ift
s,
 
de
cr
ea
se
 
in
 
D
PO
EA
 
am
pl
itu
de
s) 
an
d 
O
H
C 
lo
ss
.
 
N
o
 
ef
fe
ct
 
o
f 
A
CN
 
o
r 
N
 
al
o
n
e.
 
O
n
ly
 
do
se
 
te
st
ed
.
 
(29
7,
 
29
9)  
3,
3´
-
Im
in
o
di
pr
o
pi
o
n
itr
ile
 
(ID
PN
)  
ID
PN
 
a
lo
n
e 
10
0 
m
g/
kg
 
bw
 
15
0 
m
g/
kg
 
bw
 
-
 
Ip
.
 
in
jec
tio
n
: 
 
3 
co
n
se
cu
tiv
e 
da
ys
 
R
at
s 
R
M
A
 
H
ea
rin
g 
lo
ss
 
(de
cr
ea
se
d 
am
pl
itu
de
 
o
f a
co
u
st
ic
 
st
ar
tle
 
re
fle
x
).  
 
(73
) 
15
0 
m
g/
kg
 
bw
 
16
7 
m
g/
kg
 
bw
 
-
 
Ip
.
 
in
jec
tio
n
: 
 
3 
co
n
se
cu
tiv
e 
da
ys
 
R
at
s 
A
B
R
 
 
R
M
A
 
H
ea
rin
g 
lo
ss
 
(el
ev
at
ed
 
au
di
to
ry
 
th
re
sh
o
ld
s 
fo
r 
a 
br
o
ad
 
sp
ec
tr
u
m
 
o
f f
re
qu
en
ci
es
).  
(80
) 
ID
PN
 
co
m
bi
n
ed
 
w
ith
 
n
o
ise
 
(N
) 
N
o
 
da
ta
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1  
Ta
bl
e 
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.
 
Cr
iti
ca
l s
tu
di
es
 
o
n
 
au
di
to
ry
 
ef
fe
ct
s 
in
 
an
im
al
s 
w
ith
 
co
rr
es
po
n
di
n
g 
N
O
A
EL
s 
an
d 
LO
A
EL
s 
(in
 
pp
m
,
 
if 
n
o
t o
th
er
w
ise
 
st
at
ed
) f
o
r 
th
e 
su
bs
ta
n
ce
s 
re
v
ie
w
ed
 
in
 
th
e 
pr
es
en
t d
o
cu
m
en
t. 
Fo
r 
ab
br
ev
ia
tio
n
s,
 
se
e 
en
d 
o
f t
ab
le
.
 
 
N
O
A
EL
 
LO
A
EL
 
N
o
ise
 
(N
) 
Ex
po
su
re
 
re
gi
m
en
 
Sp
ec
ie
s 
A
u
di
to
ry
 
te
st
 
 
A
u
di
to
ry
 
ef
fe
ct
 
R
ef
er
en
ce
 
Pe
st
ic
id
es
 
In
su
ffi
ci
en
t d
at
a 
 
Po
ly
ch
lo
rin
a
te
d 
bi
ph
en
yl
s 
(P
CB
s) 
PC
Bs
 
a
lo
n
e 
0.
25
 
µg
/k
g b
w
 
PC
B
 
12
6 
1 
µg
/k
g 
bw
 
 
PC
B
 
12
6 
-
 
G
av
ag
e:
 
5 
d/
w
,
 
35
 
d 
pr
io
r 
to
 
br
ee
di
n
g 
to
 
PN
D
 
21
 
N
u
lli
-
 
pa
ro
u
s 
ra
ts
,
 
o
ffs
pr
in
g 
A
SR
 
 
R
M
A
 
H
ea
rin
g 
lo
ss
 
(el
ev
at
ed
 
au
di
to
ry
 
th
re
sh
o
ld
s 
fo
r 
lo
w
-
fre
qu
en
cy
 
to
n
es
 
bu
t n
o
t f
o
r 
hi
gh
er
 
fre
qu
en
ci
es
). 
(76
) 
-
 
1 
m
g/
kg
 
bw
 
 
A
ro
cl
o
r 
12
54
 
-
 
G
av
ag
e:
 
G
D
 
6 
to
 
PN
D
 
21
 
R
at
s,
 
o
ffs
pr
in
g 
A
B
R
 
H
ea
rin
g 
lo
ss
 
(de
cr
ea
se
d 
A
B
R
 
am
pl
itu
de
 
fo
r 
lo
w
-
fre
qu
en
cy
 
to
n
es
 
bu
t n
o
t f
o
r 
hi
gh
er
 
fre
qu
en
ci
es
). 
Lo
w
es
t d
o
se
 
te
st
ed
.
 
(15
3) 
1 
m
g/
kg
 
bw
 
PC
B
 
m
ix
tu
re
 
3 
m
g/
kg
 
bw
 
PC
B
 
m
ix
tu
re
 
-
 
In
 
di
et
: 
28
 
da
ys
 
pr
io
r 
to
 
br
ee
di
n
g 
to
 
PN
D
 
21
 
R
at
s,
 
o
ffs
pr
in
g 
A
B
R
 
D
PO
EA
 
H
ea
rin
g 
lo
ss
 
(el
ev
at
ed
 
A
B
R
 
an
d 
D
PO
EA
 
th
re
sh
o
ld
s 
ac
ro
ss
 
a 
ra
n
ge
 
o
f f
re
qu
en
ci
es
.
 
D
ec
re
as
ed
 
D
PO
EA
 
am
pl
itu
de
s).
 
 
(30
0) 
PC
Bs
 
co
m
bi
n
ed
 
w
ith
 
n
o
ise
 
(N
) 
N
o
 
da
ta
 
Su
bs
ta
n
ce
 
a
bb
re
vi
a
tio
n
s:
 
A
CN
: 
ac
ry
lo
n
itr
ile
,
 
CB
Z:
 
ch
lo
ro
be
n
ze
n
e,
 
CO
: 
ca
rb
o
n
 
m
o
n
o
x
id
e,
 
CS
2:
 
ca
rb
o
n
 
di
su
lp
hi
de
,
 
EB
Z:
 
et
hy
lb
en
ze
n
e,
 
H
CN
: 
hy
dr
o
ge
n
 
cy
an
id
e,
 
H
EP
: 
he
pt
an
e,
 
H
EX
: 
he
x
an
e,
 
H
g:
 
m
er
cu
ry
,
 
ID
PN
: 
3,
3´
-
im
in
o
di
pr
o
pi
o
n
itr
ile
,
 
M
IX
: 
so
lv
en
t m
ix
tu
re
,
 
Pb
: 
le
ad
,
 
PC
B
: 
po
ly
ch
lo
rin
at
ed
 
bi
ph
en
yl
,
 
ST
Y
: 
st
yr
en
e,
 
TC
E:
 
tr
ic
hl
o
ro
-
et
hy
le
n
e,
 
TO
L:
 
to
lu
en
e,
 
TM
T:
 
tr
im
et
hy
lti
n
,
 
X
Y
L:
 
x
yl
en
e.
 
 O
th
er
 
a
bb
re
vi
a
tio
n
s:
 
A
B
R
: 
au
di
to
ry
 
br
ai
n
st
em
 
re
sp
o
n
se
,
 
A
SR
: 
ac
o
u
st
ic
 
st
ar
tle
 
re
sp
o
n
se
,
 
B
A
: 
be
ha
v
io
u
ra
l a
u
di
o
m
et
ry
,
 
B
M
C:
 
be
n
ch
m
ar
k 
co
n
ce
n
tr
at
io
n
,
 
bw
: 
bo
dy
 
w
ei
gh
t, 
CA
P:
 
co
m
po
u
n
d 
ac
tio
n
 
po
te
n
tia
l, 
CA
R
: 
co
n
di
tio
n
ed
 
av
o
id
an
ce
 
re
sp
o
n
se
,
 
CM
: 
co
ch
le
ar
 
m
ic
ro
ph
o
n
ic
s,
 
D
PO
A
E:
 
di
st
o
rt
io
n
 
pr
o
du
ct
 
o
to
ac
o
u
st
ic
 
em
iss
io
n
s,
 
G
D
: 
ge
st
at
io
n
 
da
y,
 
ip
.
: 
in
tr
ap
er
ito
n
ea
l, 
Le
q8
h:
 
eq
u
iv
al
en
t l
ev
el
 
o
f n
o
ise
 
du
rin
g 
8 
ho
u
rs
,
 
Li
n
: 
lin
ea
r,
 
LO
A
EL
: 
lo
w
es
t o
bs
er
v
ed
 
ad
v
er
se
 
ef
fe
ct
 
le
v
el
,
 
M
A
EP
: 
m
id
dl
e 
la
te
n
cy
 
au
di
to
ry
 
ev
o
ke
d 
po
te
n
tia
ls,
 
M
E:
 
m
o
rp
ho
lo
gi
ca
l e
x
am
in
at
io
n
,
 
N
: 
n
o
ise
,
 
N
IH
L:
 
n
o
ise
-
in
du
ce
d 
he
ar
in
g 
lo
ss
,
 
N
O
A
EL
: 
n
o
 
o
bs
er
v
ed
 
ad
v
er
se
 
ef
fe
ct
 
le
v
el
,
 
O
B
N
: 
o
ct
av
e 
ba
n
d 
n
o
ise
,
 
O
H
C:
 
o
u
te
r 
ha
ir 
ce
ll,
 
PN
D
: 
po
st
n
at
al
 
da
y,
 
PT
A
: 
pu
re
-
to
n
e 
au
di
o
m
et
ry
,
 
R
M
A
: 
re
fle
x
 
m
o
di
fic
at
io
n
 
au
di
o
m
et
ry
,
 
sc
.
: 
su
bc
u
ta
n
eo
u
s,
 
SD
: 
st
an
da
rd
 
de
v
ia
tio
n
,
 
SP
: 
su
m
m
at
in
g 
po
te
n
tia
l, 
SP
L:
 
so
u
n
d 
pr
es
su
re
 
le
v
el
,
 
W
B
N
: 
w
id
e 
ba
n
d 
n
o
ise
.
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2  
 Ta
bl
e 
32
.
 
Cr
iti
ca
l s
tu
di
es
 
o
n
 
au
di
to
ry
 
ef
fe
ct
s 
in
 
hu
m
an
s 
fo
r 
th
e 
su
bs
ta
n
ce
s 
re
v
ie
w
ed
 
in
 
th
e 
pr
es
en
t d
o
cu
m
en
t (
ex
po
su
re
 
le
v
el
s 
in
 
pp
m
,
 
if 
n
o
t o
th
er
w
ise
 
st
at
ed
). H
ea
rin
g 
lo
ss
 
m
ea
n
s 
ch
an
ge
s 
m
ea
su
re
d 
w
ith
 
pu
re
-
to
n
e 
au
di
o
m
et
ry
.
 
A
u
di
to
ry
 
dy
sf
u
n
ct
io
n
 
m
ea
n
s 
ch
an
ge
s 
m
ea
su
re
d 
in
 
th
e 
ce
n
tr
al
 
au
di
to
ry
 
sy
st
em
 
w
ith
 
ev
o
ke
d 
po
te
n
tia
l t
es
tin
g 
o
r 
o
th
er
 
ce
n
tr
al
 
te
st
s.
 
Fo
r 
ab
br
ev
ia
tio
n
s,
 
se
e 
en
d 
o
f t
ab
le
.
 
Cu
rr
en
t e
x
po
su
re
 
le
v
el
,
 
 
m
ea
n
 
±
 
SD
 
(ra
n
ge
)  
Ex
po
su
re
 
du
ra
tio
n
 
N
o
ise
 
(N
) 
Si
ze
 
o
f s
tu
dy
 
gr
o
u
p 
A
u
di
to
ry
 
ef
fe
ct
 
R
ef
er
en
ce
 
St
yr
en
e 
(ST
Y)
 
 
 
 
 
 
3.
5 
(0.
05
-
22
) (
ST
Y
) 
2.
8 
(0.
00
7-
12
) (
ST
Y
+
N
) 
A
v
er
ag
e 
w
o
rk
-
lif
e 
ex
po
su
re
: 
18
 
(S
TY
) 
14
 
(S
TY
+
N
) 
17
 
(1-
39
) y
rs
 
(S
TY
) 
15
 
(2-
37
) y
rs
 
(S
TY
+
N
) 
≤
 
84
 
dB
A
 
(S
TY
) 
89
 
dB
A
 
(S
TY
+
N
) 
86
 
dB
A
 
(N
) 
65
 
ST
Y
 
89
 
ST
Y
+
N
 
78
 
N
 
81
 
co
n
tr
o
ls 
H
ea
rin
g 
lo
ss
 
an
d 
au
di
to
ry
 
dy
sf
u
n
ct
io
n
 
(sp
ee
ch
) i
n
 
ST
Y
 
an
d 
ST
Y
+
N
 
co
m
pa
re
d 
to
 
N
 
ex
po
se
d 
an
d 
co
n
tr
o
ls.
 
B
io
lo
gi
ca
l m
ar
ke
r 
fo
r 
ST
Y
 
(ur
in
ar
y 
M
A
) 
as
so
ci
at
ed
 
w
ith
 
he
ar
in
g 
lo
ss
.
 
 
(18
7,
 
25
6) 
~
5 
(0.
7-
14
) (
es
tim
at
ed
 
fro
m
 
u
rin
ar
y 
M
A
+
PG
A
) 
7 ±
 
6.
2 
yr
s 
73
 
dB
A
 
32
 
ST
Y
 
60
 
co
n
tr
o
ls 
H
ea
rin
g 
lo
ss
 
in
 
ST
Y
 
co
m
pa
re
d 
to
 
th
e 
ag
e-
m
at
ch
ed
 
co
n
tr
o
ls.
 
(24
0) 
8 
(0.
1-
93
) 
<
 
50
 
fo
r 
87
/9
3 
w
o
rk
er
s 
9.
4 ±
 
8.
9 
yr
s 
≤
 
85
 
dB
 
44
 
ST
Y
 
49
 
ST
Y
 
in
 
m
ix
tu
re
 
in
cl
.
 
TO
L 
33
 
co
n
tr
o
ls 
H
ea
rin
g 
lo
ss
 
in
 
hi
gh
-
fre
qu
en
cy
 
ra
n
ge
 
in
 
ST
Y
 
su
b-
gr
o
u
p 
(n 
=
 
54
) e
x
po
se
d 
to
 
>
 
16
 
pp
m
 
fo
r 
≥
 
5 
yr
s.
 
Th
e 
ef
fe
ct
 
co
rr
el
at
ed
 
to
 
ST
Y
 
in
 
ai
r 
an
d 
to
 
bi
o
lo
gi
ca
l m
ar
ke
r 
o
f S
TY
 
(ur
in
ar
y 
M
A
). 
(25
8) 
A
v
er
ag
e 
w
o
rk
-
lif
e 
ex
po
su
re
: 
14
 
±
 
9.
3 
(S
TY
) 
 
 
8 
±
 
6 
(S
TY
+
N
) 
-
 
80
 
dB
A
 
(S
TY
) 
89
 
dB
A
 
(S
TY
+
N
) 
89
 
dB
A
 
(N
) 
19
4 
ST
Y
 
56
 
ST
Y
+
N
 
66
 
N
 
15
7 
co
n
tr
o
ls 
H
ea
rin
g 
lo
ss
 
in
 
ST
Y
 
an
d 
in
 
ST
Y
+
N
 
co
m
pa
re
d 
to
 
N
 
an
d 
co
n
tr
o
ls.
 
A
v
er
ag
e 
w
o
rk
-
lif
e 
ex
po
su
re
 
to
 
ST
Y
 
co
rr
el
at
ed
 
to
 
he
ar
in
g 
lo
ss
.
 
 
(34
6,
 
34
7) 
22
 
(3.
7-
46
) 
5.
4 y
rs
 
69
-
76
 
dB
A
 
(S
TY
) 
82
-
86
 
dB
A
 
(N
) 
 
19
 
ST
Y
 
18
 
N
 
11
 
co
n
tr
o
ls 
H
ea
rin
g 
lo
ss
 
in
 
hi
gh
-
fre
qu
en
cy
 
ra
n
ge
 
in
 
ST
Y
 
ex
po
se
d 
co
m
pa
re
d 
to
 
N
 
an
d 
co
n
tr
o
ls.
 
 
(25
9) 
~
2-
50
 
(ra
n
ge
 
o
f m
ea
n
s,
 
es
tim
at
ed
 
fro
m
 
u
rin
ar
y 
M
A
+
PG
A
) 
6 
(1-
26
) y
rs
 
75
-
83
 
dB
A
 
24
8 
ST
Y
 
(lo
w
,
 
m
ed
iu
m
,
 
hi
gh
) 
 
H
ea
rin
g 
lo
ss
 
in
 
ST
Y
 
su
b-
gr
o
u
p 
ex
po
se
d 
to
 
hi
gh
 
le
v
el
s 
(30
-
50
 
pp
m
,
 
n
 
=
 
17
) a
t l
ea
st
 
10
 
yr
s 
w
ith
 
le
v
el
s 
>
 
50
 
pp
m
 
in
 
th
e 
pa
st
.
 
 
(37
4) 
  
13
3  
Ta
bl
e 
32
.
 
Cr
iti
ca
l s
tu
di
es
 
o
n
 
au
di
to
ry
 
ef
fe
ct
s 
in
 
hu
m
an
s 
fo
r 
th
e 
su
bs
ta
n
ce
s 
re
v
ie
w
ed
 
in
 
th
e 
pr
es
en
t d
o
cu
m
en
t (
ex
po
su
re
 
le
v
el
s 
in
 
pp
m
,
 
if 
n
o
t o
th
er
w
ise
 
st
at
ed
). H
ea
rin
g 
lo
ss
 
m
ea
n
s 
ch
an
ge
s 
m
ea
su
re
d 
w
ith
 
pu
re
-
to
n
e 
au
di
o
m
et
ry
.
 
A
u
di
to
ry
 
dy
sf
u
n
ct
io
n
 
m
ea
n
s 
ch
an
ge
s 
m
ea
su
re
d 
in
 
th
e 
ce
n
tr
al
 
au
di
to
ry
 
sy
st
em
 
w
ith
 
ev
o
ke
d 
po
te
n
tia
l t
es
tin
g 
o
r 
o
th
er
 
ce
n
tr
al
 
te
st
s.
 
Fo
r 
ab
br
ev
ia
tio
n
s,
 
se
e 
en
d 
o
f t
ab
le
.
 
Cu
rr
en
t e
x
po
su
re
 
le
v
el
,
 
 
m
ea
n
 
±
 
SD
 
(ra
n
ge
)  
Ex
po
su
re
 
du
ra
tio
n
 
N
o
ise
 
(N
) 
Si
ze
 
o
f s
tu
dy
 
gr
o
u
p 
A
u
di
to
ry
 
ef
fe
ct
 
R
ef
er
en
ce
 
To
lu
en
e 
(T
O
L)
 
 
 
 
 
 
 
26
 
±
 
20
 
 
Li
fe
-
tim
e 
w
ei
gh
te
d 
ex
po
su
re
: 
45
 
±
 
17
 
 
-
 
81
-
82
 
dB
A
 
19
2 
TO
L 
N
o
 
co
n
tr
o
ls 
N
o
 
he
ar
in
g 
lo
ss
.
 
TO
L 
le
v
el
s 
o
r 
du
ra
tio
n
 
n
o
t 
as
so
ci
at
ed
 
w
ith
 
he
ar
in
g 
lo
ss
.
 
N
O
A
EL
 
es
tim
at
ed
 
to
 
50
 
pp
m
 
by
 
au
th
o
rs
.
 
(34
2) 
(9-
37
)  
12
 
(2-
24
) y
rs
 
(T
O
L+
N
)  
 
 
6 
(3-
15
) y
rs
 
(N
) 
88
-
98
 
dB
A
 
 
TO
L+
N
 
an
d 
N
 
50
 
TO
L+
N
 
50
 
N
 
 
40
 
co
n
tr
o
ls 
W
o
rk
er
s 
w
ith
o
u
t s
ig
n
s 
o
f h
ea
rin
g 
lo
ss
 
o
n
ly
.
 
>
 
60
 
%
 
o
f T
O
L+
N
 
an
d 
N
 
gr
o
u
ps
 
ha
d 
n
o
 
re
sp
o
n
se
 
in
 
TE
O
A
E 
v
s.
 
27
 
%
 
o
f c
o
n
tr
o
ls.
 
 
49
 
%
 
o
f T
O
L+
N
 
gr
o
u
p 
ha
d 
n
o
 
co
n
tr
al
at
er
al
 
in
hi
bi
tio
n
 
in
 
TE
O
A
E 
v
s.
 
17
 
%
 
o
f N
 
an
d 
7 %
 
o
f 
co
n
tr
o
ls.
 
Th
e 
O
R
 
fo
r 
ab
se
n
ce
 
o
f c
o
n
tr
al
at
er
al
 
in
hi
bi
tio
n
 
w
as
 
12
 
(95
 
%
 
CI
 
3.
1-
43
.
5).
 
 
(31
) 
34
 
(2-
89
) (
es
tim
at
ed
 
fro
m
 
TO
L 
in
 
bl
o
o
d) 
21
.
4 
(4-
30
) y
rs
 
N
o
t g
iv
en
 
49
 
TO
L 
59
 
co
n
tr
o
ls 
A
u
di
to
ry
 
dy
sf
u
n
ct
io
n
 
o
f A
B
R
.
 
(38
4) 
(0.
04
-
24
4) 
in
 
m
ix
tu
re
+
N
 
≤
 
50
 
fo
r 
10
9/
12
4 
w
o
rk
er
s 
 
in
cl
.
 
et
hy
l a
ce
ta
te
 
an
d 
et
ha
n
o
l  
7.
7 
(1-
25
) y
rs
 
71
-
93
 
dB
A
 
12
4 
TO
L 
(in
 
m
ix
) +
 
N
 
N
o
 
co
n
tr
o
ls 
H
ea
rin
g 
lo
ss
 
in
 
49
 
%
.
 
B
io
lo
gi
ca
l m
ar
ke
r 
(ur
in
ar
y 
hi
pp
u
ric
 
ac
id
) f
o
r 
TO
L 
co
rr
el
at
ed
 
w
ith
 
he
ar
in
g 
lo
ss
.
 
(25
7) 
97
 
 
12
-
14
 
yr
s 
N
o
t g
iv
en
 
40
 
TO
L 
 
40
 
co
n
tr
o
ls 
A
u
di
to
ry
 
dy
sf
u
n
ct
io
n
 
o
f A
B
R
 
sh
o
w
n
 
in
 
TO
L 
ex
po
se
d 
(on
ly
 
w
o
rk
er
s 
w
ith
 
n
o
rm
al
 
PT
A
 
in
cl
u
de
d).
 
(2)
 
Ca
rb
o
n
 
di
su
lp
hi
de
 
(C
S 2
) 
 
 
 
 
 
3-
8 
(ve
n
til
at
io
n
 
im
pr
o
v
ed
 
 
14
 
yr
s 
ag
o
) 
2-
7 
yr
s 
u
p 
to
 
>
 
20
 
yr
s 
N
o
t g
iv
en
 
 
25
 
CS
2 
(2-
7 
yr
s) 
34
 
CS
2 
(>
 
20
 
yr
s) 
40
 
co
n
tr
o
ls 
A
u
di
to
ry
 
dy
sf
u
n
ct
io
n
 
o
f A
B
R
 
sh
o
w
n
 
in
 
CS
2 
ex
po
se
d 
>
 
20
 
yr
s.
 
 
(15
8) 
1.
6-
20
.
1 
≥
 
20
 
yr
s 
fo
r 
90
/1
31
 
80
-
91
 
dB
A
 
(C
S 2
+
N
) 
83
-
90
 
dB
A
 
(N
) 
 
13
1 
CS
2+
N
 
10
5 
N
 
11
0 
co
n
tr
o
ls 
H
ig
he
r 
pr
ev
al
en
ce
 
(68
 
%
) o
f h
ea
rin
g 
lo
ss
 
in
 
ex
po
se
d  t
ha
n
 
in
 
N
 
gr
o
u
p 
an
d 
co
n
tr
o
ls.
 
G
re
at
ly
 
in
cr
ea
se
d 
ris
k 
fo
r 
ex
po
su
re
s 
>
 
14
.
6 
pp
m
.
 
(58
) 
  
13
4  
Ta
bl
e 
32
.
 
Cr
iti
ca
l s
tu
di
es
 
o
n
 
au
di
to
ry
 
ef
fe
ct
s 
in
 
hu
m
an
s 
fo
r 
th
e 
su
bs
ta
n
ce
s 
re
v
ie
w
ed
 
in
 
th
e 
pr
es
en
t d
o
cu
m
en
t (
ex
po
su
re
 
le
v
el
s 
in
 
pp
m
,
 
if 
n
o
t o
th
er
w
ise
 
st
at
ed
). H
ea
rin
g 
lo
ss
 
m
ea
n
s 
ch
an
ge
s 
m
ea
su
re
d 
w
ith
 
pu
re
-
to
n
e 
au
di
o
m
et
ry
.
 
A
u
di
to
ry
 
dy
sf
u
n
ct
io
n
 
m
ea
n
s 
ch
an
ge
s 
m
ea
su
re
d 
in
 
th
e 
ce
n
tr
al
 
au
di
to
ry
 
sy
st
em
 
w
ith
 
ev
o
ke
d 
po
te
n
tia
l t
es
tin
g 
o
r 
o
th
er
 
ce
n
tr
al
 
te
st
s.
 
Fo
r 
ab
br
ev
ia
tio
n
s,
 
se
e 
en
d 
o
f t
ab
le
.
 
Cu
rr
en
t e
x
po
su
re
 
le
v
el
,
 
 
m
ea
n
 
±
 
SD
 
(ra
n
ge
)  
Ex
po
su
re
 
du
ra
tio
n
 
N
o
ise
 
(N
) 
Si
ze
 
o
f s
tu
dy
 
gr
o
u
p 
A
u
di
to
ry
 
ef
fe
ct
 
R
ef
er
en
ce
 
Xy
le
n
e 
(X
YL
), e
th
yl
be
n
ze
n
e 
(E
BZ
), c
hl
o
ro
be
n
ze
n
e 
(C
BZ
), t
ric
hl
o
ro
et
hy
le
n
e 
(T
CE
), n
-
he
xa
n
e 
(n-
H
EX
), n
-
he
pt
a
n
e 
(n-
H
EP
)   
 
N
o
 
da
ta
 
 
 
 
 
 
So
lv
en
t m
ix
tu
re
s 
 
 
 
 
 
N
o
t s
u
ffi
ci
en
t d
at
a 
 
 
 
 
 
Le
a
d 
(P
b) 
(bl
o
o
d 
le
ve
l) 
 
 
 
 
 
 
(10
-
61
) µ
g/
dl
 
 
-
 
79
-
86
 
dB
A
 
26
 
Pb
+
N
 
17
 
N
 
 
N
o
 
he
ar
in
g 
lo
ss
 
bu
t a
u
di
to
ry
 
dy
sf
u
n
ct
io
n
 
(se
n
sit
ise
d 
sp
ee
ch
) i
n
 
Pb
+
N
 
gr
o
u
p.
 
 
(17
7) 
(12
-
64
) µ
g/
dl
 
1-
18
 
yr
s 
N
o
t g
iv
en
 
22
 
Pb
 
22
 
co
n
tr
o
ls 
A
u
di
to
ry
 
dy
sf
u
n
ct
io
n
 
(P
30
0 
an
d 
A
B
R
). A
B
R
 
co
rr
el
at
ed
 
w
ith
 
Pb
 
bl
o
o
d 
le
v
el
s.
 
Sa
m
e 
st
u
dy
 
gr
o
u
p 
as
 
in
 
A
ra
ki
 
et
 
a
l (
13
). 
(26
6) 
M
ed
ia
n
: 
30
 
(12
-
59
) µ
g/
dl
 
1-
18
 
yr
s 
N
o
t g
iv
en
 
22
 
Pb
 
14
 
co
n
tr
o
ls 
A
u
di
to
ry
 
dy
sf
u
n
ct
io
n
 
(P
30
0) 
in
 
Pb
 
ex
po
se
d.
 
B
lo
o
d 
Pb
 
le
v
el
 
co
rr
el
at
ed
 
w
ith
 
au
di
to
ry
 
dy
sf
u
n
ct
io
n
.
 
(13
) 
37
 
±
 
4.
4 
µg
/d
l 
-
 
<
 
50
 
dB
 
45
 
Pb
 
 
45
 
co
n
tr
o
ls 
H
ea
rin
g 
lo
ss
 
in
 
Pb
 
ex
po
se
d.
 
B
lo
o
d 
Pb
 
le
v
el
 
co
rr
el
at
ed
 
w
ith
 
he
ar
in
g 
lo
ss
.
 
(11
0) 
28
 
±
 
8 
(4-
62
) µ
g/
dl
 
Li
fe
-
tim
e 
w
ei
gh
te
d 
av
er
ag
e:
 
39
 
±
 
12
 
(4-
66
) µ
g/
dl
 
Li
fe
-
tim
e 
in
te
gr
at
ed
 
bl
o
o
d 
Pb
 
in
de
x
: 
71
9 
µg
-
yr
/d
l  
17
 
(0.
2-
26
) y
rs
 
N
o
t g
iv
en
 
35
9 
Pb
 
N
o
 
co
n
tr
o
ls 
 
Pb
 
ex
po
su
re
 
in
te
rfe
re
d 
w
ith
 
A
B
R
 
in
 
a 
do
se
-
de
pe
n
de
n
t m
an
n
er
.
 
Cu
rr
en
t a
n
d 
lif
e-
tim
e 
w
ei
gh
te
d 
av
er
ag
e 
bl
o
o
d 
Pb
 
le
v
el
 
as
so
ci
at
ed
 
w
ith
 
th
e 
A
B
R
 
w
av
e 
I l
at
en
cy
 
w
hi
le
 
th
e 
lif
e-
tim
e 
in
de
x
 
w
as
 
as
so
ci
at
ed
 
w
ith
 
th
e 
w
av
e 
II
I l
at
en
cy
.
 
 
(35
) 
42
 
±
 
16
 
(13
-
67
) µ
g/
dl
 
 
Pr
ev
io
u
s 
5 
yr
s 
o
f e
x
po
su
re
: 
31
 
±
 
13
 
(18
-
70
) µ
g/
dl
 
17
 
(4-
29
) y
rs
 
N
o
t g
iv
en
 
15
 
Pb
 
39
 
co
n
tr
o
ls 
A
u
di
to
ry
 
dy
sf
u
n
ct
io
n
 
(A
B
R
) i
n
 
Pb
 
ex
po
se
d.
 
 
(15
6) 
  
13
5  
Ta
bl
e 
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.
 
Cr
iti
ca
l s
tu
di
es
 
o
n
 
au
di
to
ry
 
ef
fe
ct
s 
in
 
hu
m
an
s 
fo
r 
th
e 
su
bs
ta
n
ce
s 
re
v
ie
w
ed
 
in
 
th
e 
pr
es
en
t d
o
cu
m
en
t (
ex
po
su
re
 
le
v
el
s 
in
 
pp
m
,
 
if 
n
o
t o
th
er
w
ise
 
st
at
ed
). H
ea
rin
g 
lo
ss
 
m
ea
n
s 
ch
an
ge
s 
m
ea
su
re
d 
w
ith
 
pu
re
-
to
n
e 
au
di
o
m
et
ry
.
 
A
u
di
to
ry
 
dy
sf
u
n
ct
io
n
 
m
ea
n
s 
ch
an
ge
s 
m
ea
su
re
d 
in
 
th
e 
ce
n
tr
al
 
au
di
to
ry
 
sy
st
em
 
w
ith
 
ev
o
ke
d 
po
te
n
tia
l t
es
tin
g 
o
r 
o
th
er
 
ce
n
tr
al
 
te
st
s.
 
Fo
r 
ab
br
ev
ia
tio
n
s,
 
se
e 
en
d 
o
f t
ab
le
.
 
Cu
rr
en
t e
x
po
su
re
 
le
v
el
,
 
 
m
ea
n
 
±
 
SD
 
(ra
n
ge
)  
Ex
po
su
re
 
du
ra
tio
n
 
N
o
ise
 
(N
) 
Si
ze
 
o
f s
tu
dy
 
gr
o
u
p 
A
u
di
to
ry
 
ef
fe
ct
 
R
ef
er
en
ce
 
45
 
±
 
20
 
(11
-
80
) µ
g/
dl
 
-
 
N
o
t g
iv
en
 
30
 
Pb
 
N
o
 
co
n
tr
o
ls 
A
u
di
to
ry
 
dy
sf
u
n
ct
io
n
 
(A
B
R
) i
n
 
Pb
 
su
b-
gr
o
u
p 
w
ith
 
m
ea
n
 
Pb
 
le
v
el
 
47
 
µg
/d
l. 
Se
n
so
rin
eu
ra
l h
ea
rin
g 
lo
ss
 
(in
cr
ea
se
d 
au
di
o
m
et
ric
 
th
re
sh
o
ld
s),
 
w
hi
ch
 
m
ay
 
be
 
at
tr
ib
u
ta
bl
e 
to
 
N
 
co
m
bi
n
ed
 
w
ith
 
Pb
 
in
to
x
ic
at
io
n
.
 
 
(70
) 
47
 
±
 
9.
2 
µg
/d
l 
9 
yr
s 
N
o
t g
iv
en
 
22
 
Pb
 
22
 
co
n
tr
o
ls 
A
u
di
to
ry
 
dy
sf
u
n
ct
io
n
 
(A
B
R
) i
n
 
Pb
 
gr
o
u
p.
 
St
ro
n
ge
st
 
ef
fe
ct
 
w
he
n
 
m
ea
n
 
Pb
 
le
v
el
 
w
as
 
>
 
50
 
µg
/d
l. 
 
(89
) 
55
 
±
 
16
 
µg
/d
l  
7 
yr
s 
N
o
t g
iv
en
 
49
 
Pb
 
49
 
co
n
tr
o
ls 
A
u
di
to
ry
 
dy
sf
u
n
ct
io
n
 
(A
B
R
) i
n
 
Pb
 
gr
o
u
p.
 
St
ro
n
ge
st
 
ef
fe
ct
 
w
he
n
 
m
ea
n
 
Pb
 
le
v
el
 
w
as
 
>
 
50
 
µg
/d
l f
o
r 
3 
yr
s.
 
(90
) 
57
 
µg
/d
l 
Lo
n
g-
te
rm
 
86
 
dB
A
 
Le
q 
22
0 
Pb
 
 
11
9 
co
n
tr
o
ls 
H
ea
rin
g 
lo
ss
 
co
rr
el
at
ed
 
to
 
hi
gh
 
an
d 
lo
n
g-
te
rm
 
Pb
 
ex
po
su
re
 
in
de
x
 
(du
ra
tio
n
 
o
f e
m
pl
o
ym
en
t a
n
d 
am
bi
en
t 
Pb
 
co
n
ce
n
tr
at
io
n
). N
o
 
co
rr
el
at
io
n
 
to
 
N
 
al
o
n
e 
o
r 
to
 
th
e 
in
te
ra
ct
io
n
 
be
tw
ee
n
 
N
 
an
d 
sh
o
rt
-
 
o
r 
lo
n
g-
te
rm
 
Pb
 
ex
po
su
re
.
 
(38
6) 
M
er
cu
ry
 
(H
g) 
 
 
 
 
 
0.
00
8 
m
g/
m
3 ,
 
pr
es
u
m
ab
ly
 
5 
µg
/l 
bl
o
o
d 
16
 
yr
s 
(m
ea
n
) 
N
o
t g
iv
en
 
40
 
H
g 
 
36
 
co
n
tr
o
ls)
 
A
u
di
to
ry
 
dy
sf
u
n
ct
io
n
 
(A
B
R
) m
o
re
 
fre
qu
en
t i
n
 
ex
po
se
d 
th
an
 
in
 
co
n
tr
o
ls 
(42
 
%
 
v
s.
 
18
 
%
). 
(26
0) 
32
5 ±
 
46
4 
µg
/g
 
cr
ea
tin
in
e 
in
 
u
rin
e 
12
 
yr
s 
(m
ea
n
) 
N
o
t g
iv
en
 
8 
H
g 
8 
co
n
tr
o
ls 
A
u
di
to
ry
 
dy
sf
u
n
ct
io
n
 
(A
B
R
). 
(89
) 
17
.
5 
µg
/l 
bl
o
o
d 
(ex
po
se
d) 
 
 
3.
0 
µg
/l 
bl
o
o
d 
(co
n
tr
o
ls)
 
-
 
N
o
t g
iv
en
 
36
 
H
g 
(ch
ild
re
n
) 
39
 
H
g 
(ad
u
lts
) 
34
 
co
n
tr
o
ls 
A
u
di
to
ry
 
dy
sf
u
n
ct
io
n
 
(A
B
R
). C
o
rr
el
at
io
n
 
be
tw
ee
n
 
H
g 
bl
o
o
d 
le
v
el
s 
an
d 
A
B
R
.
 
(71
) 
Tr
im
et
hy
lti
n
 
(T
M
T)
 
 
 
 
 
 
N
o
 
da
ta
 
 
 
 
 
 
  
13
6  
Ta
bl
e 
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.
 
Cr
iti
ca
l s
tu
di
es
 
o
n
 
au
di
to
ry
 
ef
fe
ct
s 
in
 
hu
m
an
s 
fo
r 
th
e 
su
bs
ta
n
ce
s 
re
v
ie
w
ed
 
in
 
th
e 
pr
es
en
t d
o
cu
m
en
t (
ex
po
su
re
 
le
v
el
s 
in
 
pp
m
,
 
if 
n
o
t o
th
er
w
ise
 
st
at
ed
). H
ea
rin
g 
lo
ss
 
m
ea
n
s 
ch
an
ge
s 
m
ea
su
re
d 
w
ith
 
pu
re
-
to
n
e 
au
di
o
m
et
ry
.
 
A
u
di
to
ry
 
dy
sf
u
n
ct
io
n
 
m
ea
n
s 
ch
an
ge
s 
m
ea
su
re
d 
in
 
th
e 
ce
n
tr
al
 
au
di
to
ry
 
sy
st
em
 
w
ith
 
ev
o
ke
d 
po
te
n
tia
l t
es
tin
g 
o
r 
o
th
er
 
ce
n
tr
al
 
te
st
s.
 
Fo
r 
ab
br
ev
ia
tio
n
s,
 
se
e 
en
d 
o
f t
ab
le
.
 
Cu
rr
en
t e
x
po
su
re
 
le
v
el
,
 
 
m
ea
n
 
±
 
SD
 
(ra
n
ge
)  
Ex
po
su
re
 
du
ra
tio
n
 
N
o
ise
 
(N
) 
Si
ze
 
o
f s
tu
dy
 
gr
o
u
p 
A
u
di
to
ry
 
ef
fe
ct
 
R
ef
er
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12. Evaluations and recommendations by national and inter-
national bodies  
In its 1996 National Occupational Research Agenda, the US NIOSH identified 
both hearing loss and multiple exposures as research priorities for the occupational 
safety and health community. In two publications, NIOSH also argued for broad-
ening the scope of risk assessment of hearing risks and preventive initiatives (280, 
282). NIOSH and the American College of Occupational and Environmental 
Medicine both recommend that hearing loss prevention programmes take chemical 
exposures into account when monitoring hazards, assessing hearing and controlling 
exposures (11, 280, 282). These recommendations do not include specific in-
formation on exposure levels of concern. 
ACGIH states that periodic audiograms are advised and should be carefully re-
viewed in settings where there may be exposures to noise and to carbon monoxide, 
lead, manganese, styrene, toluene or xylene. Other substances under investigations 
for ototoxic effects include arsenic, carbon disulphide, mercury and trichloro-
ethylene (7).  
In 1998, the US Army started requiring consideration of ototoxic chemical 
exposures for inclusion in hearing conservation programmes, “particularly when  
in combination with marginal noise” (375). 
The most detailed and specific recommendation to date is one offered in 2003 
by the US Army, in which it is stated that since the exposure threshold for oto-
toxic effects is not known, audiometric monitoring is necessary to find out if the 
substance is affecting the hearing of exposed workers. Yearly audiograms are re-
commended for workers whose airborne exposures (without regard to the use of 
respiratory protection) are at 50 % of the most stringent criteria for OELs (either  
of the US OSHA permissible exposure limit or the ACGIH threshold limit value) 
for toluene, xylene, n-hexane, organic tin, carbon disulphide, mercury, organic 
lead, hydrogen cyanide, diesel fuel, kerosene fuel, jet fuel, JP-8 fuel, organo-
phosphate pesticides or chemical warfare nerve agents, regardless of the noise 
level (376). 
Best practice guidelines recommending hearing tests for those exposed to 
ototoxic agents were also published in Australia and New Zealand, without 
information on exposure levels (20). Legislation regarding compensation for 
hearing loss associated with chemical exposure at work has changed in Australia 
(19) and Brazil (246) making it possible for workers to apply for compensation  
for hearing loss because of exposure to ototoxic chemicals in the workplace.  
In February 2003, the European Parliament published the Directive 2003/10/EC 
on minimum health and safety requirements regarding the exposure of workers to 
the risks arising from noise. In the Directive, it is stated that when carrying out 
risk assessments, employers should “…give particular attention to: any effects on 
workers’ health and safety resulting from interactions between noise and work-
related ototoxic substances…” (108). In April 2004, because of its demonstrated 
ototoxicity, toluene was labelled as R48/20: Danger of serious damage to health 
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by prolonged exposure through inhalation. It was stated that toluene-induced 
chronic impairment of auditory function had been demonstrated in a number of 
animal studies, substantiated by morphological evidence of cell loss in the rat 
cochlea and that existing data suggest that humans are sensitive to this effect at 
exposure levels which may be encountered in the working environment (106, 
107).  
Besides the present document, comprehensive evaluations of ototoxic sub-
stances (387) and of the hazards of combined workplace exposure to noise and 
ototoxic chemical substances (105) have recently been published by other bodies.  
The Canadian Occupational Health and Safety Research Institute (IRSST) (387) 
did not include data on the interaction between noise and chemicals. Still, the 
conclusions are in agreement with those of the present document in classifying 
lead and its inorganic compounds, toluene, styrene and trichloroethylene as 
“ototoxic substances”.  
The report published by the European Agency for Safety and Health (105) 
included noise interactions and focused on the qualitative properties of chemicals 
inducing ototoxic effects. The list of chemicals included is slightly different from 
that in the present document as is the rating strategy used. Still, conclusions are  
in agreement. The report from the European Agency also highlights policies from 
specific member states and the possible impact of the 2007 new regulations Re-
gistration, Evaluation, Authorisation and Restriction of Chemical substances 
(REACH), which will not be repeated here. 
13. Evaluation of human health risks 
13.1 Assessment of risks of hearing impairment 
Robust evidence from a large number of animal studies has demonstrated that 
toluene, styrene, solvent mixtures, lead and carbon monoxide (the latter only  
in combination with noise) are ototoxic. For these substances, the number of 
existing studies is relatively large, and comprehensive approaches have been  
taken in investigating their ototoxicity (testing of different exposure parameters 
and combinations of agents, attempting benchmark dose calculations, testing of 
hypothesis for the inhibition of the observed effects). 
Other chemicals that have been studied in less detail with respect to ototoxicity 
include xylenes, ethylbenzene, chlorobenzene, trichloroethylene, n-hexane, n-
heptane, carbon disulphide, mercury, organotins, hydrogen cyanide, acrylonitrile, 
IDPN, pesticides and PCBs. Hitherto, the existing evidence indicates that also 
these substances have ototoxic properties (in some cases, only with concurrent 
noise). 
Cochlear histopathology has been investigated in studies on several solvents, 
pesticides, PCBs, organotins and mercury, in conjunction with functional tests, 
often of evoked potentials. The studies have consistently demonstrated a greater 
effect with increasing exposure, independently of noise. This is also true for lead 
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exposures even if no cochlear histopathology reports were identified. However, an 
association between increasing blood lead levels and greater auditory dysfunction 
has been reported. 
For chemicals such as n-hexane, n-heptane, carbon disulphide, lead and mercury, 
the auditory effect is connected to the neurotoxic effect of these substances. Thus, 
they exhibit more central neurotoxic effects than pure ototoxic effects.  
Human data supports the evidence from animal studies that toluene, styrene, 
solvent mixtures and lead are ototoxic. Although less investigated, also trichloro-
ethylene, carbon disulphide, mercury, carbon monoxide and some pesticides have 
been associated with auditory effects in humans. Observed auditory effects of n-
hexane have been interpreted as a sign of its well-known central nervous system 
toxicity. No human studies on the ototoxicity of xylenes, ethylbenzene, chloro-
benzene, n-heptane, organotins, hydrogen cyanide, acrylonitrile, IDPN and PCBs 
were identified, even though xylenes, ethylbenzene and chlorobenzene are 
common components in solvent mixtures that have been shown to be ototoxic  
in humans.  
Early reports on solvents suggested that the exposure levels needed to cause an 
auditory effect in experimental animals were rather high in relation to OELs. In 
contrast, several occupational reports (on styrene, toluene, solvent mixtures and 
lead) indicated that much lower levels in industrial settings were associated with 
hearing deficits. The reasons for the difference between the lowest levels that 
cause an effect in humans and in animals, respectively, are not understood. How-
ever, recent research in animals has demonstrated that addition of other stressors 
(such as impact or continuous noise, other chemicals or drugs, or keeping the 
animals active during chemical exposure) reduces the lowest solvent exposure 
level needed to elicit an auditory effect (210, 233, 234).  
In contrast to experimental animals, humans are characterised by great indivi-
dual variability. The variability can be explained by genetic differences that create 
individual susceptibility for hearing loss, but also from individual differences in 
medical and exposure histories. This variability makes it challenging to characterise 
risk and to separate the effects of each agent in a combined exposure scenario,  
and to measure with precision the interaction between agents such as noise and 
chemicals. When investigating causal associations of a certain factor, it is of ut-
most importance to determine known medical factors such as past diseases, intake 
of certain ototoxic drugs, noise or head trauma accidents as well as non-medical 
risk factors such as leisure time or past occupational noise and/or chemical ex-
posures and life-style factors associated with the outcome to be investigated. In 
several of the reviewed investigations, this was accomplished by the examination 
of existing health or exposure records or by a questionnaire, while others did not 
report on even the most recognised confounders, such as noise exposure. Still, 
particularly in occupational studies, complete historical exposure information for 
hazards is rarely available. Given all these limitations, a large body of knowledge 
shows that hearing losses are more common in work settings where certain 
chemical exposures occur. Chemical-induced hearing losses are often moderate  
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to severe, as is also the case with noise-induced hearing loss. The audiometric 
high-frequency “notch” common in noise-induced hearing loss is often present 
following long-term chemical exposures, although some reports indicate that a 
wider range of audiometric frequencies are affected when compared to the range 
of frequencies affected by noise.  
It should also be noted that the prevalence of chemical-induced hearing loss 
(identified through pure-tone audiometry) varies across studies. This is often  
also the case in studies with noise-induced hearing loss, a finding that has been 
explained by the wide range of possible exposure scenarios and the modifying  
or confounding factors mentioned above. Further, different definitions of hearing 
loss have been used. Still, more relevant limitations are insufficient or unreliable 
exposure history data and lack of comparability between study and control groups 
regarding solvent and noise exposures. 
Mausner and Bahn stated that five conditions should be met before a causal 
relationship between exposure and disease is established (242). These conditions 
were: 1) exposure to the factor must antedate the onset of disease, 2) the asso-
ciation between exposure and outcome must be biologically plausible, 3) the 
outcome must be specific, 4) must be strong and 5) must be consistent with other 
findings. 
The first criterion could not be evaluated in the reviewed human studies because 
of the study design.  
The second criterion of biological plausibility was considered by most pub-
lications reviewed in the present document. Thus, robust animal research has 
indicated that the reviewed chemicals have ototoxic properties. Many of these 
chemicals also have recognised neurotoxic properties and the mechanisms of 
action of neurotoxicants lend support to the possibility of central auditory effects 
of chemicals such as solvents, metals, asphyxiants and pesticides (23, 311, 326, 
352, 396). 
In several of the reviewed studies, central auditory tests were performed to com-
plement the findings from pure-tone audiometry in workers exposed to solvents  
or metals (136, 137, 187, 254, 257, 301, 379, 395, 396). Although noise is parti-
cularly damaging to the cochlea, industrial chemicals can affect both the cochlear 
structures and the central auditory system. This means that not only the detection 
but also the discrimination of sounds may be impaired (i.e. not only will sounds  
be perceived as less loud, but also as distorted). Such audiological test results 
indicate that the third criterion, which addresses specificity of response, was met 
in the case of organic solvents and lead. With solvents, both peripheral and central 
effects have been confirmed in several studies. Lead has been clearly associated 
with central auditory effects. 
The fourth criterion for evaluating the likelihood of a causal association is the 
strength of an association as expressed in the ratios of disease in exposed versus 
non-exposed, which should be analysed for each study.  
Finally, as Mausner and Bahn stated, support for the causal nature of an associ-
ation exists if the findings persist in other study populations (242). As discussed 
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earlier, with some exceptions (toluene, styrene and solvents mixtures), there are 
only a few studies on the ototoxicity of industrial chemicals, most of which have 
been conducted with experimental animals. Still, they indicate that chemicals 
found in the workplace can have deleterious effects on the auditory system. 
In summary, the findings of the association between industrial chemical exposure 
and hearing impairments are biologically plausible, the association between ex-
posure and outcome is strong, but because of the large confidence intervals, the 
possibility of no effect exists. The association is confined to specific effects on the 
auditory system.  
In 2008, Hoet and Lison proposed a “noise notation” inspired by the widely 
used “skin notation” (skin notation criteria were introduced almost 50 years ago  
as a qualitative indicator of a hazard related to dermal absorption at work). They 
suggested that “a noise notation” could be added to the OELs of chemical agents 
for which there is significant concern about a possible ototoxic effect, e.g. when 
experimental data suggest that ototoxicity is the critical health effect or that oto-
toxic effects occur at a level close to the OEL (160). 
As combined exposure (e.g. chemical and noise) is currently not taken care of  
in the regular OEL setting procedure, a noise notation can be used to indicate an 
increased risk of hearing loss after exposure to the chemical with concurrent noise 
exposure. 
13.2 Groups at extra risk 
There is no firm evidence to identify groups of humans at extra risk for developing 
hearing impairment. However, factors that have been shown to influence the 
occurrence and degree of hearing loss other than noise and chemicals include age, 
foetal and neonatal development, gender, race, socio-economic and life-style 
factors, physical work load and use of medications (94, 372). 
Age 
Age is an important factor to consider when examining hearing disorders. Animal 
experiments suggest that young animals are more susceptible to the effects of 
noise (198, 290) than older ones. Similarly, young rats (14 weeks of age) were 
more vulnerable to the effects of styrene than aged rats (49). Toluene and noise 
were found to accelerate the age-related hearing loss in mice with a genetic pre-
disposition for age-induced hearing loss, but not in mice from a strain without  
this predisposition (218). These studies suggest that younger populations may be 
more susceptible to hearing loss, but that has not yet been clearly demonstrated  
in humans. On the other hand, toughening of ears through low intensity noise 
exposures has been demonstrated in animals and might make young ears more 
resistant to noise (316, 355).  
Foetal and neonatal development  
Ototoxic effects of chemical exposure of rats during pregnancy and early lactation 
(a period in which the auditory system develops rapidly in rats) were investigated 
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for toluene, lead, mercury, IDPN and PCBs and were demonstrated in the offspring 
(76, 144, 145, 153, 154, 162, 204, 332). Similar findings have not been reported in 
humans. 
Gender and race  
Gender and race seem to be associated with susceptibility to noise-induced hearing 
loss. Studies conducted with groups with similar jobs and exposures have indicated 
that Caucasian males have poorer auditory thresholds and higher prevalence of 
noise-induced hearing loss, while African American females have the lowest pre-
valence of hearing loss (91, 365). The issue of gender is not fully understood since 
both environmental and occupational noise exposure histories can be heavily 
influenced by gender. The issue of race and susceptibility to noise could be ex-
plained by the protective role played by the presence of melanine in the inner ear 
(24, 25). Regarding solvents, albino and pigmented rats have been used in oto-
toxicity experiments and both species are susceptible to auditory effects but no 
formal investigation compared species for this specific feature. Eastman, Young 
and Fechter examined the role of melanine following animal exposures to tri-
methyltin and did not observe significant effects (93).  
Socio-economic and life-style factors 
Low social class in childhood and adulthood was also found to be associated with 
poorer hearing thresholds (94) and is likely to interact with occupational risks, 
leisure noise or non-occupational chemical exposures, and medical history factors 
such as middle ear disease, lack of appropriate treatment or use/abuse of medi-
cation.  
Studies on the interaction between hearing loss and smoking indicate that heavy 
smoking can affect hearing (41, 343, 383) and interact with noise, thus causing a 
more severe hearing loss in humans (176, 247, 353, 372). Other epidemiological 
investigations of solvents have controlled for smoking and no significant associa-
tions were reported (254, 256, 257, 346, 348). Similarly, epidemiological studies 
(176, 254, 256, 257, 346, 348) have not confirmed that alcohol consumption 
potentiates the effect of solvent exposure on hearing as demonstrated in animals 
(44). Information about alcohol consumption can be considered sensitive and is 
thereby difficult to obtain in human studies. 
Physical workload 
Physical exercise has been shown to increase the susceptibility to noise (87, 224). 
It has also been demonstrated that styrene concentrations required to induce audi-
tory damage were much lower for active rats in comparison to sedentary rats 
(210). Studies indicate that the total absorbed styrene dose can be increased six-
fold with physical work and increased respiratory rate (96). It has been suggested 
that auditory effects of solvents may be observed at lower concentrations in 
humans because humans are generally exposed to solvents in combination with  
a multitude of other factors (several combined exposures, physical demands, etc.), 
whereas animal experiments typically involve isolated chemical exposures (210). 
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Medication 
Finally, the ototoxicity of therapeutic drugs has been recognised for a long time 
(Table 2) but their interaction with work-related risk factors has rarely been 
examined. A synergistic interaction between acetyl salicylic acid and toluene was 
shown by Johnson. Acetyl salicylic acid did not cause hearing loss but potentiated 
the ototoxic effect caused by toluene (182). These results might be of interest since 
pain killers of this type in lower doses are likely to be used by workers including 
those exposed to toluene. 
13.3 Scientific basis for occupational standards  
Ototoxicity in animals has been reported for all substances included in this review. 
Except for hydrogen cyanide, ototoxicity has only been observed at high exposure 
levels (far above most common OELs). For some substances, data for combined 
chemical and noise exposure are also available. 
Auditory effects have also been indicated in humans for all substances covered 
in this document for which there are data. However, most human studies lack in-
formation on historic as well as current peak chemical and noise exposure. Styrene 
and toluene are the substances most studied to date, because of the ubiquity in use 
and the magnitude of the exposed populations.  
As combined exposure (e.g. chemical and noise) is currently not taken care of  
in the regular OEL setting procedure, a noise notation can be used to indicate an 
increased risk of hearing loss after exposure to the chemical at a level close to the 
OEL (or biological exposure limit) with concurrent noise exposure.  
The strength of evidence for ototoxicity differs between the agents covered but 
falls basically into three categories discussed in the following: 
 
1) Human data indicate auditory effects under or near existing OELs. There  
are also robust animal data supporting an effect on hearing from exposure. 
2) Human data are lacking whereas animal data indicate an auditory effect  
under or near existing OELs. 
3) Human data are poor or lacking. Animal data indicate an auditory effect  
well above existing OELs.  
 
Category 1. Human data indicate auditory effects under or near existing OELs. 
There are also robust animal data supporting an effect on hearing from exposure. 
 
Styrene In occupational studies, the lowest current exposure levels associated with 
hearing loss were 3.5-22 ppm. One study demonstrated that an average work-life 
styrene exposure of 14 ppm was associated with an increased risk for hearing loss. 
Noise levels in these studies were below 85 dB. A synergistic interaction with noise 
was demonstrated in animals only above the lowest effect level for styrene alone. 
In humans, the interaction with noise is not clear.  
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Toluene In some occupational studies, ototoxic effects have been associated with 
current exposure levels of approximately 10-50 ppm. Historic toluene and/or noise 
levels were not well characterised. In one study, chronic exposure to an average of 
97 ppm caused hearing loss but noise levels were not given. No auditory effects 
were observed in a study in which both current and historic levels of toluene were 
up to 50 ppm and noise levels were low. A synergistic interaction with noise was 
demonstrated in animals only at high levels. In humans, the interaction with noise 
is not clear. 
 
Carbon disulphide The less investigated solvent carbon disulphide increased the 
risk for hearing loss significantly at current occupational exposure levels of 3-8 
ppm (noise levels not reported but expected to be rather high) and above 14 ppm 
(noise levels at 80-91 dB), respectively. No animal studies investigating inter-
action with noise were identified.  
 
Lead In occupational studies, current and life-time weighted average blood  
levels of 28-57 µg/dl (i.e. levels also found in the general population) have  
been associated with auditory effects. Effects in monkeys have been reported at 
approximately the same levels. Noise levels were not reported in most studies, 
since they focused on central auditory effects. The only study that controlled for 
noise did not detect an interaction between lead and noise exposure in humans. 
 
Mercury The human data are weak but a few studies indicate auditory effects 
around the current biological exposure limits. Interaction with noise was not 
studied, neither in animals nor humans.  
 
Carbon monoxide The animal data are strong. Without concomitant noise exposure, 
no auditory effects were reported in rats at high exposure levels. However, com-
bined exposure to carbon monoxide and noise produced unexpectedly, large and 
permanent thresholds shift even in scenarios in which noise exposure alone had  
no effect. Decreasing noise exposure did not always decrease the severity of the 
auditory effect. Human data are sparse but suggest that carbon monoxide can 
affect hearing even in the absence of excessive noise exposure. The only dose-
response data identified (based on two individuals) indicated an effect at 16-35 
ppm in combination with noise. 
 
Category 2. Human data are lacking whereas animal data indicate an auditory 
effect under or near existing OELs. 
 
Xylenes p-Xylene, but not m- or- o-xylene, has shown to be ototoxic in rats at high 
levels. However, combined exposure to a mixture containing only 50 ppm each of 
p-xylene and ethylbenzene (as well as the other xylene isomers) caused enhanced 
auditory effects compared to ethylbenzene alone in rats. The interaction with noise 
was not studied.  
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Ethylbenzene Auditory effects of ethylbenzene have been demonstrated in rats  
at 200 ppm and at 50 ppm in combination with p-xylene (see above, the lowest 
doses tested). A synergistic interaction with noise was shown at 300 ppm, the  
only exposure level tested.  
 
Hydrogen cyanide In the only study available, hydrogen cyanide alone was not 
ototoxic at levels up to 50 ppm in rats but potentiated noise-induced hearing loss 
at 30 ppm. The lower bounds for benchmark doses that affected the auditory 
thresholds were 2-16 ppm. 
 
Category 3. Human data are poor or lacking. Animal data indicate an auditory 
effect well above existing OELs.  
 
Trichloroethylene Available studies indicate that trichloroethylene may be oto-
toxic in humans, but exposure levels were not reported and there was also a lack 
of data on noise and possible co-exposures to other chemicals. In one animal study, 
high trichloroethylene exposure was shown to interact synergistically with noise. 
 
n-Hexane Auditory effects in workers have been interpreted as a sign of the 
substance’s well-known central nervous system toxicity. 
 
Trimethyltin In animal studies, trimethyltin (intraperitoneal injection) disrupted 
auditory function (effects on the peripheral auditory system) at doses far below 
those shown to elicit general neurotoxicity. Interaction with noise was not studied. 
No human studies were identified. 
 
Chlorobenzene and n-heptane Only one animal study was identified for each 
substance and no human studies were identified.  
 
Solvent mixtures Effects on the auditory system have been indicated in several 
occupational studies.  
 
Acrylonitrile In animal studies, acrylonitrile (subcutaneous injection) alone was 
not ototoxic but potentiated noise-induced hearing loss at a high dose (only dose 
tested). No human data were identified. 
 
IDPN Auditory effects in humans have not been investigated. 
 
Pesticides Effects on the auditory system have been indicated in several 
occupational studies.  
 
PCB mixtures as well as the individual congener PCB 126 have not been in-
vestigated for auditory effects in humans.  
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14. Research needs 
The state-of-the art and research needs in the area of ototoxic chemicals have been 
examined in two workshops (in 2002 and 2006) dedicated to the issue (253, 351). 
Consensus on research needs was reached by the participant experts on several 
topics presented below. 
OELs are often based on an adverse health effect detected at the lowest exposure 
level. The auditory system is not an endpoint tested routinely but consideration 
should be given to including it in a toxicity evaluation battery. It could also be 
used as an early indicator of neurotoxicity. 
Because of the enormous number of existing industrial chemicals and the 
thousands of new ones that are placed in the market every year, it is of crucial 
importance to understand the mechanisms by which chemicals affect the auditory 
system. Such an understanding could lead to a prediction of which chemicals to 
target by preventive efforts. This is a very complex task, a challenge that was 
scrutinised by Fechter (115, 116). 
Some of the specific issues to be considered in mechanistic research include: 
• Different species respond differently to the studied chemicals. Examining these 
differences could offer clues to the mechanism of ototoxicity. 
• Toxic interactions among agents present the need to manipulate exposure 
parameters: doses, duty cycles, presentation order (sequential or simultaneous 
exposures).  
• Physical or endogenous factors should also be taken into consideration: health 
status of the study participants (blood pressure, respiration, etc.), genetics, and 
age. 
Identifying priority chemicals is of utmost importance, not only for research 
purposes but also for establishing recommendations or identifying best practices 
for hearing loss prevention. The potential for human exposure and the magni- 
tude of exposed populations is an important factor in giving priority to a specific 
chemical. A second criterion for the inclusion of a chemical in the research 
priority list is evidence of the chemical’s ototoxicity, general toxicity as well as 
neurotoxicity (since most of the chemicals found to affect the auditory system  
are potentially neurotoxic). Information on whether a chemical produces ROS 
could also help in the decision to examine that agent’s ototoxicity (253, 351).  
A few studies of the reviewed chemicals have reported effects in the vestibular 
system and balance function (252, 271, 277, 301, 373, 395, 397, 398). Their 
findings underscore the need for further research on this outcome. 
The issue of how the ototoxicity of chemicals should be assessed in humans 
through audiological tests needs further investigation. When pure-tone audio- 
metry is the only test performed, information by means of a questionnaire on 
speech discrimination difficulties or other auditory problems that are inconsistent 
with pure-tone thresholds can help in detecting some of the effects by chemicals 
on the auditory system. Comparing prevalences of hearing disorders between 
groups with different exposure conditions and calculating risk ratios may also 
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allow for the detection of effects caused by chemicals. A more robust approach 
involves auditory testing to assess more central portions of the auditory system,  
as a complement to the findings from pure-tone audiometry and a help in di-
stinguishing between noise and chemically induced effects.  
A golden standard auditory test battery is not yet available. Although ideal,  
a comprehensive audiological test battery in occupational studies may not be 
feasible because of time and cost constraints. Screening workers to select those 
who should undergo further testing can also prove to be a fruitful approach.  
When selecting hearing tests, administration time, ease of analysis, sensitivity  
and specificity, and the site of the auditory system should be evaluated. 
Dose-response information for ototoxicity is needed for most of the chemicals 
in this document. Such information could be used in the examination of inclusion 
criteria for workers exposed to chemicals (alone or in combination with noise)  
in hearing loss prevention programmes. Such expansion of the current re-
commendation to incorporate also chemical exposures would consequently  
require examination of the recommended action to be taken. 
 
In summary, research needs on ototoxic chemicals include: 
• Assessing potential interactions to allow for decision making on strategic 
directions and priorities of mixed exposures research. 
• Evaluating mechanisms of interaction to provide a rational basis for extra-
polation of toxicological information across different mixtures, dose levels, 
exposure parameters and routes. 
• Conducting multidisciplinary epidemiological investigations, which include 
careful mixed-exposure assessment, preferably collected by personal air 
monitoring and biological monitoring. 
• Evaluating non-occupational risk factors and individual variability in response  
to occupational environmental and organisational factors. 
• Improving the toxicity testing of new chemicals to properly evaluate their 
ototoxicity. 
• Identifying levels of simultaneous noise and specific chemicals’ exposures  
that can be considered safe to the human auditory system. 
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15. Summary  
Johnson A-C, Morata TC. The Nordic Expert Group for Criteria Documentation 
of Health Risks from Chemicals. 142. Occupational exposure to chemicals and 
hearing impairment. Arbete och Hälsa 2010;44(4):1-177. 
 
Research conducted over the last two decades has brought attention to the oto-
toxicity of chemicals in the workplace and their interaction with noise. Chemicals 
that have been specifically studied for their ototoxicity include solvents, metals, 
asphyxiants, PCBs and pesticides. 
Noise exposure is particularly damaging to the cochlea, a part of the peripheral 
auditory system, whereas chemicals tend to affect both the cochlear structures and 
the central auditory system. Reduced blood flow and free radical formation are im-
portant ototoxic mechanisms shared by noise and chemical exposures. Solvents 
and asphyxiants may also disrupt intrinsic anti-oxidant defences and make the ear 
more vulnerable to the effects of e.g. noise exposure. 
The chemicals reviewed in the present document have all been associated with 
auditory effects in animals. Some of the solvents and the asphyxiants interact 
synergistically with noise or potentiate noise effects on the auditory system. Com-
binations of chemical exposure with noise and other stressors such as physical 
activity during exposure may lower the concentration of the chemical exposure 
necessary for induction of an auditory effect.  
Auditory effects have also been indicated in humans for all agents covered in 
this document for which there are data. Noise is often present in the occupational 
arena, which makes prediction of the outcome challenging. 
As combined exposure (e.g. chemical and noise) is currently not taken care of in 
the regular occupational exposure limit (OEL) setting procedure, a noise notation 
can be used to indicate an increased risk of hearing loss after exposure to the 
chemical at a level close to the OEL with concurrent noise exposure. The strength 
of evidence for ototoxicity differs between the agents but falls basically into three 
categories, i.e. agents for which:  
1) human data indicate auditory effects under or near existing OELs and robust 
animal data support an effect on hearing from exposure (styrene, toluene, 
carbon disulphide, lead, mercury and carbon monoxide), 
2) human data are lacking whereas animal data indicate auditory effects under  
or near existing OELs (p-xylene, ethylbenzene and hydrogen cyanide), 
3) human data are poor or lacking and animal data indicate an auditory effect  
well above the existing OELs (chlorobenzene, trichloroethylene, n-hexane,  
n-heptane, some solvent mixtures, trimethyltin, acrylonitrile, 3,3'-iminodi-
propionitrile, pesticides and PCBs). 
 
Keywords: asphyxiant, auditory, hearing, metal, noise, occupational exposure 
limit, ototoxic, PCB, pesticide, review, risk assessment, solvent. 
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16. Summary in Swedish  
Johnson A-C, Morata TC. The Nordic Expert Group for Criteria Documentation 
of Health Risks from Chemicals. 142. Occupational exposure to chemicals and 
hearing impairment. Arbete och Hälsa 2010;44(4):1-177. 
Att kemikalier som är vanliga i arbetslivet kan vara skadliga för hörseln och också 
kan samverka med buller har uppmärksammats i forskningsrapporter de senaste 20 
åren. De kemiska ämnen som speciellt har uppmärksammats som hörselskadande 
är lösningsmedel, metaller, cellandningshämmare, PCB och bekämpningsmedel.  
Buller ger främst skador på det perifera hörselsystemet genom att påverka hår-
cellerna i innerörat medan kemiska ämnen kan orsaka skador både på det perifera 
och centrala hörselsystemet. Både exponering för buller och ototoxiska kemikalier 
kan orsaka skador i innerörat via gemensamma mekanismer såsom minskat blod-
flöde och bildandet av fria radikaler. Lösningsmedel och cellandningshämmare 
kan också störa eller hindra kroppens eget antioxidantförsvar mot fria radikaler 
och därmed göra innerörat mer mottagligt för skador av t.ex. buller.  
Alla kemiska ämnen som presenteras i denna översikt har i djurförsök visats  
ha en effekt på hörseln. Några av lösningsmedlen och cellandningshämmarna kan 
interagera med buller och potentiera bullrets skadliga effekter på hörselsystemet. 
Exponering för kemikalier i kombination med buller, andra kemikalier eller 
faktorer såsom fysisk aktivitet har visats kunna ge hörselskador vid lägre nivåer  
än exponering enbart för ett kemiskt ämne. 
Humandata saknas för flera av ämnena i denna översikt. För de ämnen som 
studerats har dock tecken på hörselpåverkan också setts hos människa. Buller 
förekommer ofta på samma arbetsplatser som kemiska ämnen, vilket gör effekten 
svår att förutsäga. 
Kombinationsexponeringar (t.ex. för kemikalier och buller) hanteras för när-
varande inte i gränsvärdessättningen. En bullermärkning skulle därför kunna 
användas för att uppmärksamma en ökad risk för hörselskador efter exponering 
för en kemikalie vid nivåer nära gränsvärdet vid samtidig bullerexponering.  
Styrkan i data som visar ototoxicitet varierar för de olika kemiska ämnena  
men faller huvudsakligen i tre kategorier, dvs. ämnen för vilka: 
1) humandata antyder hörselpåverkan vid nivåer under eller i närheten av nu-
varande gränsvärden och starka djurdata stöder att hörselskador uppkommer 
efter exponering (styren, toluen, koldisulfid, bly, kvicksilver och kolmonoxid), 
2) humandata saknas men djurdata antyder effekter på hörseln vid nivåer under 
eller i närheten av nuvarande gränsvärden (p-xylen, etylbensen och cyanväte), 
3) humandata är svaga eller saknas och djurdata antyder hörselpåverkan klart över 
nuvarande gränsvärden (klorbensen, trikloretylen, n-hexan, n-heptan, vissa 
lösningsmedelsblandningar, trimetyltenn, akrylnitril, 3,3'-iminodipropionitril, 
pesticider och PCB).  
Nyckelord: bekämpningsmedel, buller, cellandningshämmare, hygieniskt gräns-
värde, hörsel, lösningsmedel, metaller, ototoxisk, PCB, riskbedömning, översikt. 
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18. Data bases used in the search for literature  
Experimental and epidemiological studies included in this review were identified 
through a literature search covering the period between 1950 and November 2007. 
The search was not limited to studies published in English. Full-text copies of 
each of these articles were obtained and read in detail by at least one of the 
authors. In addition, the bibliography of each article was scanned to identify 
potential references that were missed by our searches. All studies were collected 
without consideration of research design. Databases searched included:  
 
PubMed (US NLM) 
Toxline (US NLM)  
NIOSHTIC-2 (US NIOSH)  
Arbline (Stockholm University, Sweden)  
RISKLINE (Swedish Chemicals Agency)  
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 Aperfeiçoamento de Pessoal de Nível Superior, Brazil) 
 
A final search in PubMed was performed in February 2010. 
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Appendix 2. Previous NEG criteria documents 
NEG criteria documents published in the scientific serial Arbete och Hälsa (Work 
and Health): 
 
Substance/Agent Arbete och Hälsa issue 
Acetonitrile 1989:22, 1989:37* 
Acid aerosols, inorganic 1992:33, 1993:1* 
Acrylonitrile 1985:4 
Allyl alcohol 1986:8 
Aluminium 1992:45, 1993:1* 
Ammonia 1986:31, 2005:13* 
Antimony 1998:11* 
Arsenic, inorganic 1981:22, 1991:9, 1991:50* 
Arsine 1986:41 
Asbestos 1982:29 
Benomyl 1984:28 
Benzene 1981:11 
1,2,3-Benzotriazole 2000:24*D 
Boric acid, Borax 1980:13 
1,3-Butadiene 1994:36*, 1994:42 
1-Butanol 1980:20 
γ-Butyrolactone 2004:7*D 
Cadmium 1981:29, 1992:26, 1993:1* 
7/8 Carbon chain aliphatic monoketones 1990:2*D 
Carbon monoxide 1980:8 
Ceramic Fibres, Refractory 1996:30*, 1998:20 
Chlorine, Chlorine dioxide 1980:6 
Chloromequat chloride 1984:36 
4-Chloro-2-methylphenoxy acetic acid 1981:14 
Chlorophenols 1984:46 
Chlorotrimethylsilane 2002:2 
Chromium 1979:33 
Cobalt 1982:16, 1994:39*, 1994:42 
Copper 1980:21 
Creosote 1988:13, 1988:33* 
Cyanoacrylates 1995:25*, 1995:27 
Cyclic acid anhydrides 2004:15*D 
Cyclohexanone, Cyclopentanone 1985:42 
n-Decane 1987:25, 1987:40* 
Deodorized kerosene 1985:24 
Diacetone alcohol 1989:4, 1989:37* 
Dichlorobenzenes 1998:4*, 1998:20 
Diesel exhaust 1993:34, 1993:35* 
Diethylamine 1994:23*, 1994:42 
2-Diethylaminoethanol 1994:25*N 
Diethylenetriamine 1994:23*, 1994:42 
Diisocyanates 1979:34, 1985:19 
Dimethylamine 1994:23*, 1994:42 
Dimethyldithiocarbamates 1990:26, 1991:2* 
Dimethylethylamine 1991:26, 1991:50* 
Dimethylformamide 1983:28 
Dimethylsulfoxide 1991:37, 1991:50* 
Dioxane 1982:6 
Enzymes, industrial 1994:28*, 1994:42 
Epichlorohydrin 1981:10 
Ethyl acetate 1990:35* 
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Ethylbenzene 1986:19 
Ethylenediamine 1994:23*, 1994:42 
Ethylenebisdithiocarbamates and Ethylenethiourea 1993:24, 1993:35* 
Ethylene glycol 1980:14 
Ethylene glycol monoalkyl ethers 1985:34 
Ethylene oxide 1982:7 
Ethyl ether 1992:30* N 
2-Ethylhexanoic acid 1994:31*, 1994:42 
Flour dust 1996:27*, 1998:20 
Formaldehyde 1978:21, 1982:27, 2003:11*D 
Fungal spores 2006:21* 
Furfuryl alcohol 1984:24 
Gasoline 1984:7 
Glutaraldehyde 1997:20*D, 1998:20 
Glyoxal 1995:2*, 1995:27 
Halothane 1984:17 
n-Hexane 1980:19, 1986:20 
Hydrazine, Hydrazine salts 1985:6 
Hydrogen fluoride 1983:7 
Hydrogen sulphide 1982:31, 2001:14*D 
Hydroquinone 1989:15, 1989:37* 
Industrial enzymes 1994:28* 
Isoflurane, sevoflurane and desflurane 2009;43(9)* 
Isophorone 1991:14, 1991:50* 
Isopropanol 1980:18 
Lead, inorganic 1979:24, 1992:43, 1993:1* 
Limonene 1993:14, 1993:35* 
Lithium and lithium compounds 2002:16* 
Manganese 1982:10 
Mercury, inorganic 1985:20 
Methacrylates 1983:21 
Methanol 1984:41 
Methyl bromide 1987:18, 1987:40* 
Methyl chloride 1992:27*D 
Methyl chloroform 1981:12 
Methylcyclopentadienyl manganese tricarbonyl 1982:10 
Methylene chloride 1979:15, 1987:29, 1987:40* 
Methyl ethyl ketone 1983:25 
Methyl formate 1989:29, 1989:37* 
Methyl isobutyl ketone 1988:20, 1988:33* 
Methyl methacrylate 1991:36*D 
N-Methyl-2-pyrrolidone  1994:40*, 1994:42 
Methyl-tert-butyl ether 1994:22*D 
Microbial volatile organic compounds (MVOCs) 2006:13* 
Microorganisms 1991:44, 1991:50* 
Mineral fibers 1981:26 
Nickel 1981:28, 1995:26*, 1995:27 
Nitrilotriacetic acid 1989:16, 1989:37* 
Nitroalkanes 1988:29, 1988:33* 
Nitrogen oxides 1983:28 
N-Nitroso compounds 1990:33, 1991:2* 
Nitrous oxide 1982:20 
Oil mist 1985:13 
Organic acid anhydrides 1990:48, 1991:2* 
Ozone 1986:28 
Paper dust 1989:30, 1989:37* 
Penicillins 2004:6* 
Permethrin 1982:22 
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Petrol 1984:7 
Phenol 1984:33 
Phthalate esters 1982:12 
Platinum 1997:14*D, 1998:20 
Polyethylene,  1998:12* 
Polypropylene, Thermal degradation products in the 
processing of plastics 
1998:12* 
Polystyrene, Thermal degradation products in the 
processing of plastics 
1998:12* 
Polyvinylchloride, Thermal degradation products in the 
processing of plastics 
1998:12* 
Polytetrafluoroethylene, Thermal degradation products 
in the processing of plastics 
1998:12* 
Propene 1995:7*, 1995:27 
Propylene glycol 1983:27 
Propylene glycol ethers and their acetates 1990:32*N  
Propylene oxide 1985:23 
Refined petroleum solvents 1982:21 
Refractory Ceramic Fibres 1996:30* 
Selenium 1992:35, 1993:1* 
Silica, crystalline 1993:2, 1993:35* 
Styrene 1979:14, 1990:49*, 1991:2 
Sulphur dioxide 1984:18 
Sulphuric, hydrochloric, nitric and phosphoric acids 2009;43(7)* 
Synthetic pyretroids 1982:22 
Tetrachloroethane 1996:28*D 
Tetrachloroethylene 1979:25, 2003:14*D 
Thermal degradation products of plastics 1998:12* 
Thiurams 1990:26, 1991:2* 
Tin and inorganic tin compounds 2002:10*D 
Toluene 1979:5, 1989:3, 1989:37*, 2000:19* 
1,1,1-Trichloroethane 1981:12 
Trichloroethylene 1979:13, 1991:43, 1991:50* 
Triglycidyl isocyanurate 2001:18* 
n-Undecane 1987:25, 1987:40* 
Vanadium 1982:18 
Vinyl acetate 1988:26, 1988:33* 
Vinyl chloride 1986:17 
Welding gases and fumes 1990:28, 1991:2* 
White spirit 1986:1 
Wood dust 1987:36 
Xylene 1979:35 
Zinc 1981:13 
* in English, remaining documents are in a Scandinavian language.  
D = collaboration with the Dutch Expert Committee on Occupational Safety (DECOS).  
N = collaboration with the US National Institute for Occupational Safety and Health (NIOSH).  
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